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ABSTRACT 
 
BIOMATERIAL-MEDIATED REPROGRAMMING OF THE WOUND INTERFACE 
TO ENHANCE MENISCAL REPAIR 
 
Feini Qu 
Robert L. Mauck 
 
Endogenous repair of fibrous connective tissues is limited, and there exist few successful 
strategies to improve healing after injury. As such, new methods that advance repair by 
enhancing cell migration to the wound interface, extracellular matrix (ECM) production, 
and tissue integration would represent a marked clinical advance. Using the adult 
meniscus as a test platform, we hypothesized that ECM density and stiffness increase 
throughout tissue maturation, and that these age-related changes present biophysical 
barriers to interstitial cell migration during wound healing. We further posited that 
modulating the matrix could remove these impediments, enabling endogenous cells to 
reach the injury site. To test our hypotheses, we compared the microenvironment of fetal 
and adult meniscal ECM via atomic force microscopy (AFM) indentation and second 
harmonic generation (SHG) imaging of the collagenous matrix. We also explored 
interstitial cell mobility through fetal and adult native tissue environments using a three-
dimensional ex vivo system. We further investigated strategies that might expedite cell 
migration, including enzymatic degradation of the ECM with collagenase to reduce matrix 
stiffness and increase porosity. To restrict these biological manipulations to the wound 
interface, we fabricated a delivery system in which selected biofactors were stored inside 
composite electrospun nanofibrous scaffolds and released upon hydration. The ability for 
bioactive scaffolds to enhance the cellularity and integration of meniscal injuries was 
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evaluated in vivo using tissue explants in a subcutaneous implantation model, as well as 
an orthotopic meniscal injury model. Our findings suggest that matrix stiffness, density, 
and organization increase with meniscal development at the expense of cell mobility. Our 
results also indicate that partial digestion of the wound interface with collagenase 
improves repair by creating a more compliant and porous microenvironment that facilitates 
cell migration. Furthermore, when scaffolds containing collagenase-releasing fibers were 
placed inside meniscal defects, enzymatic digestion was localized and resulted in 
improved cellular colonization and closure of the wound site, similar to treatment with 
aqueous collagenase. This innovative approach of targeted delivery may aid the many 
patients that exhibit meniscal tears by promoting integrative repair, thereby circumventing 
the pathologic consequences of partial meniscus removal, and may find widespread 
application in the treatment of injuries to a variety of dense connective tissues. 
 viii 
 
TABLE OF CONTENTS 
 
ACKNOWLEDGMENTS.................................................................................................iii 
ABSTRACT....................................................................................................................vi 
LIST OF TABLES ........................................................................................................ xiii 
LIST OF FIGURES ....................................................................................................... xiv 
CHAPTER 1: INTRODUCTION ................................................................................ 1 
CHAPTER 2: BASIC SCIENCE OF MENISCUS REPAIR: LIMITATIONS AND 
EMERGING STRATEGIES ............................................................................................ 5 
2.1 Abstract .......................................................................................................... 5 
2.2 Introduction .................................................................................................... 5 
2.3 Endogenous Limitations to Meniscal Repair................................................ 9 
2.3.1 Vascular Supply .......................................................................................10 
2.3.2 Cell and Matrix Density ............................................................................11 
2.3.3 Soluble and Mechanical Factors ...............................................................13 
2.4 Emerging Strategies to Promote Meniscal Repair ......................................13 
2.4.1 Methods to Enhance Vascularity ..............................................................14 
2.4.2 Methods to Improve Cellularity .................................................................18 
2.4.3 Influence of Soluble Factors .....................................................................21 
2.4.4 Influence of Mechanical Factors ...............................................................24 
2.5 Summary and Future Directions ..................................................................26 
2.6 Acknowledgments .........................................................................................27 
CHAPTER 3: CELL MIGRATION IN 3D ENVIRONMENTS: IMPLICATIONS FOR 
FIBROUS WOUND REPAIR AND TISSUE ENGINEERING .........................................29 
3.1 Abstract .........................................................................................................29 
3.2 Introduction ...................................................................................................29 
3.3 Cellular Factors Affecting 3D Migration.......................................................31 
3.3.1 Cell Adhesion and Mechanotransduction .................................................31 
 ix 
 
3.3.2 Nuclear Mechanics ...................................................................................33 
3.3.3 Cell-Mediated Matrix Degradation ............................................................35 
3.4 Extracellular Matrix Factors Affecting 3D Migration ...................................36 
3.4.1 Matrix Micromechanics .............................................................................37 
3.4.2 Matrix Microstructure ................................................................................40 
3.4.3 Biochemical Signals .................................................................................42 
3.5 Role of Cell Migration in Dense Connective Tissue Repair ........................43 
3.5.1 Phases of Wound Repair ..........................................................................44 
3.5.2 Cellular and Extracellular Changes with Age ............................................45 
3.6 Cell Migration in Engineered Materials ........................................................48 
3.6.1 Scaffold Micromechanics ..........................................................................49 
3.6.2 Scaffold Microstructure .............................................................................52 
3.6.3 Biochemical Signals .................................................................................55 
3.7 Summary and Future Directions ..................................................................58 
CHAPTER 4: BIOMATERIAL-MEDIATED DELIVERY OF DEGRADATIVE 
ENZYMES TO IMPROVE MENISCUS INTEGRATION AND REPAIR ..........................60 
4.1 Abstract .........................................................................................................60 
4.2 Introduction ...................................................................................................61 
4.3 Methods and Materials ..................................................................................64 
4.3.1 Preparation and Culture of Meniscal Repair Constructs ...........................64 
4.3.2 Histological, Biochemical, and MicroCT Analysis......................................65 
4.3.3 Fabrication and Characterization of Enzyme-Releasing Nanofibers .........66 
4.3.4 Fabrication and Characterization of Collagenase-Releasing Nanofibers ..67 
4.3.5 Scaffold-Mediated Degradation of the Meniscal Interface .........................68 
4.3.6 Statistical Analyses ..................................................................................69 
4.4 Results ...........................................................................................................69 
4.4.1 Partial Enzymatic Degradation Enhances Meniscal Integration ................69 
4.4.2 Nanofibers Store and Deliver Bioactive Enzymes .....................................71 
4.4.3 Nanofibrous Composites Localize Enzyme Release to the Wound Site ....74 
4.5 Discussion .....................................................................................................76 
4.6 Conclusions ...................................................................................................81 
4.7 Acknowledgements .......................................................................................81 
 x 
 
CHAPTER 5: REPAIR OF DENSE CONNECTIVE TISSUES VIA BIOMATERIAL-
MEDIATED MATRIX REPROGRAMMING OF THE WOUND INTERFACE ..................82 
5.1 Abstract .........................................................................................................82 
5.2 Introduction ...................................................................................................82 
5.3 Methods and Materials ..................................................................................85 
5.3.1 Cellular Egress from Meniscal Explants with Digestion ............................85 
5.3.2 Integration of Meniscal Repair Constructs with Digestion .........................85 
5.3.3 Tissue Micromechanics in Meniscal Repair Constructs with Digestion .....86 
5.3.4 Fabrication of Nanofibrous Scaffolds to Enable Localized Digestion ........86 
5.3.5 Subcutaneous Assessment of Collagenase-Releasing Scaffolds .............87 
5.3.6 Assessment of Collagenase-Releasing Scaffolds in an Ovine Model .......88 
5.3.7 Statistical Analyses ..................................................................................89 
5.4 Results ...........................................................................................................90 
5.4.1 Enzymatic Digestion Enhances Cellular Egress from Explants .................90 
5.4.2 Degradation of the Wound Interface Reduces Matrix Density, Increases 
Cellularity, and Alters Micromechanics ...................................................................91 
5.4.3 Scaffolds Improve Integration in a Subcutaneous Model ..........................93 
5.4.4 Scaffolds Promote Meniscal Repair in an Ovine Model ............................97 
5.5 Discussion .....................................................................................................99 
5.6 Conclusions ................................................................................................. 104 
5.7 Acknowledgements ..................................................................................... 104 
CHAPTER 6: MATRIX REPROGRAMMING ENHANCES INTERSTITIAL CELL 
MIGRATION IN THE ADULT MENISCUS ................................................................... 106 
6.1 Abstract ....................................................................................................... 106 
6.2 Introduction ................................................................................................. 107 
6.3 Materials and Methods ................................................................................ 109 
6.3.1 Tissue Substrate Fabrication .................................................................. 109 
6.3.2 Second Harmonic Generation Imaging and Microstructural Analysis ...... 110 
6.3.3 Atomic Force Spectroscopy and Micromechanical Analysis ................... 110 
6.3.4 Scanning Electron Microscopy ............................................................... 111 
6.3.5 Cell Egress onto Tissue Substrates ........................................................ 111 
6.3.6 Confocal Imaging and Morphometric Analysis ........................................ 112 
 xi 
 
6.3.7 Analysis of Interstitial Cell Migration ....................................................... 113 
6.3.8 Enzymatic Degradation of Tissue Substrates ......................................... 114 
6.3.9 Statistical Analyses ................................................................................ 115 
6.4 Results ......................................................................................................... 115 
6.4.1 Microstructural and Micromechanical Changes with Meniscus Age ........ 115 
6.4.2 Cell Morphology and Migration Are Dependent on ECM Properties ....... 117 
6.4.3 Dose-Dependent ECM Degradation Enhances Interstitial Cell Migration 120 
6.5 Discussion ................................................................................................... 125 
6.6 Conclusions ................................................................................................. 130 
6.7 Acknowledgments ....................................................................................... 130 
CHAPTER 7: DIRECTING CELL MIGRATION VIA A CHEMOATTRACTIVE 
GRADIENT TO ENHANCE MENISCAL REPAIR........................................................ 131 
7.1 Abstract ....................................................................................................... 131 
7.2 Introduction ................................................................................................. 131 
7.3 Materials and Methods ................................................................................ 135 
7.3.1 Cell Isolation and Culture ....................................................................... 135 
7.3.2 Transwell Migration Assay ...................................................................... 135 
7.3.3 Cell Age and Pore Size-Dependent Migration ........................................ 136 
7.3.4 Tissue Boyden Migration Assay ............................................................. 137 
7.3.5 Traction Force Microscopy ..................................................................... 138 
7.3.6 Nanofibrous Scaffold Fabrication ............................................................ 139 
7.3.7 In Vitro Biofactor Release and Activity Assays ....................................... 141 
7.3.8 In Vitro Cell Behavior on Nanofibrous Scaffolds ..................................... 142 
7.3.9 Subcutaneous Xenotransplant Model ..................................................... 143 
7.3.10 Statistical Analyses ................................................................................ 145 
7.4 Results ......................................................................................................... 145 
7.4.1 Platelet-Derived Growth Factor-AB Stimulates Cell Migration ................ 145 
7.4.2 Cell Mobility is Dependent on Pore Size and Cell Age ............................ 146 
7.4.3 Controlled Biofactor Release from Tri-Component Scaffolds .................. 151 
7.4.4 Bioactive Scaffolds Enhance Meniscal Cellularity and Integration .......... 155 
7.5 Discussion ................................................................................................... 158 
7.6 Conclusions ................................................................................................. 164 
7.7 Acknowledgments ....................................................................................... 164 
 xii 
 
CHAPTER 8: SUMMARY AND FUTURE DIRECTIONS ....................................... 165 
8.1 Summary ...................................................................................................... 165 
8.2 Limitations and Future Directions .............................................................. 168 
8.2.1 Cellular and Extracellular Matrix Changes with Age ............................... 168 
8.2.2 Multiple Biofactor Delivery In Vivo .......................................................... 174 
8.2.3 Translational Animal Models .................................................................. 179 
8.2.4 Method to Assess Joint Kinematics in Humans and Large Animals ........ 181 
8.2.4.1 Introduction ..................................................................................... 181 
8.2.4.2 Methods .......................................................................................... 181 
8.2.4.3 Results ............................................................................................ 183 
8.2.4.4 Discussion ....................................................................................... 185 
8.2.4.5 Acknowledgements ......................................................................... 186 
8.3 Conclusion ................................................................................................... 187 
APPENDIX I: RELATED MANUSCRIPTS .................................................................. 188 
APPENDIX II: RELATED CONFERENCE ABSTRACTS ............................................ 189 
BIBLIOGRAPHY ......................................................................................................... 192 
 
 xiii 
 
LIST OF TABLES 
 
Table 2-1: Biologic factors of interest for meniscal repair and their effect on meniscal cell behavior 
and impact on integrative potential. ............................................................................................... 23 
Table 6-1: Morphometric descriptors used for 2D projected cells. .............................................. 113 
Table 7-1: Polymer fiber fraction calculations (% mass) based on solution flow rate and 
concentration for a 3.5 hour electrospinning period. .................................................................... 140 
Table 7-2: Biofactor loading calculations (µg/mg scaffold) based on solution flow rate and 
concentration for a 3.5 hour electrospinning period. .................................................................... 140 
 xiv 
 
LIST OF FIGURES 
 
Figure 2-1: Anatomy of the knee meniscus. Anterior (left) and top-down (right) views of the medial 
and lateral menisci within the knee joint. Adapted from www.aaos.org (left) and (Pagnani et al. 
1995) (right). ..................................................................................................................................... 6 
Figure 2-2: Anisotropic collagen organization of the extracellular matrix enhances mechanical 
functionality of the knee meniscus. (A) During axial loading, the meniscus is displaced radially and 
converts compressive stresses from the femur to tensile hoop stresses (Fc) born by the 
circumferential collagen fibers and the horn attachments to the tibial plateau. However, lower 
tensile modulus in the radial direction results in poor resistance to radial shear forces (Fr). Adapted 
from (Kawamura et al. 2003). (B) Schematic showing the dominant circumferential collagen fiber 
organization of the meniscus, with an interspersion of radial ‘tie’ fibers. (C) Schematic of 
circumferential (Circ) and radial (Rad) meniscal samples for tensile testing. Circ samples have >3x 
higher tensile modulus than Rad samples, demonstrating mechanical anisotropy. Adapted from 
(LeRoux et al. 2002). ........................................................................................................................ 7 
Figure 2-3: Surgical approaches to meniscal injuries. (A) Arthroscopic image of a suture repair. 
Repairs stabilize simple tears but rarely result in tissue integration. (B) Illustration of partial 
resection of damaged tissue. Tissue removal alters joint loading and causes cartilage degradation 
(C) Replacement options such as allografts or engineered implants restore function in the short-
term, but their long-term benefits are unclear. Images courtesy of (A) www.tarlowknee.com, (B) 
www.cartilagerestoration.org, and (C) www.medimagery.net and www.ivysportsmed.com. .......... 8 
Figure 2-4: Schematic of a horizontal meniscal tear highlighting the limitations to repair 
(hypovascularity, hypocellularity, and inflammation) and pro-repair strategies, including enhancing 
vascularity (angiogenesis, fibrin clot, vascularized graft or conduit), improving cellularity 
(recruitment or delivery), and generating an instructive environment via biochemical (inflammatory 
inhibitors and anabolic growth factors) and mechanical cues (dynamic loading). ......................... 10 
Figure 2-5: Meniscal properties change with age, contributing to a reduced integrative potential in 
mature patients. (A) Matrix proteoglycan content and collagen density increase in the adult 
meniscus (arrow indicates the inner zone’s concentration of proteoglycans) while cellularity 
decreases compared to fetal meniscus (dashed line indicates wound interface). Adapted from 
(Ionescu et al. 2011) and (Qu et al. 2013). (B) The compressive modulus of adult bovine meniscus 
is greater than that of fetal meniscus. Adapted from (Ionescu et al. 2011). (C) Integration is tested 
by pushing a cylindrical core out from a surrounding annulus. (D) Integration strength for adult 
 xv 
 
meniscus is lower than fetal meniscus and does not improve with time in culture. Adapted from 
(Ionescu et al. 2011). ..................................................................................................................... 12 
Figure 2-6: Lack of vasculature in the inner meniscus (white-white zone) results in limited healing 
after injury. (A) Vascular perfusion shows the perimeniscal capillary plexus (PCP) of the medial 
meniscus. Adapted from (Arnoczky et al. 1982). Strategies to enhance vascularity include 
increasing vascular access via a trephine/conduit or synovial graft, promoting angiogenesis, and 
introducing vascular elements. (B) Trephine/conduit schematic. (C) Tissue and vascular ingrowth 
using bioabsorbable conduit. Adapted from (Cook et al. 2007). (D) Synovial graft placed above 
meniscal allograft results in vascularization after 8 weeks as seen by microangiography. Adapted 
from (Yamazaki et al. 2003). (E) Factor VIII immunostaining indicates early vessel formation in 
meniscus repaired with VEGF-coated sutures. Adapted from (Petersen et al. 2007). (F) Fibrin clot 
placed into meniscal tear with sutures. Adapted from (Sethi et al. 2003). ..................................... 15 
Figure 2-7: Cellularity can be increased by (A) direct injection of cells into the lesion or (B) delivery 
via a scaffold. (C) Bone marrow-derived mesenchymal stem cells seeded onto a hyaluronan-
collagen composite scaffold improved matrix production and integration in rabbits compared to 
untreated and acellular groups. Adapted from (Zellner et al. 2010). SEM image shows the 
integrated interface of the tissue (white arrow) and pre-cultured scaffold (black arrow). .............. 19 
Figure 2-8: Modification of the environment via biochemical and mechanical cues can augment 
integration. (A) The addition of IL-1 receptor antagonist (IL-1ra) in the presence of inflammatory 
cytokine IL-1 increases integrative shear strength of porcine meniscus in vitro. Adapted from 
(McNulty et al. 2007). (B) The application of dynamic loading increases integrative shear strength 
of porcine meniscus in vitro, overriding the catabolic effects of IL-1. Adapted from (McNulty et al. 
2010). (C) Supplementation with the pro-matrix growth factor TGF-β3 improves integration strength 
of juvenile bovine meniscus in vitro, while addition of pro-mitotic bFGF does not enhance repair, 
even when applied in conjunction with TGF-β3. Adapted from (Ionescu et al. 2012b). ................ 26 
Figure 3-1: Cell adhesion and contractility are required for 3D migration. (A) Mechanosensing 
matrix rigidity via the RhoA/ROCK/myosin II axis. Adapted from (Petrie et al. 2012). (B) Blocking 
cell adhesion via an anti-β1 integrin antibody (4B4, top) and contractility via the ROCK inhibitor Y-
27632 (bottom) reduces cell migration speed in collagen gels. Cell-produced MMPs are inhibited 
in the GM6001 group. Adapted from (Wolf et al. 2013). ................................................................ 32 
Figure 3-2: Nuclear stiffness is a physical impediment to interstitial cell migration. (A) Schematic 
showing a cell migrating through a fibrous matrix, deforming the cell body and nucleus as it passes 
through a constriction. (B) Phases of nuclear deformation: (1) resistance, (2) local prolapse, (3) 
compression and gliding, and (4) rear release. Plot illustrating nuclear velocity over time for the 
 xvi 
 
phases above. Scale = 5 µm. Adapted from (Friedl et al. 2011). (C) Plot illustrating cell migration 
speed as a function of lamin A expression (Knockout (KO), Wild Type (WT), Overexpression (OE)). 
Migration efficiency is highest with a moderate level of lamin A KO. Adapted from (Swift et al. 2014). 
(D) Lamin A KO enhances cell migration through porous barriers. Adapted from (Greiner et al. 
2013). (E) Lamin A OE reduces cell migration through microporous membranes. Adapted from 
(Rowat et al. 2013). ........................................................................................................................ 34 
Figure 3-3: Stages of interstitial migration with or without matrix remodeling. (1) Initial cell 
polarization with rotation of the nucleus, (2) cellular adhesion of integrins, (3) cytoskeletal 
contraction of stress fibers (red), (4a) surface localization and secretion of matrix-degrading 
enzymes (green) to enlarge the matrix pores allowing for cell passage without deformation, and 
(4b) non-proteolytic migration requiring deformation of the cell and nucleus. Adapted from (Friedl 
et al. 2011). .................................................................................................................................... 36 
Figure 3-4: Collagen content and organization of native tissues. (A) Collagen content (µg/mg wet 
weight) of various mouse and bovine tissues. Data adapted from QuickZyme Biosciences 
(www.quickzyme.com). (B) Matrix density and organization of loose connective tissue (lymph 
gland, Methenamine Silver/Mallory Trichome), dense irregular connective tissue (dermis, H&E), 
and dense regular connective tissue (tendon, H&E). Adapted from Histology Guide, University of 
Leeds (www.histology.leeds.ac.uk). (C) Type I collagen content and corresponding stiffness of 
various mouse tissues. Adapted from (Swift et al. 2013). (D) Pore size (top) and storage modulus 
(bottom) of collagen gels commonly used in migration studies, as a function of collagen gel 
concentration. Adapted from (Miron-Mendoza et al. 2010). .......................................................... 38 
Figure 3-5: Cell migration is impaired in stiff and dense matrices. (A) Cell migration through RGD-
modified PEG hydrogels decreases with increasing gel stiffness. Addition of MMP-degradable 
linkages partially rescues migration. Adapted from (Ehrbar et al. 2011). (B) Migration speed through 
collagen gels decreases as a function of pore size. Cell-produced MMPs are inhibited in the 
GM6001 group. Adapted from (Wolf et al. 2013). (C) Confocal cross-sections show cells migrating 
though polycarbonate pores of increasing size (red = cytoplasm, green = nucleus). Cells are 
immobilized by 1 µm diameter pores. Scale = 10 µm. Adapted from (Wolf et al. 2013). .............. 41 
Figure 3-6: Collagen organization of fiber-reinforced tissues. (A) Scanning electron micrographs of 
the annulus fibrosus of the intervertebral disc, (B) knee meniscus, and (C) ligament. (D) Top down 
view of the aligned circumferential collagen fibrils in the knee meniscus. (E) Fibrochondrocytes 
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Scale = (A) 200 µm, (B) 500 µm, (C) 100 µm, and (D and F) 2 µm. Adapted from (A) (Iatridis et al. 
2004), (B) (Petersen et al. 1998), (C) (Provenzano et al. 2002), and (E) (Chevrier et al. 2009). 
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Figure 3-7: Dense connective tissues become denser, stiffer, and less cellular with age. Tendons 
from fetal and adult sheep illustrate changes with maturation. (A) H&E staining showing ECM and 
cells, (B) immunostaining for type I collagen (green) with DAPI nuclear counterstain (blue), and (C) 
DAPI staining for cell nuclei. Cells in fetal tendon are numerous and ellipsoid, whereas the few cells 
in adult tendon are elongated along the fiber direction. Collagen content and organization increase 
with tendon age. § = tendon tissue proper, * = endotenon. Scale = (A) 50 µm, (B) 25 µm, and (C) 
10 µm. Adapted from (Russo et al. 2015). (D) Radial sections from fetal, juvenile, and adult bovine 
menisci stained with Picrosirius Red (collagen) and Alcian Blue (proteoglycans). Adult tissue 
contains more proteoglycans in the inner zone than fetal and juvenile tissues. Scale = 10 mm. (E) 
Micromechanics (elastic modulus normalized to fetal tissue, measured via AFM indentation) and 
bulk mechanics (compressive equilibrium modulus) of fetal, juvenile, and adult bovine meniscus. 
Tissue becomes stiffer on both length scales with age. Adapted from (Ionescu et al. 2011). ....... 46 
Figure 3-8: Nuclear stiffness and lamin A content increase with cell age. (A) Schematic showing 
relative nuclear stiffness of stem cells as they differentiate over time. Adapted from (Swift et al. 
2014). (B) Nuclear modulus and (C) lamin A content (normalized to β-actin) of fetal (Fet), juvenile 
(Juv), and adult (Adu) bovine meniscal fibrochondrocytes, and juvenile bovine mesenchymal stem 
cells (MSCs). Data courtesy of Claire McLeod (B) and Tristan Driscoll (C). ................................. 47 
Figure 3-9: MMP-degradable hydrogels enhance cell invasion, matrix remodeling, and matrix 
synthesis. (A) H&E staining of soft and stiff MMP-degradable and MMP-insensitive (Non-
degradable) poly(ethylene glycol) (PEG) hydrogels implanted within rat calvarial defects. After 2 
weeks, endogenous cells invade, degrade, and remodel MMP-degradable matrices in a stiffness-
dependent manner. Cell invasion is homogenous in soft gels and becomes less regular in stiff gels, 
and fewer cells invade Non-degradable gels. Adapted from (Ehrbar et al. 2011). (B) Schematic 
showing encapsulation of human mesenchymal stem cells (hMSCs) in hyaluronic acid (HA) 
hydrogels using either MMP-degradable peptides or MMP-insensitive (Non-degradable) 
crosslinkers. (C) Glycosaminoglycan (GAG) and collagen content (normalized to the DNA content) 
of hMSC-laden HA hydrogels after 4 weeks of in vitro culture. Adapted from (Feng et al. 2014). 51 
Figure 3-10: Nanofibrous topography organizes cells and matrix. (A) Scanning electron 
micrographs of aligned (top) and non-aligned (bottom) PCL scaffolds. Scale = 50 µm. (B) 
Mesenchymal stem cells cultured on nanofibrous scaffolds for 7 days (green = actin, blue = nuclei). 
Cells are oriented with the primary fiber axis on the aligned scaffold. Scale = 50 µm. (C) En face 
section of scaffold stained after 10 weeks of in vitro culture with Picrosirius Red (collagen) and 
Alcian Blue (proteoglycans). Deposited collagen is aligned with the fiber direction. Scale = 100 µm. 
Adapted from (Baker et al. 2007, Mauck et al. 2009). ................................................................... 53 
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Figure 3-11: Fast-degrading nanofibers in a composite scaffold increase scaffold porosity, cell 
infiltration, and integration with native tissue. (A) Schematic illustrating composite PCL/PEO 
scaffold with fast-degrading PEO fibers (green) and slow-degrading PCL fibers (red) before and 
after removal of PEO. (B) Scanning electron micrographs of scaffold with 0% or 60% PEO content 
removed. Scale = 50 µm. (C) DAPI staining showing nuclei of cell-seeded scaffolds after 12 weeks 
of in vitro culture indicates enhanced cell colonization of 60% PEO scaffold. Scale = 0.5 mm. (D) 
Percent of nuclei in the center of the scaffold after 12 weeks of in vitro culture. (A–D) Adapted from 
(Baker et al. 2012). (E) Integration strength of PCL/PEO scaffold with native meniscus after 4 and 
8 weeks of in vitro culture shows enhanced scaffold-tissue integration with 60% PEO scaffold at 8 
weeks. Adapted from (Ionescu et al. 2013). .................................................................................. 54 
Figure 4-1: Aqueous collagenase treatment reduces matrix density and increases cellularity in the 
adult meniscus, producing a more fetal-like tissue state. (A) Schematic of annulus and core 
meniscal repair constructs. (B) H&E (left) and DAPI (right) staining of constructs after 4 weeks of 
culture, where the dashed line indicates the wound interface (n=1–2/group). Scale = 0.25 mm. . 70 
Figure 4-2: Improved integration and interface cellularity of adult meniscus after low- (LC) and high-
dose (HC) collagenase treatment, compared to controls (BM). (A) Left: 1 week µCT scans showing 
low (red) and high (yellow) signal intensity correlating to matrix loss at the wound interface 
(n=4/group). Scale = 1 mm. Right: 8 week PSR staining of the interface imaged under polarized 
light showing improved integration with treatment (n=4/group). Scale = 0.25 mm. (B) Quantification 
of % integration normalized to core perimeter (n=3–4/group), (C) cell density at the interface 
(n=4/group), and (D) total DNA content per dry weight (n=6–7/group). * = p≤0.05 vs. BM. + = p≤0.05 
vs. BM and LC. Line = p≤0.05 between 4 and 8 weeks. ............................................................... 71 
Figure 4-3: Sacrificial PEO nanofibers deliver functional enzymes upon hydration. (A) Morphology 
of cell monolayers treated with eluant from fibers containing trypsin for 60 minutes as a function of 
fiber mass (n=2/group). Scale = 0.2 mm. (B) Proteoglycan removal from cartilage cylinders after 6 
hours of incubation with BM or HBSS (controls) or eluant from PEO or PEO-T nanofibers 
(n=3/group). Scale = 0.5 mm. (C) % AB staining of proteoglycan in cartilage cylinders as a function 
of treatment group and time, normalized to BM controls (n=3/group). Dashed line indicates 
treatment with 1.25% w/v trypsin for 20 minutes as a positive control. * = p≤0.05 vs. other groups 
at 3 hours. ** = p≤0.05 vs. all other groups and time points. ......................................................... 72 
Figure 4-4: Fabrication of enzyme-delivering nanofibrous composites. (A) SEM micrographs of 
PEO (left) and PEO-HC (right) nanofibers. Scale = 5 μm. (B) Schematic of electrospinning setup 
and (C) composite scaffolds produced with PEO fiber fractions that deliver enzyme. .................. 73 
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Figure 4-5: Release of active collagenase from PEO fibers. (A) Combined AB and PSR staining of 
cartilage cylinders after 6 hours of exposure to BM, PEO, PEO-C, or aqueous collagenase (aqC, 
0.1% w/v) solution (n=4/group). Scale = 0.5 mm. (B) GAG content of cartilage cylinders as a 
function of treatment and time (n=4/group). Dashed line indicates treatment with aqC for 3 hours. 
* = p≤0.05 compared to other groups at 3 hours. ** = p≤0.05 compared to all other groups at 6 
hours. ............................................................................................................................................. 74 
Figure 4-6: Integrative repair of juvenile meniscus treated with collagenase-releasing scaffolds. (A) 
Schematic of repair construct with scaffold placed inside a horizontal meniscal tear. (B) AB staining 
of meniscus on day 7 with insertion of control and of collagenase-releasing composite scaffolds 
(n=3/group). Scale = 5 mm. (C) DAPI staining of wound interface after 50 days of culture with 
PCL/PEO, PCL/PEO-LC, and PCL/PEO-HC scaffolds (n=2/group). Scale = 0.25 mm. (D) 
Integration strength as a function of culture duration. Inset shows mechanical testing setup (n=5–
6/group). * = p≤0.05 compared to PCL/PEO-HC. Line = p≤0.05 between 25 and 50 days. ......... 75 
Figure 4-7: Improved repair of adult meniscus with collagenase-releasing composite scaffolds. (A) 
Repair construct schematic with annular scaffold insert. (B) AB and (C) H&E staining of constructs 
containing annular PCL/PEO-LC scaffolds on day 7. Scale = 1 mm. (D) Magnified areas from (C). 
Left: lack of integration at the edge occupied by the scaffold (asterisk). Right: bridging tissue in the 
interior after collagenase delivery. Scale = 0.25 mm. .................................................................... 76 
Figure 5-1: Partial enzymatic digestion with collagenase enhances cellular egress from meniscal 
explants in vitro. (A) Alcian Blue (AB) and Picrosirius Red (PSR) staining for proteoglycans (PGs) 
and collagen, respectively. Collagenase digestion removes PGs and collagens from the tissue 
edge. Scale = 100 µm. (B) Top-down schematic illustrating partial enzymatic digestion of ring-
shaped explants and emergent cells (blue dots). Box indicates area imaged for (A). (C) Cell 
outgrowth onto tissue culture-treated plates 10 days after pre-treatment with low- (LowC; 0.02 
mg/mL) and high-dose (HighC; 0.06 mg/mL) collagenase (n=3 samples/group, 4 
measurements/sample, mean ± standard deviation). * = p≤0.05 vs. Control and LowC. .............. 90 
Figure 5-2: Degradation of the wound interface reduces matrix density and increases cellularity in 
an in vitro meniscal repair model. (A) Second harmonic generation imaging shows collagen fibers 
(green) at the wound interface of control, low-dose collagenase (LowC; 0.01 mg/mL), and high-
dose collagenase (HighC; 0.05 mg/mL) repair constructs after 1 week of in vitro culture. Blue 
indicates autofluorescent signal. Arrows point to cells within the matrix. Scale = 100 µm. (B) DAPI 
staining of axial sections show cell nuclei at the interface (dashed line) after 1 week. Scale = 100 
µm. (C) Cell density at the interface with respect to treatment group and in vitro culture time (n=4 
samples/group, mean ± standard deviation). Cores (dark) and annuli (light) were counted as 
independent data points (no statistical difference). Inset shows schematic of repair explant in an 
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axial section, where the boxes highlight the cell counting regions. * = p≤0.05 vs. Control. † = p≤0.05 
vs. Control and LowC. There was no difference between time points within the same treatment 
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Figure 5-3: Location-dependent matrix micromechanics of repair constructs after 8 weeks of in vitro 
culture. (A) Schematic of AFM nanoindentation measurements of matrix stiffness across the wound 
interface of a HighC construct stained with PSR (collagen). Scale = 50 µm. (B) Force indentation 
curves for each condition taken at the wound edge (mean ± standard error of the mean for all 
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constructs (n=3 samples/group, 10 measurements/sample, mean ± standard deviation). * = p≤0.05 
vs. Control. † = p≤0.05 vs. Control and LowC. ‡ = p≤0.05 vs. all other groups. ........................... 93 
Figure 5-4: Fabrication of composite nanofibrous scaffolds with and without collagenase. (A) 
Schematic of tri-jet electrospinning. (B) Schematic of composite scaffold composed of poly(ε-
caprolactone) (PCL) and poly(ethylene oxide) (PEO) fiber fractions, where enzyme activity was 
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AB staining of cartilage after 72 hours in Control, Scaffold, and Scaffold+C groups. Staining 
intensity decreased at the tissue edge, indicating bioactivity of the released collagenase. Scale = 
250 µm. .......................................................................................................................................... 94 
Figure 5-5: Collagenase treatment improves meniscal integration after 4 weeks of subcutaneous 
implantation. (A) Schematic of repair construct assembly. Scaffold is fenestrated to allow tissue-to-
tissue contact. (B) Quantification of histological integration normalized to defect length (n=3–4 
samples/group, mean ± standard deviation). Line indicates trend for difference between groups 
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Figure 5-6: Cellularity proximal to the wound interface increases with collagenase treatment after 
4 weeks of subcutaneous implantation. (A) Thresholded images of DAPI-stained nuclei for each 
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Figure 5-7: Collagenase-releasing scaffolds promote repair at 4 weeks in an ovine meniscal defect 
model. (A) Schematic and photograph of surgical approach, longitudinal meniscal injury, and suture 
repair with scaffold. Asterisk indicates the bone block. (B) Radial sections of the repaired meniscus 
at 4 weeks, stained with PSR (collagen). Arrow indicates suture track. Scale = 2 mm. Magnified 
area shows enhanced integration of Scaffold+C with adjacent tissue, where the asterisk indicates 
the scaffold. Scale = 100 µm. (C) Quantification of damage to cartilage using India ink. Collagenase 
release by Scaffold+C did not adversely affect the cartilage. ........................................................ 98 
Figure 5-8: Extracellular matrix reprogramming of the wound interface to a fetal-like state augments 
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releasing cells from these steric constraints. The wound gap is bridged as cells colonize the defect 
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Figure 6-1: Collagen fiber organization increases with age. SHG images of fetal and adult meniscal 
ECM in orthogonal planes with composite SHG (green) and autofluorescent signal (red). (A) 
Longitudinal and (B) Cross Section substrates show circumferential and radial fibers parallel to the 
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Figure 6-2: Adult meniscal microenvironment is denser and stiffer than that of fetal tissue. (A) 
Experimental schematic. (B) Top: SHG signal (green) of fECM and aECM. Scale = 50 µm. Bottom: 
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modulus measured via AFM indentation and normalized to fECM (n=50 indentations/group, mean 
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Figure 6-3: Cell morphology is dependent on tissue age and treatment. (A) Experimental schematic. 
(B) 2D z-projections of cells on fECM, aECM, and aECM-C. Scale = 50 µm. (C) Morphology of 
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Figure 6-4: Interstitial cell migration is dependent on tissue age and treatment. (A) 2D confocal 
slices showing cells (green) within the tissue depth (blue). Scale = 50 µm. (B) 3D confocal 
reconstruction of the cells in (A). Arrows indicate protrusions. Scale = 10 µm. (C) Cell infiltration 
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depth with schematic inset (n=15 cells/group, mean ± standard error of the mean). (D) Cumulative 
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Figure 6-8: Migratory cell morphology is determined by exogenous and endogenous matrix 
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(A) 3D confocal reconstruction of adult cells (green) passing through microporous membranes (red) 
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Figure 7-3: Construction of a ‘tissue Boyden chamber.’ (A) Experimental schematic. (B) Tissue 
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Figure 8-1: Cell morphology is dependent on ECM age, cell age, and cell passage. (A) 
Representative binarized images of fetal and adult meniscal cells spread on fetal and (B) adult 
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CHAPTER 1: INTRODUCTION 
 
The musculoskeletal system is the fundamental scaffold that provides support for body 
infrastructure and allows for physical movement. As such, orthopaedic injuries significantly 
impact both quality of life and life expectancy. While some tissues, such as bone, can 
remodel to pre-injury equivalence after damage, dense connective tissues, including the 
knee meniscus, annulus fibrosus of the intervertebral disc, tendon, and ligament, exhibit 
poor healing capacity in adults. The microstructure of these tissues (at the cell level) is 
dominated by aligned collagen bundles, which provide mechanical anisotropy and greater 
tensile strength in the loading direction, allowing function in mechanically demanding 
environments. For example, the meniscus promotes stifle joint congruency and stability 
by distributing load over a large surface area. It is mainly comprised of circumferentially 
arranged collagen bundles that serve to resist tensile hoop stresses in the knee. Tears 
that disrupt this collagen architecture predispose the joint to altered biomechanics and 
eventually osteoarthritis. Despite the common occurrence of such injuries, there are 
limited restorative strategies available (e.g. allograft replacement), and in many cases 
damage culminates in a total joint replacement. An ideal alternative would be to 
reestablish native tissue function by promoting cell growth, organized extracellular matrix 
(ECM) production, and, most importantly, integration of the newly formed tissue via the 
creation of an instructive regenerative microenvironment. 
 
The overall goal of this thesis is to expedite dense connective tissue repair by identifying 
and manipulating the cellular and ECM impediments to wound healing. This body of work 
focuses on the knee meniscus, but the principles outlined within are applicable to other 
fiber-reinforced soft tissues. Chapter 2 will introduce meniscus structure and function, 
describe the biological limitations to intrinsic repair, and review strategies to augment the 
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healing response. Interestingly, the meniscus exhibits a robust repair capacity early in 
development, but this potential declines with aging. To overcome the restricted blood 
supply and sparse cell population of the mature meniscus, most experimental therapies 
attempt to directly boost the vascularity and cellularity at the defect. Others strategies seek 
to increase the anabolic activity of resident cells via the provision of biochemical and 
mechanical cues. 
 
While several of these studies appear promising, few address the biophysical barrier of 
the ECM itself, which may affect the interstitial migration of endogenous cells to the injury 
site and subsequent repair. The cellular and extracellular determinants of 3D migration, a 
complex set of interdependent factors absent from 2D migration, will be detailed in 
Chapter 3. This chapter begins by discussing the basic mechanisms of cell locomotion in 
confined 3D environments and constraints to mobility posed by the cell and its 
environment. The remaining sections explore the implication of 3D migration in fibrous 
tissue repair and tissue engineering, processes that rely on a sufficient population of cells 
to produce, remodel, and maintain the ECM. While tissues and scaffolds are optimized for 
mechanical function, their dense and stiff microenvironments may hinder cell mobility and 
infiltration. Recent advances in biomaterial design that mitigate these issues are also 
highlighted. 
 
Building on these concepts, we hypothesized that the density and stiffness of the adult 
meniscal ECM prevent cell migration to the wound margin, and that removing these 
inhibitions will facilitate cell migration and tissue repair. To achieve this, we developed a 
novel electrospun polymer nanofiber system from which bioactive factors are released to 
initiate and enhance repair. The challenges of this project are two-fold: first, to create a 
local wound environment favorable to cell migration by delivering a matrix-degrading 
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enzyme, and second, to enforce and instruct matrix deposition in the regenerate tissue 
that bridges the wound interface with a structural scaffold. Chapter 4 investigates the effect 
of partial digestion of the wound interface with the enzyme collagenase on meniscal repair 
using a tissue explant model. Additionally, a technique to fabricate bioactive, enzyme-
delivering nanofibers that can modulate tissue properties is presented. Chapter 5, which 
continues this work in vivo, assesses the use of composite collagenase-releasing 
scaffolds to enhance meniscal repair in a subcutaneous implantation model (rat) and an 
orthotopic meniscal defect model (sheep). These studies demonstrate that partial 
degradation of the wound margin leads to local micromechanical and microstructural 
changes in the ECM, which becomes more compliant and porous. A targeted burst release 
of collagenase from nanofibrous scaffolds localizes this effect to the tissue margin. 
Importantly, enzyme treatment results in higher cell density and physical integration of the 
meniscal wound interface, suggesting that endogenous cells are capable of repair when 
the steric impediments of the ECM are reduced. 
 
To better comprehend this mechanism on the microscale, a method to visualize and 
quantify interstitial cell migration through native tissue is developed in Chapter 6. Here, 
the influence of the tissue microenvironment on migratory efficacy is investigated using 
fetal, adult, and adult meniscal tissue substrates with and without pre-digestion with 
collagenase. Results suggest that age-related biophysical changes to the 
microenvironment affect cell migration, which may partly explain the differential repair 
capacity of fetal and adult tissues. This work confirms that cell mobility is extremely limited 
in the adult meniscus, but can be enhanced by modulating tissue stiffness and density via 
enzymatic digestion.  
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In addition to enabling cell mobility, scaffolds may be further functionalized to deliver 
biochemical signals that guide native cells to the injury site. Chapter 7 explores the 
application of a soluble chemoattractant to trigger directed cell migration to the wound site 
after matrix degradation. A novel tissue-based migration chamber to study interstitial 
chemotaxis is designed for this purpose. To determine whether aging also changes a cell’s 
intrinsic mobility, the ability of fetal and adult meniscal cells to translocate through 
increasingly small pores is evaluated, along with other biophysical features of the cell. 
Platelet-derived growth factor-AB (PDGF-AB) is identified as a chemoattractant for cells 
of both ages, as well as its dose-dependent and pore-size dependent impact on cell 
migration. Further, fetal cells appear more mobile than adult cells, potentially due to their 
smaller and more deformable nuclei. Finally, this chapter details the development of a tri-
component nanofibrous scaffold that delivers collagenase, PDGF-AB, or both biofactors 
in a temporally controlled manner. Cell infiltration into these nanofibrous composites is 
assessed in vitro prior to their evaluation in a subcutaneous implantation model. As 
expected, cell migration into scaffolds is limited by nanofiber density and inter-fiber pore 
size. In vivo results indicate that local PDGF-AB delivery alone can enhance cellularity at 
the wound interface in the short-term, but that collagenase-mediated reprogramming of 
the ECM may be essential for cell invasion of the scaffold in the long-term. Taken together, 
these findings illustrate the importance of biophysical barriers to interstitial migration, as 
well as the feasibility of delivering multiple agents in a staged fashion to prime the wound 
microenvironment for repair. 
 
Finally, Chapter 8 provides a summary of the findings herein and describes their impact 
on dense connective tissue repair and the current understanding of cell behavior in 
physiologic 3D environments. The limitations and future directions of this research are 
also discussed, a testament to the exploratory nature of this work. 
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CHAPTER 2: BASIC SCIENCE OF MENISCUS REPAIR: LIMITATIONS AND 
EMERGING STRATEGIES 
 
2.1 Abstract 
Meniscal tears, especially in the inner avascular zone, have limited healing capacity and 
a high failure rate when repair is attempted. Endogenous repair, characterized by cell 
proliferation and matrix deposition at the injury site, is hindered by a lack of vascular 
supply, low cell density, and a catabolic state induced by inflammation. To biologically 
augment the healing response, experimental methods have focused on directly 
addressing these issues by enhancing vascularity, increasing cellularity, and providing an 
instructive extracellular environment via biochemical and mechanical cues. With further 
clinical development, these emerging regenerative strategies have potential to render 
meniscal repair a favorable operation in patients who would otherwise undergo partial 
meniscectomy (removal of the damaged segment). 
 
2.2 Introduction 
The meniscus, a semilunar fibrocartilaginous tissue located between the femur and tibia, 
is essential to the mechanical functionality of the knee (Figure 2-1). Besides contributing 
to joint congruency, stability, shock absorption, and lubrication (Ghosh et al. 1987), it plays 
a significant role in tibiofemoral load bearing (Shrive et al. 1978). The meniscal 
extracellular matrix (ECM) contains 85–95% dry weight collagen, of which over 90% is 
fibrillar type I collagen (Eyre et al. 1983). The remaining dry weight components include 
types II, III, V, and VI collagens (1–2%) (McDevitt et al. 1992) and proteoglycans (<2–3%) 
(Adams et al. 1992), with water making up 72–77% of the tissue wet weight (Adams et al. 
1992). A sparse population of resident cells, collectively known as meniscal 
fibrochondrocytes (MFCs), maintains and remodels the ECM via a balance of matrix 
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synthesis and catabolism by matrix metalloproteinases (Upton et al. 2003, Verdonk et al. 
2005).  
 
 
Figure 2-1: Anatomy of the knee meniscus. Anterior (left) and top-down (right) views of the 
medial and lateral menisci within the knee joint. Adapted from www.aaos.org (left) and 
(Pagnani et al. 1995) (right). 
 
The ultrastructure and biochemical content of the meniscus vary with anatomical location 
and illustrate the tissue’s adaptations to regional mechanical demands. A meshwork of 
thin fibrils cover the superficial surface, underneath which lies a lamellar layer of radially 
distributed fibers (Petersen et al. 1998). Within the tissue center, the circumferentially 
aligned type I collagen fibers, the primary component of the ECM, give rise to anisotropic 
(direction dependent) mechanical properties that allow the meniscus to bear greater 
tensile forces along the fiber direction (Fithian et al. 1990) (Figure 2-2B). During axial 
loading, the meniscus is displaced radially and converts compressive stresses from the 
femur to tensile hoop stresses that are transmitted to the circumferential collagen fibers 
and the horn attachments to the tibial plateau (Shrive et al. 1978) (Figure 2-2A). A small 
fraction of interdigitating radial ‘tie’ fibers constrains the main fiber bundles (Skaggs et al. 
1994) and may aid in local strain transmission (Lai et al. 2010) (Figure 2-2B). During 
normal physiological loading conditions, bulk tensile strains are in the range of 2–6% 
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(Jones et al. 1996, Richards et al. 2003), with the tissue transmitting 50% of the load in 
the knee at full extension and 85% of the load at 90º flexion (Ahmed et al. 1983). The 
circumferential tensile modulus ranges from 48–259 MPa, whereas the radial modulus is 
much lower (3–70 MPa) (Bullough et al. 1970, LeRoux et al. 2002, Proctor et al. 1989) 
(Figure 2-2C). Consequently, the meniscus offers less resistance to radial shear forces 
and is predisposed to longitudinal tears (Kawamura et al. 2003). 
 
 
Figure 2-2: Anisotropic collagen organization of the extracellular matrix enhances 
mechanical functionality of the knee meniscus. (A) During axial loading, the meniscus is 
displaced radially and converts compressive stresses from the femur to tensile hoop 
stresses (Fc) born by the circumferential collagen fibers and the horn attachments to the 
tibial plateau. However, lower tensile modulus in the radial direction results in poor 
resistance to radial shear forces (Fr). Adapted from (Kawamura et al. 2003). (B) Schematic 
showing the dominant circumferential collagen fiber organization of the meniscus, with an 
interspersion of radial ‘tie’ fibers. (C) Schematic of circumferential (Circ) and radial (Rad) 
meniscal samples for tensile testing. Circ samples have >3x higher tensile modulus than 
Rad samples, demonstrating mechanical anisotropy. Adapted from (LeRoux et al. 2002). 
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Load-bearing capability decreases when the fiber-reinforced microstructure is 
compromised, consequently increasing tibiofemoral contact pressures and predisposing 
the joint to degenerative osteoarthritis (OA). The incidence of meniscal tears is reported 
to be 60–70 per 100,000 persons (Hede et al. 1992, Nielsen et al. 1991) and accounts for 
over 1 million arthroscopic procedures each year (Hasan et al. 2014). While repair success 
ranges from 63% to 91% for simple peripheral tears (Boyd et al. 2003, DeHaven 1999, 
Eggli et al. 1995, Hanks et al. 1991, Miller 1988, Morgan et al. 1991), tears in the inner 
avascular zone of the meniscus have a much poorer prognosis, with up to 75% failing to 
heal completely and 20% requiring repeat surgery (Rubman et al. 1998). 
 
 
Figure 2-3: Surgical approaches to meniscal injuries. (A) Arthroscopic image of a suture 
repair. Repairs stabilize simple tears but rarely result in tissue integration. (B) Illustration of 
partial resection of damaged tissue. Tissue removal alters joint loading and causes cartilage 
degradation (C) Replacement options such as allografts or engineered implants restore 
function in the short-term, but their long-term benefits are unclear. Images courtesy of (A) 
www.tarlowknee.com, (B) www.cartilagerestoration.org, and (C) www.medimagery.net and 
www.ivysportsmed.com. 
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Partial meniscectomy is the standard treatment after repair failure (Figure 2-3), yet tissue 
resection also leads to osteoarthritic changes in the affected knee compartment (Aagaard 
et al. 1999, Englund 2004, Fairbank 1948). Furthermore it appears that degenerative 
changes positively correlate with amount of meniscal resection. When the tissue is 
damaged beyond repair, it is completely removed (total meniscectomy). Current 
replacement strategies include meniscal allograft transplants or engineered substitutes 
(e.g., collagen or polyurethane scaffolds) (Figure 2-3), although the long-term outcome 
of these relatively new therapies is unclear (Rongen et al. 2015, Smith et al. 2015, 
Vrancken et al. 2012). As such, methods that improve meniscal repair or salvage would 
be a marked advance to the treatment of this common injury. 
This chapter will begin by reviewing the basic science understanding of the limited 
endogenous healing capacity of the meniscus, with an emphasis on the implications of 
hypovascularity, hypocellularity, and inflammation at the tear site. Following this 
discussion, we will describe extant and emerging regenerative medicine approaches that 
are designed to directly address these issues. This section will include a review of repair 
strategies and experimental methods that are aimed at 1) enhancing vascularity, 2) 
increasing cellularity, and 3) promoting matrix deposition and new tissue formation via 
biochemical and/or mechanical cues at the wound site. 
 
2.3 Endogenous Limitations to Meniscal Repair 
Multiple factors influence the intrinsic healing capacity of meniscus, the most significant 
being zonal differences in vascularity, alterations in matrix composition and density, 
insufficient cellular density, and other soluble and mechanical factors (Figure 2-4). Each 
of these factors is described below as they relate to compromised endogenous healing in 
the adult meniscus. 
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Figure 2-4: Schematic of a horizontal meniscal tear highlighting the limitations to repair 
(hypovascularity, hypocellularity, and inflammation) and pro-repair strategies, including 
enhancing vascularity (angiogenesis, fibrin clot, vascularized graft or conduit), improving 
cellularity (recruitment or delivery), and generating an instructive environment via 
biochemical (inflammatory inhibitors and anabolic growth factors) and mechanical cues 
(dynamic loading). 
 
2.3.1 Vascular Supply  
Healing is characterized by cellular invasion into the defect, with subsequent proliferation, 
ECM remodeling, and synthesis of new matrix proteins to bridge the wound gap. Thus, 
the availability of a vascular supply that can deliver regenerative cells, nutrients, and 
growth factors, is likely to be crucial to a successful repair response. The region-specific 
healing that is seen clinically is largely attributed to degrees of vascularity, where limited 
vascularization precludes the formation of a fibrin clot that stimulates cellular infiltration 
and matrix remodeling in the inner, avascular zones of the tissue. Since vessels from the 
perimeniscal capillary plexus fail to penetrate past the peripheral one-third of the meniscus 
in the adult (red-red zone) (Arnoczky et al. 1982, Day et al. 1985) (Figure 2-6A), this 
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results in an inner avascular zone (white-white zone) with poor healing capacity (Arnoczky 
et al. 1983, Ghadially et al. 1986, Heatley 1980, King 1936). Junctional tears (red-white 
zone), as expected, possess intermediate healing capacity. Thus, attempted repair of an 
avascular tear has a high failure rate and is generally not recommended despite the 
pathological consequences of partial meniscus removal (Greis et al. 2002, Noyes et al. 
2012). 
 
2.3.2 Cell and Matrix Density  
The presence of a sufficient number of cells at the wound interface is also critical in the 
healing response. Meniscal cells normally are responsible for maintaining tissue structure, 
an active process wherein the ECM is continuously being remodeled due to physiologic 
loading. These same cells can respond to injury or altered loading by upregulating 
production of matrix proteins and/or enzymes to affect repair. However, cellularity 
decreases progressively with maturation until a low cell density is reached in the adult 
(Figure 2-5A) (Clark et al. 1983, Ionescu et al. 2011). Along with a loss in cellularity, 
collagen and proteoglycan content increase with age, increasing the overall ECM density 
and compressive modulus (Figure 2-5A and Figure 2-5B). The lack of viable cell density 
in older patients renders them more susceptible to meniscal degeneration and re-tear after 
repair (Mesiha et al. 2007) (Figure 2-5C and Figure 2-5D). Furthermore, the increased 
ECM density likely reduces the capacity of endogenous cells to migrate and remodel the 
tissue after injury (Clark et al. 1983, Ionescu et al. 2011). 
In addition to changes that occur with maturation, there are also zonal differences of the 
cells within the meniscus itself. A superior healing response is often seen in the peripheral 
region, even after eliminating contributions from the microvasculature and synovium, 
indicating that there may be intrinsic zonal cellular differences that influence repair 
(Kobayashi et al. 2004). Cell morphology and gene expression vary with meniscal region, 
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with fusiform cells located superficially, fibroblast-like cells in the fibrous periphery, and 
chondrocyte-like cells in the inner fibrocartilage (Fuller et al. 2012, Hellio Le Graverand et 
al. 2001, McDevitt et al. 2002, Upton et al. 2006a). ECM components also differ by region, 
where the outer portion consists mainly of type I collagen to resist tensile stresses and the 
inner portion has a greater percentage of type II collagen and proteoglycans, which are 
more resistant to compressive forces (McDevitt et al. 1992) (Figure 2-5A). As a result, 
there are zonal differences in regenerative mechanisms, sensitivity to cytokines, and 
response to growth factors (Fuller et al. 2012). 
 
 
Figure 2-5: Meniscal properties change with age, contributing to a reduced integrative 
potential in mature patients. (A) Matrix proteoglycan content and collagen density increase 
in the adult meniscus (arrow indicates the inner zone’s concentration of proteoglycans) 
while cellularity decreases compared to fetal meniscus (dashed line indicates wound 
interface). Adapted from (Ionescu et al. 2011) and (Qu et al. 2013). (B) The compressive 
modulus of adult bovine meniscus is greater than that of fetal meniscus. Adapted from 
(Ionescu et al. 2011). (C) Integration is tested by pushing a cylindrical core out from a 
surrounding annulus. (D) Integration strength for adult meniscus is lower than fetal 
meniscus and does not improve with time in culture. Adapted from (Ionescu et al. 2011). 
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2.3.3 Soluble and Mechanical Factors 
Meniscal healing is also affected by soluble and mechanical cues. Inflammatory cytokines 
that are up-regulated post-injury, especially interleukin-1β (IL-1β) and tumor necrosis 
factor α (TNFα), inhibit integrative repair (McNulty et al. 2007). Specifically, IL-1β 
increases the expression of matrix metalloproteinases (MMPs), catabolic enzymes that 
cleave collagens and other ECM components (McNulty et al. 2009). On the other hand, 
cells are stimulated to proliferate and produce matrix when exposed to anabolic growth 
factors. Mechanical loading, such as static or dynamic compression, can also alter gene 
expression and modulate inflammation (McNulty et al. 2010, Upton et al. 2003). Thus, 
introduction of bioactive factors that reduce inflammation and potentiate anabolism and/or 
loading of the extracellular milieu has the potential to create a matrix-forming environment 
more conducive to repair. 
 
2.4 Emerging Strategies to Promote Meniscal Repair 
Numerous techniques have been investigated to address the biologic issues of suboptimal 
meniscal healing and to improve repair (Figure 2-4). One approach is to enhance 
vascularity by increasing access to pre-existing vasculature or promoting neo-
vascularization to improve delivery of nutrients, reparative cells, and growth factors to the 
wound site (Figure 2-6). Another method is to improve the cellularity of the interface by 
recruiting endogenous cells or introducing exogenous cells (Figure 2-7). A related 
approach is to then encourage the cell population to proliferate and increase matrix 
synthesis by introducing soluble factors and/or mechanical stimulation that promote 
anabolic activity and inhibit inflammation (Figure 2-8). These experimental strategies to 
enhance integrative repair will be discussed in the following sections. 
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2.4.1 Methods to Enhance Vascularity 
Inability of the avascular, inner portion of the meniscus to heal has driven the impetus to 
investigate means to enhance vascularity via surgical approaches (Figure 2-6). These 
approaches include mechanical rasping, trephination, and the introduction of vascularized 
grafts to the wound site. Partial removal of the wound interface by abrasion has been 
shown to encourage vascularization by inducing production and release of growth factors 
and cytokines beneficial to healing (Ochi et al. 2001, Okuda et al. 1999). This technique 
has been used experimentally to repair longitudinal meniscal tears of the avascular zone 
in rabbits and humans, although it was reported that success was dependent on the 
distance of the joint capsule to the tear site as well as the size and stability of the tear, 
indicating that proximity of a vascularized source was still necessary (Uchio et al. 2003). 
This problem can be addressed by creating vascular ‘access’ channels that connect the 
inner zone to the peripheral vasculature (Figure 2-6B). The provision of a such a vascular 
conduit was pioneered separately by Gershuni et al. (Gershuni et al. 1989) and Zhang et 
al. (Zhang et al. 1995, Zhang et al. 1988) in animal models. However, trephined channels 
are prone to collapse during normal physiologic loading, and the removal of meniscal 
cores can disrupt the aligned collagen fibers and further destabilize meniscal architecture. 
In a prospective study, Zhang et al. found that symptomatic re-tear rates decreased after 
combining arthroscopic trephination with suturing to ensure stability, but healing was not 
evaluated (Zhang et al. 1996). To maintain biomechanical integrity after core removal, 
Cook et al. developed a bioabsorbable conduit composed of poly(l-lactic) acid that allowed 
for fibrovascular tissue ingrowth, which proved superior to trephination alone in a canine 
model (Cook et al. 2007) (Figure 2-6C).  
 
 15 
 
 
Figure 2-6: Lack of vasculature in the inner meniscus (white-white zone) results in limited 
healing after injury. (A) Vascular perfusion shows the perimeniscal capillary plexus (PCP) 
of the medial meniscus. Adapted from (Arnoczky et al. 1982). Strategies to enhance 
vascularity include increasing vascular access via a trephine/conduit or synovial graft, 
promoting angiogenesis, and introducing vascular elements. (B) Trephine/conduit 
schematic. (C) Tissue and vascular ingrowth using bioabsorbable conduit. Adapted from 
(Cook et al. 2007). (D) Synovial graft placed above meniscal allograft results in 
vascularization after 8 weeks as seen by microangiography. Adapted from (Yamazaki et al. 
2003). (E) Factor VIII immunostaining indicates early vessel formation in meniscus repaired 
with VEGF-coated sutures. Adapted from (Petersen et al. 2007). (F) Fibrin clot placed into 
meniscal tear with sutures. Adapted from (Sethi et al. 2003). 
 
Alternatively, parameniscal synovial abrasion can be applied to increase vascularity and 
provide chemotactic factors up to 5 mm from the outer meniscal rim (Henning et al. 1987). 
Vascularized synovial flaps can also be placed within the meniscal defect to provide both 
a blood supply and a source of synoviocytes that can infiltrate the wound site and lay down 
matrix to bridge the gap (Gershuni et al. 1989, Ghadially et al. 1986, Jitsuiki et al. 1994, 
Ochi et al. 1996) (Figure 2-6D). Indeed, interpositional free synovial autografts can 
improve integration in vitro despite these grafts lacking connections to the systemic 
vasculature in this model. This indicates that the mechanism of action may be in provision 
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of an added source of regenerative cells or by the graft itself acting as a scaffold for cell 
migration (Ochi et al. 1996, Yamazaki et al. 2003). In fact, it is thought that superficial cells 
of the meniscus originated from the synovium and that these cells may be implicated in 
meniscal healing (Hu et al. 2001, Kambic et al. 2000). 
To enhance vascularity without surgically removing or introducing tissue, angiogenic 
factors such as vascular endothelial growth factor (VEGF) (Kopf et al. 2010, Petersen et 
al. 2007) and angiogenin (King et al. 1991) have been utilized to promote neo-
vascularization (new vessel formation) at the site of repair. VEGF is a potent endothelial 
cell chemokine and mitogen that induces formation of new capillaries when delivered at 
high concentrations (Phillips et al. 1994), whereas angiogenin interacts with both 
endothelial and smooth muscle cells to promote formation of vascular structures (Gao et 
al. 2008). Although angiogenin was found to promote neo-vascularization of the avascular 
zone in rabbits, two sheep studies investigating the application of VEGF released through 
poly(d,l-lactide) acid suture coatings concluded that local treatment with VEGF did not 
enhance meniscal angiogenesis or healing in either the vascular or avascular zone (Kopf 
et al. 2010, Petersen et al. 2007) (Figure 2-6E). In these latter studies, the authors 
speculated that a longer duration of growth factor delivery, using a combination of several 
angiogenic factors involved in vessel wall assembly, may be necessary. These issues 
could be addressed by using a composite scaffold, where discrete components can be 
incorporated to release multiple bioactive factors with differing temporal release profiles 
(Richardson et al. 2001). For instance, Ionescu et al. recently developed an electrospun 
scaffold for fibrous connective tissue engineering that releases VEGF rapidly from water-
soluble poly(ethylene oxide) nanofibers and gradually from embedded poly(lactic-co-
glycolic acid) microspheres (Ionescu et al. 2012a). Using this versatile platform of gradual 
elution, a combination of VEGF, angiogenin, platelet-derived growth factor, and/or 
angiopoietin may be used to promote neovascularization. 
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Endogenous cells can also be acquired from the vasculature to increase cellularity and 
stimulate healing at the wound site, either via the introduction of a fibrin clot or through 
microfracture of the underlying bone. It has been argued that it is the hematoma and 
consequent clotting, rather than the continuous bloody supply, that are critical to the 
induction of a repair response (Webber et al. 1985). Acting as a source of reparative cells, 
growth factors, and temporary matrix, exogenous fibrin clots can be precipitated and 
inserted into meniscal defects to stimulate a healing response (Arnoczky et al. 1988, 
Henning et al. 1990, Henning et al. 1991, Nakhostine et al. 1991, van Trommel et al. 
1998). In a canine model, Arnockzy et al. found that meniscal defects filled with fibrin clots 
remodeled into fibrocartilage with chondroid cells after six months, although the reparative 
tissue could still be histologically distinguished from native tissue (Arnoczky et al. 1988). 
Clinical repair of acute, isolated meniscal tears, including complete radial tears that cross 
avascular regions, were also improved after clot injection (Henning et al. 1990, Ra et al. 
2012, van Trommel et al. 1998). Despite some experimental success, fibrin clots have not 
been widely adopted because they are difficult to place arthroscopically and are often 
destroyed or lost during the insertion process. To prevent loss after placement, the fibrin 
clot can be covered by a fascia sheath (Henning et al. 1991) or secured by a suture (Jang 
et al. 2011) (Figure 2-6F). A minimally invasive intra-articular method to create a fibrin clot 
in situ was also developed to bypass the difficulty of clot acquisition and placement (Sethi 
et al. 2003). Similarly, an artificial hematoma that releases marrow elements into the joint 
space via microfracture of the intercondylar notch can expedite early recovery (Driscoll et 
al. 2012, Freedman et al. 2003). To attract and protect endogenous fibrin clots and other 
host elements after hemarthrosis, small intestine submucosal grafts may be used to 
promote cellular attachment and expedite regeneration (Bradley et al. 2007, Cook et al. 
2006, Fox et al. 2004, Gastel et al. 2001). 
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2.4.2 Methods to Improve Cellularity 
While strategies for enhancing vascularization are promising, a more established 
approach is to harvest and deliver therapeutic cells to the wound site, independent of the 
blood supply (Figure 2-7). Cells can be recruited from adjacent tissues, injected directly 
into the lesion, or delivered via a scaffold to improve the intrinsically low cellularity of the 
native tissue. Ideally, cells should be autologous and abundant, easily acquired and 
expanded in vitro, and able to produce fibrocartilaginous matrix (Hoben et al. 2006). The 
success of autologous chondrocyte implantation (ACI) for cartilage repair demonstrates 
that cell therapy is clinically feasible and could be adapted to improve meniscal repair. Of 
particular interest for such applications are synoviocytes, chondrocytes, and meniscal 
cells, as well as multipotent mesenchymal stem cells (MSCs) that can differentiate into a 
meniscal-like cell phenotype.  
Located just adjacent to the meniscus, fibroblast-like type B synoviocytes produce matrix 
proteins such as collagen and hyaluronan for the intimal interstitium (Iwanaga et al. 2000). 
Studies by Arnoczky et al. have demonstrated that these cells can cross the synovio-
meniscal boundary to reach the wound site and contribute to the repair process (Arnoczky 
et al. 1985). It is also likely that cells of synovial origin play a role in integrating free synovial 
grafts (Ochi et al. 1996, Yamazaki et al. 2003) as well as repopulating meniscal allografts 
(Arnoczky et al. 1992, Rodeo et al. 2000). To that end, parameniscal abrasion of the 
synovial intima may liberate these cells and expedite their migration to the defect 
(Nakhostine et al. 1990).  
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Figure 2-7: Cellularity can be increased by (A) direct injection of cells into the lesion or (B) 
delivery via a scaffold. (C) Bone marrow-derived mesenchymal stem cells seeded onto a 
hyaluronan-collagen composite scaffold improved matrix production and integration in 
rabbits compared to untreated and acellular groups. Adapted from (Zellner et al. 2010). SEM 
image shows the integrated interface of the tissue (white arrow) and pre-cultured scaffold 
(black arrow). 
 
On the other hand, chondrocytes are typically harvested from articular cartilage, expanded 
in vitro, and delivered to the lesion site seeded inside a biocompatible scaffold. When 
inserted into a defect, allogenic chondrocytes improved bonding of the meniscal margins 
by depositing cartilaginous matrix that integrated the scaffold, in this case devitalized 
meniscus, with the native tissue (Peretti et al. 2004). In a more recent integration study, 
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Weinand et al. found that auricular chondrocytes seeded onto Vicryl meshes may provide 
more healing capacity than articular chondrocytes due to increased production of elastin 
(Weinand et al. 2006). Unlike synoviocytes and chondrocytes, meniscal cells have been 
evaluated more for their use in engineering replacement tissue than for their role in directly 
modulating repair. Nevertheless, due to their ability to deposit fibrocartilage when seeded 
onto 3D scaffolds, meniscal cells have potential to be used in the same way as 
chondrocytes for integrative repair (Baker et al. 2009a, Freymann et al. 2012, Ibarra et al. 
2000, Mueller et al. 1999, Nakata et al. 2001). Interestingly, the ability of meniscal cells to 
produce ECM in vitro does not decrease with age, making meniscal surgical debris a 
potential source of viable cells for implantation (Baker et al. 2009a). 
Another source of regenerative cells for meniscal repair applications is undifferentiated 
MSCs. These cells are capable of differentiating into chondrocytes or cells of other 
mesodermal lineage if provided the appropriate biochemical and mechanical cues. MSCs 
can be obtained from several sources, including bone marrow, synovium, and adipose 
tissue, thus bypassing the need to harvest meniscal or chondral tissue to isolate 
autologous cells. The most common technique for MSC delivery is injection either into the 
joint space or directly into the tear site, which is then often closed with sutures (Figure 
2-7A). Abdel-Hamid et al. found that injection of bone marrow MSCs into a meniscal tear 
in a canine model improved healing by promoting angiogenesis, chondrogenesis, and 
collagen fiber deposition (Abdel-Hamid et al. 2005). In rat and rabbit models, fluorescently 
labeled synovium-derived MSCs injected into the joint space filled meniscal defects and 
differentiated into chondrocytes that produced type II collagen (Horie et al. 2009, Horie et 
al. 2012, Mizuno et al. 2008). Adipose-derived MSCs produced similar regenerative 
effects when injected directly into avascular meniscal lesions in rabbits (Ruiz-Iban et al. 
2011). The first human case of autologous MSC transplantation for meniscal cartilage 
regeneration was done via percutaneous intra-articular injection (Centeno et al. 2008). 
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Bone marrow-derived MSCs were harvested from the iliac crest, expanded in vitro, and 
injected into the joint space of an osteoarthritic knee. Analysis via MRI showed evidence 
of increased meniscal volume after 3 months, although a biopsy was not performed to 
determine the composition of the new tissue.  
Despite the promise of cell therapy, it is often difficult to localize or retain cells at the lesion 
using injection alone. A study by Agung et al. tracking intra-articular injected bone marrow 
MSCs with green fluorescent protein (GFP) found that MSCs must be delivered in high 
numbers (1 x 107) for them to actively mobilize to the meniscus and generate extracellular 
matrix at the site of injury. However, this high concentration of cells also caused the 
formation of unwanted scar tissue (Agung et al. 2006) and may result in the undesirable 
colonization of surrounding structures. Consequently, it may be more effective to localize 
cell delivery to the region of interest with the use of a pre-seeded biodegradable scaffold 
(Figure 2-7B). For example, fluorescent tracking of transplanted MSCs that were 
embedded in fibrin glue demonstrated retention of cells inside the meniscal defect (Dutton 
et al. 2010, Izuta et al. 2005). Other successful biomaterials that have been used include 
collagen scaffolds (Pabbruwe et al. 2010) and hyaluronan-collagen composites (Zellner 
et al. 2010) (Figure 2-7C). It is important to note that while pre-culture of cells may 
generate fibrocartilage and thus improve mechanical properties, formation of new tissue 
also could inhibit integration of the scaffold in vivo (Ionescu et al. 2013, Zellner et al. 2010). 
Thus, while there are still many factors to optimize for cell-based treatments, there is 
strong evidence that viable autologous cells, and MSCs in particular, can significantly 
augment meniscal healing. 
 
2.4.3 Influence of Soluble Factors 
The mere presence of viable cells at the wound site does not in and of itself guarantee a 
robust repair response. To expedite the healing process, cells should be in a non-
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inflammatory, instructive environment that encourages proliferation and synthesis of 
extracellular matrix. McNulty et al. demonstrated that inhibition of inflammatory cytokines 
IL-1 and TNFα with IL-1 receptor antagonist (IL-1ra) and anti-TNFα monocolonal antibody 
(TNFα mAB), respectively, as well as inhibition of matrix metalloproteinase (MMP) activity 
improved the integration strength of meniscal explants in vitro (McNulty et al. 2007, 
McNulty et al. 2009) (Figure 2-8A and Table 2-1). MMP inhibitors, such as tetracycline, 
hold promise as agents that may potentiate meniscal healing. 
Conversely, growth factors such as transforming growth factor-beta (TGF-β) (Collier et al. 
1995, Esparza et al. 2012, Imler et al. 2004, Ionescu et al. 2012b, Kasemkijwattana et al. 
2000, McNulty et al. 2008), platelet-derived growth factor-AB (PDGF-AB) (Bhargava et al. 
1999, Imler et al. 2004, Kasemkijwattana et al. 2000, Lietman et al. 2003, Spindler et al. 
1995, Tumia et al. 2009), insulin-like growth factor-1 (IGF-1) (Bhargava et al. 1999, 
Esparza et al. 2012, Imler et al. 2004, Kasemkijwattana et al. 2000, Tumia et al. 2004b), 
and basic fibroblast growth factor (bFGF) (Esparza et al. 2012, Imler et al. 2004, Narita et 
al. 2009, Tumia et al. 2004a, Webber et al. 1985), have been investigated for their 
mitogenic and anabolic effects on meniscal cells (Table 2-1). Since integrative strength is 
correlated with collagen deposition and crosslinking (DiMicco et al. 2002), the most 
significant improvement occurs when ECM synthesis increases as a result of growth factor 
stimulation. Throughout the literature, the most successful growth factor for increasing cell 
division and proteoglycan and collagen production in cell cultures and tissue explants in 
vitro is TGF-β1 (Imler et al. 2004). McNulty et al. found that TGF-β1 supplementation 
increases the interfacial shear strength of meniscal explants enough to overcome the 
catabolic effects of IL-1-mediated MMP activity (McNulty et al. 2008). TGF-β3 has also 
been investigated for its pro-matrix effects and has been shown to improve the integration 
of juvenile and adult meniscal explants when delivered continuously over time in vitro 
(Ionescu et al. 2012b) (Figure 2-8C). 
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Growth 
factor 
Cellular effect 
Integrative 
potential 
Method(s) 
TGF-β 
Potent stimulator of 
matrix deposition 
Increased 
Monolayer (Collier et al. 
1995, Esparza et al. 2012, 
Kasemkijwattana et al. 
2000), Explant (Collier et al. 
1995) (Ionescu et al. 
2012b) (Imler et al. 2004, 
McNulty et al. 2008), 
Scaffold (Ionescu et al. 
2012b) 
PDGF-AB 
Intermediate stimulator 
of matrix deposition, 
proliferation, and 
migration 
No data 
Monolayer (Bhargava et al. 
1999, Kasemkijwattana et 
al. 2000, Tumia et al. 2009), 
Explant (Imler et al. 2004, 
Lietman et al. 2003, 
Spindler et al. 1995) 
IGF-1 
Monolayer (Bhargava et al. 
1999, Esparza et al. 2012, 
Kasemkijwattana et al. 
2000, Tumia et al. 2004b), 
Explant (Imler et al. 2004) 
bFGF 
Potent stimulator of 
proliferation 
No effect 
Monolayer (Esparza et al. 
2012, Kasemkijwattana et 
al. 2000, Tumia et al. 
2004a, Webber et al. 1985), 
Explant (Imler et al. 2004, 
Ionescu et al. 2012b, Narita 
et al. 2009), Scaffold 
(Ionescu et al. 2012b) 
Inflammatory 
inhibitor 
Cellular and/or 
environmental effect 
Integrative 
potential 
Method(s) 
IL-1ra 
Receptor antagonist 
competitively blocks IL-
1 receptor 
Increased  
Explant (McNulty et al. 
2007) 
Anti-TNF 
mAB 
Monoclonal antibody 
binds and inhibits TNFα 
Increased  
Explant (McNulty et al. 
2007) 
MMP inhibitor 
GM 6001 
Broad-spectrum MMP 
inhibitor 
Increased  
Explant (McNulty et al. 
2009) 
Table 2-1: Biologic factors of interest for meniscal repair and their effect on meniscal cell 
behavior and impact on integrative potential. 
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Growth factors of intermediate efficacy include PDGF-AB and IGF-1 (Imler et al. 2004). 
PDGF-AB also induces meniscal cell migration (Bhargava et al. 1999) as well as 
proteoglycan production (Imler et al. 2004, Lietman et al. 2003), making it an attractive 
agent for recruiting endogenous cells to the wound margin. However, region-specific 
response to PDGF-AB has been reported, where proliferation increased within meniscal 
explants from peripheral zone but not so in central region, possibly due to local variation 
in growth factor receptors (Spindler et al. 1995). Subsequent studies found that meniscal 
cells from all zones show a proliferative response in monolayer culture, suggesting that 
regional matrix sequestration of soluble factors may be the cause instead (Bhargava et al. 
1999, Tumia et al. 2009). IGF-1 supplementation similarly enhances cellularity and ECM 
synthesis, and is especially stimulatory for cells in the inner avascular zone (Tumia et al. 
2004b). Less successful have been growth factors that stimulate proliferation but little to 
no increase in matrix protein production, such as bFGF (Esparza et al. 2012, Imler et al. 
2004, Ionescu et al. 2012b, Kasemkijwattana et al. 2000, Tumia et al. 2004a, Webber et 
al. 1985), perhaps because less resources are devoted to repair when cells are in a mitotic 
state (Figure 2-8C). In this case, it may be beneficial to deliver a mitogen over the short-
term, coupled with sustained delivery of a pro-matrix growth factor either via drug-
releasing scaffolds or sutures, or gene transfer to ensure long-term stability. 
 
2.4.4 Influence of Mechanical Factors  
Inflammation and matrix production, and therefore the repair outcome, is also mechano-
responsive. Meniscal cell gene expression controlling the balance of structural protein 
synthesis and degradation can be altered by mechanical stimuli, such as tensile and 
compressive loading. Meniscal cells in monolayer respond to cyclic biaxial stretch by 
increasing matrix protein biosynthesis (Upton et al. 2006b). MSCs cultured in nanofibrous 
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scaffolds respond similarly to dynamic tensile loading, with improvements in matrix 
production and tensile modulus in engineered fibrocartilage (Baker et al. 2011). In studies 
done with meniscal explants, static but not dynamic compression increased MMP activity 
and inhibited matrix production, even in the presence of anabolic growth factors (Imler et 
al. 2004, Upton et al. 2003). In fact, cyclic loading was required for meniscal homeostasis 
(Natsu-Ume et al. 2005) and treatment with dynamic compression antagonized the 
catabolic effects of IL-1-mediated MMP degradation and consequent glycosaminoglycan 
release in meniscal explants (McNulty et al. 2010) (Figure 2-8C). Nonetheless, 
overloading the meniscus at high strains (10–20%) (Zielinska et al. 2009) or high strain 
rates (50%/s) may cause cell lysis and tissue damage that is physically undetectable 
(Nishimuta et al. 2012). These studies clearly show that the mechanical environment can 
synergize with the biochemical environment to promote (or delay) repair, depending on 
the duration and degree of loading applied. 
These effects of mechanical forces on meniscal repair are also seen in vivo. For instance, 
prolonged cast immobilization prevented collagen production in a canine model, indicating 
that normal joint mobility is essential to encourage meniscal healing (Dowdy et al. 1995). 
Furthermore, immobilization significantly reduced blood flow post-injury in rabbits and 
promoted menisci degeneration (Bray et al. 2001, Huang et al. 1991, Ochi et al. 1997). A 
sheep study yielded similar findings, where weight-bearing menisci supported more load 
than those that were immobilized after suture repair (Guisasola et al. 2002). Collectively, 
these results suggest that controlled mobilization should be initiated as soon as possible 
after repair to encourage long-term healing of isolated lesions, although rehabilitation 
should be passive or at a low, controlled intensity to prevent tear destabilization and intra-
articular damage in the immediate post-operative period. 
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Figure 2-8: Modification of the environment via biochemical and mechanical cues can 
augment integration. (A) The addition of IL-1 receptor antagonist (IL-1ra) in the presence of 
inflammatory cytokine IL-1 increases integrative shear strength of porcine meniscus in 
vitro. Adapted from (McNulty et al. 2007). (B) The application of dynamic loading increases 
integrative shear strength of porcine meniscus in vitro, overriding the catabolic effects of 
IL-1. Adapted from (McNulty et al. 2010). (C) Supplementation with the pro-matrix growth 
factor TGF-β3 improves integration strength of juvenile bovine meniscus in vitro, while 
addition of pro-mitotic bFGF does not enhance repair, even when applied in conjunction 
with TGF-β3. Adapted from (Ionescu et al. 2012b). 
 
2.5 Summary and Future Directions 
As the negative sequelae of meniscectomy become clearer, development of novel 
methods aimed at the biologic augmentation of meniscal healing has increased 
tremendously in recent years. Other emerging approaches that aim to enhance repair 
include high frequency stimulation (Pavlovich 1998), partial enzymatic degradation of the 
wound margin (Qu et al. 2013), and pro-matrix gene therapy (Kasemkijwattana et al. 2000, 
Zhang et al. 2009). The advancement of biocompatible scaffolds, either as a vehicle for 
delivering cells and/or bioactive molecules or as engineered meniscal replacements, is 
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also highly promising. Such tissue engineered constructs could be used to replace large 
portions of resected degenerate tissue injured beyond physical repair. Already, two 
synthetic implants have been clinically approved for use in Europe, one composed of 
collagen (Collagen Meniscus Implant (CMI), Ivy Sports Medicine LLC) and the other 
polyurethane (Actifit®, Orteq Ltd) (Vrancken et al. 2012). However, these implants are not 
tailored to match individual patient dimensions, nor do their microstructure replicate the 
mechanical anisotropy seen in native meniscus. Novel approaches to generate 
anatomically correct structures have recently emerged, including the use of image-guided 
injection molding to replicate meniscus geometry (Ballyns et al. 2008) and the 
electrospinning of circumferentially oriented nanofibers to mimic collagen alignment and 
mechanical properties (Fisher et al. 2013). These engineered constructs offer promise for 
replacement when endogenous repair cannot resolve the meniscal injury. 
Regardless of the specific technique or application (improvement of repair or replacement 
of damaged tissue), future directions will increasingly focus on combining minimally 
invasive surgical stabilization with cell therapy and stimulatory environmental cues to 
encourage vascularization and integration at the lesion site. As these experimental 
methods for avascular tear repair become clinically available, the current standard of 
partial meniscal removal will be shifted towards a paradigm of preservation and 
regeneration. This transition towards regeneration and/or functional replacement has the 
potential to dramatically improve long-term joint health in the many thousands of patients 
who suffer from the sequelae of acute and degenerative meniscus pathology. 
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CHAPTER 3: CELL MIGRATION IN 3D ENVIRONMENTS: IMPLICATIONS FOR 
FIBROUS WOUND REPAIR AND TISSUE ENGINEERING 
 
3.1 Abstract 
Cell migration in physiologic 3D microenvironments is considerably different than 
migration on 2D substrates. Steric hindrances force cells to adapt to the shape of its 
confines, deform past biophysical barriers, and/or remodel their pericellular matrix in order 
to migrate. These issues are especially important for dense connective tissue repair, 
where endogenous cells must navigate through a dense and stiff collagenous matrix to 
reach the wound site. Cells infiltrating into biomimetic scaffolds face similar challenges. 
This chapter will address the complexities of the 3D microenvironment from three separate 
but interdependent perspectives: basic science, physiology, and tissue engineering. By 
appreciating the fundamental mechanisms governing interstitial cell migration, improved 
methods may emerge that maximize endogenous cell-mediated repair and regeneration. 
 
3.2 Introduction 
Cell migration plays a pivotal role in numerous physiological and pathophysiological 
processes, including embryogenesis, tissue morphogenesis, immune surveillance and 
inflammation, wound healing, and cancer metastasis (Franz et al. 2002). The efficacy and 
mode of migration is governed by a multifaceted set of biophysical and biochemical factors 
that are dependent on both cellular and extracellular matrix (ECM) properties. In the most 
general sense, a net protrusive force generated by cytoskeletal contraction allows the cell 
to overcome the frictional resistance from the environment and move forward (Friedl et al. 
2000a). First, actin assembly at the leading edge of the cell results in cell polarization and 
the formation of actin-rich protrusions, orienting it in the direction of intended movement. 
Transmembrane adhesion receptors mediate interaction with the surrounding ECM, 
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allowing the cell to form focal adhesions upon which to generate traction at the leading 
edge. Actomyosin cytoskeletal contraction then produces tension between the leading and 
trailing edges, resulting in the detachment of adhesions in the trailing edge and at last, 
forward sliding of the cell rear. 
While the mechanisms of migration have been probed extensively on planar substrates, 
these 2D systems are not reflective of the in vivo environment, where most cells exist 
within a complex and physically restrictive 3D matrix. Cells moving on 2D surfaces are not 
constrained in the horizontal plane and consequently exhibit flat, well-spread 
morphologies with adhesions limited to the basal surface, with their movement guided by 
broad, leading lamellipodia (Friedl et al. 2000b, Friedl et al. 2010). In contrast, cells in 3D 
tend to assume stellate or spindle shapes, with adhesions distributed in all directions and 
cylindrical protrusions known as pseudopodia (Cukierman et al. 2001, Pathak et al. 2011). 
This extra dimensionality introduces ECM density, stiffness, organization, and biochemical 
composition as determinants of cell locomotion. Cells may dynamically respond to these 
factors by adapting their shape, actomyosin machinery, and migration strategy (Friedl et 
al. 2010). Furthermore, cells are sensitive to mechanical and chemical gradients in their 
environment, which can potentiate motility and directed movement. 
Understanding how cells migrate in native tissue environments is key to optimizing tissue 
repair and regeneration. In the first two sections of this chapter, the different cellular and 
environmental factors influencing 3D migration will be independently considered. The third 
section will describe the role of interstitial migration in dense connective tissue repair and 
the changes that occur during aging. Finally, current methods to enhance cell migration 
into artificial scaffolds will be discussed, with an emphasis on the implications for fibrous 
tissue engineering. 
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3.3 Cellular Factors Affecting 3D Migration 
Interstitial migration is a coordinated dance of adhesion, cytoskeletal dynamics, 
deformation of the cell body and its intracellular constituents, and/or matrix remodeling. 
The mode of migration is primarily dependent on the cell type. Leukocytes are ellipsoid, 
deformable, and move rapidly in an ‘amoeboid’ mode, which is characterized by transient 
adhesion and low contractility (Friedl et al. 2010). In contrast, spindle-shaped fibroblasts 
move in a slower ‘mesenchymal’ mode, which involves the formation of focal adhesions 
and contractile stress fibers. Single-cell migration is also different from collective 
migration, where cellular aggregates move in a coordinated stream or sheet, relying in 
part on their adhesion to one another to influence mobility (Friedl et al. 2010). Although 
the rest of this chapter will focus on single-cell ‘mesenchymal’ migration, the basic 
principles covered apply to all migrating cells. 
 
3.3.1 Cell Adhesion and Mechanotransduction 
Cell-matrix adhesion occurs when transmembrane receptors known as integrins engage 
with ECM components. Integrins are heterodimeric proteins that consist of α and β 
subunits, which bind to various ligands via specific peptide sequences (Walters et al. 
2015). When integrins bind to their respective ligands, both structural and signaling 
molecules are recruited to the cell membrane to form focal adhesions that join with actin 
filaments to mechanically link the ECM and cytoskeleton. Focal adhesions anchor the cell 
to its substrate, enabling transmission of mechanical information as the actomyosin 
machinery contracts via the sliding of nonmuscle myosin II and actin filament stress fibers 
(Figure 3-1A). This increase in cytoskeletal tension is transmitted back to the ECM to pull 
the cell forward. Force sensation by stress fibers can also feed back to alter the focal 
adhesions themselves, activating the RhoA/ROCK (Rho associated protein kinase) 
pathway to increase contractility (Petrie et al. 2012). Blocking integrin-mediated adhesion, 
 32 
 
as well as ROCK phosphorylation of its downstream effector, myosin light chain (MLC), 
reduces migration speed in a dose-dependent manner (Wolf et al. 2013) (Figure 3-1B 
and Figure 3-1C). 
 
 
Figure 3-1: Cell adhesion and contractility are required for 3D migration. (A) 
Mechanosensing matrix rigidity via the RhoA/ROCK/myosin II axis. Adapted from (Petrie et 
al. 2012). (B) Blocking cell adhesion via an anti-β1 integrin antibody (4B4, top) and 
contractility via the ROCK inhibitor Y-27632 (bottom) reduces cell migration speed in 
collagen gels. Cell-produced MMPs are inhibited in the GM6001 group. Adapted from (Wolf 
et al. 2013). 
 
Several studies report that migration occurs most rapidly at an intermediate adhesive 
ligand density (Lautscham et al. 2015, Singh et al. 2014), similar to migration in 2D 
(Palecek et al. 1997). Interestingly, focal adhesion proteins that normally form aggregates 
on 2D surfaces (e.g., vinculin, paxillin, talin, α‑actinin) remain diffuse in cells moving within 
3D environments. Fraley and colleagues found that, rather than producing a single 
prolonged protrusion, focal adhesions in 3D were associated with increased protrusive 
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activity and matrix deformation, suggesting that cells actively engage with their 
environment before selecting a route for migration (Fraley et al. 2010). 
 
 
3.3.2 Nuclear Mechanics 
In confined passages, cells must physically deform to move forward (Figure 3-2A). The 
nucleus is considered the rate-limiting organelle in migration due to its large size and 
stiffness, which is 2–4 times higher than the surrounding cytoplasm (Guilak et al. 2000). 
When the nuclear cross-sectional area is >4 times the area of the constriction, cells stall 
at the channel entrance and migration speed significantly declines as they enter (Friedl et 
al. 2011, Lautscham et al. 2015) (Figure 3-2B). As the nucleus exits the constriction, its 
velocity increases due to the dissipation of stored elastic energy. Indeed, nuclear 
deformation of most cells is limited to a diameter of 3–4 μm (Wolf et al. 2013). This 
limitation is partly a function of the chromatin structure, such that higher degrees of 
chromatin condensation reduce nuclear plasticity and increase stiffness (Friedl et al. 2011, 
Pajerowski et al. 2007). Of equal importance are type V intermediate filament proteins 
called lamins that provide structure and stability to the nuclear envelope, with lamins A 
and C (lamin A/C) being the major contributors to nuclear mechanics (Lammerding et al. 
2006). While cells with stiff nuclei display limited migratory capacity inside dense collagen 
gels, cells with compliant nuclei that lack lamin A/C, such as leukocytes and certain cancer 
cells, remain highly mobile (Friedl et al. 2011, Rowat et al. 2013, Wolf et al. 2013). 
Restoring nuclear plasticity by reducing lamin A/C enhances 3D migration through small 
pores (Greiner et al. 2014, Harada et al. 2014), whereas overexpressing lamin A reduces 
migratory capacity (Booth-Gauthier et al. 2013, Lautscham et al. 2015, Rowat et al. 2013) 
(Figure 3-2C–E). Since nuclear deformation also relies on actomyosin-generated 
contractility and nuclear-cytoskeletal force transmission (Driscoll et al. 2015), disrupting 
 34 
 
linkers of the nucleoskeleton to the cytoskeleton likewise reduces migration (Khatau et al. 
2012). Alternatively, the nucleus may also act as a piston that physically 
compartmentalizes the cytoplasm, such that increasing hydrostatic pressure between the 
nucleus and the forward elements of the cell can act to push the cell forward (Petrie et al. 
2014). It should be recognized that while the nucleus is a steric barrier to migration, 
depletion of lamin beyond certain levels can make them susceptible to stress-induced cell 
death, where the act of squeezing the nucleus through a small pore results in nuclear 
fragmentation (Harada et al. 2014). 
 
  
Figure 3-2: Nuclear stiffness is a physical impediment to interstitial cell migration. (A) 
Schematic showing a cell migrating through a fibrous matrix, deforming the cell body and 
nucleus as it passes through a constriction. (B) Phases of nuclear deformation: (1) 
resistance, (2) local prolapse, (3) compression and gliding, and (4) rear release. Plot 
illustrating nuclear velocity over time for the phases above. Scale = 5 µm. Adapted from 
(Friedl et al. 2011). (C) Plot illustrating cell migration speed as a function of lamin A 
expression (Knockout (KO), Wild Type (WT), Overexpression (OE)). Migration efficiency is 
highest with a moderate level of lamin A KO. Adapted from (Swift et al. 2014). (D) Lamin A 
KO enhances cell migration through porous barriers. Adapted from (Greiner et al. 2013). (E) 
Lamin A OE reduces cell migration through microporous membranes. Adapted from (Rowat 
et al. 2013). 
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3.3.3 Cell-Mediated Matrix Degradation 
Interstitial migration through dense or impenetrable matrices is often aided by cell-
produced matrix metalloproteinases (MMPs), which cleave ECM molecules at specific 
peptide sequences to generate a gap wide enough to allow for cell passage (Lu et al. 
2011) (Figure 3-3). MMP expression is also mechanosensitive: it is enhanced on stiff 
substrates (Haage et al. 2014, Nukuda et al. 2015) via increased focal adhesion kinase 
(FAK) activity that is triggered by integrin clustering (Wu et al. 2005, Zhao et al. 2015). 
Cells can likewise remodel the matrix by contact-dependent, membrane-bound MMPs or 
by secretion of MMPs into the pericellular space (Friedl et al. 2000a). Cell surface binding 
of MMPs, which includes MMP-2, MMP-9, and membrane-type (MT)-MMPs, localizes 
proteolysis to the cell periphery, such that tube-like trails are generated behind the 
migrating cell (Friedl et al. 2009). Normal fibroblasts use this method, as do malignant 
neoplastic cells during metastatic invasion (Friedl et al. 2000a). In contrast, protease 
secretion results in a diffuse proteolysis that reduces biophysical matrix resistance at 
distances further than the cell membrane, acting to soften the tissue around pre-existing 
gaps in the ECM so as to make it easier to deform during passage. This method is 
commonly used in large-scale tissue remodeling events, such as morphogenesis and 
wound healing, although deregulated expression of matrix-degrading enzymes can result 
in collective tumor invasion (Lu et al. 2011). If cell-produced MMPs are inhibited, cells 
migrate (where they can) by adapting their shape to squeeze through pre-existing pores 
and by locally deforming the ECM network (Friedl et al. 2010), significantly reducing 
migration speed (Raeber et al. 2007, Wolf et al. 2013, Zaman et al. 2006). However, when 
pore dimensions are below the lower limit of nuclear deformation, cells become 
immobilized (Wolf et al. 2013). 
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Figure 3-3: Stages of interstitial migration with or without matrix remodeling. (1) Initial cell 
polarization with rotation of the nucleus, (2) cellular adhesion of integrins, (3) cytoskeletal 
contraction of stress fibers (red), (4a) surface localization and secretion of matrix-degrading 
enzymes (green) to enlarge the matrix pores allowing for cell passage without deformation, 
and (4b) non-proteolytic migration requiring deformation of the cell and nucleus. Adapted 
from (Friedl et al. 2011). 
 
3.4 Extracellular Matrix Factors Affecting 3D Migration 
Synthesized by resident cells, the ECM provides shape and structure to tissues, offers 
binding sites for cells and growth factors, and regulates cell behavior, intercellular 
communication, and mechanical load transmission (Mouw et al. 2014). Besides water, 
major ECM molecules include fibrillar and non-fibrillar collagens, elastin, 
glycosaminoglycans (GAGs) (e.g., hyaluronan, chondroitin sulfate), proteoglycans (PGs) 
(e.g., decorin, biglycan, aggrecan), and glycoproteins (e.g., fibronectin, laminin) (Halper 
et al. 2014). Collagen and elastin fibers are the primary structural proteins in the ECM and 
are important for tensile load bearing and tissue elasticity. Of note, fibrillar collagens 
(especially type I collagen) are the most abundant component of connective tissues. 
Single collagen molecules (tropocollagen) are organized into increasingly larger rope-like 
aggregates (fibrils, fibers, fiber bundles) via covalent crosslinks and/or interactions with 
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other ECM components, and are highly aligned and tightly packed in dense connective 
tissues. GAGs and PGs contain hydrophilic polysaccharides with a high density of 
negative charges, resulting in osmotic swelling of the tissue that imparts resistance to 
compressive forces. Small leucine-rich PGs (SLRPs), including decorin and biglycan, are 
also implicated in collagen fibrillogenesis, assembly, and organization (Connizzo et al. 
2013). Glycoproteins reinforce the structural ECM network, as well as facilitate 
connections between cells and the ECM via binding to cellular integrins (Halper et al. 
2014). Within this intricate 3D environment, cells must translate extracellular stimuli into 
intracellular signals that ultimately influence downstream behaviors, including migration. 
Three major ECM determinants of migration will be discussed in the following sections. 
These include: matrix micromechanics, matrix microstructure (fiber alignment and 
density), and insoluble and soluble biochemical cues (adhesive and chemoattractive 
signals). 
 
3.4.1 Matrix Micromechanics 
Variations in the biochemical composition and organization of ECM molecules give rise to 
the biophysical and biological functions of different tissues (Figure 3-4). For example, the 
ECM can be classified as loose connective tissue (e.g., adipose, lymphoid organs), dense 
irregular connective tissue (e.g., joint capsule, fascia, dermis), or dense regular connective 
tissue (e.g., meniscus, tendon/ligament) (Figure 3-4B). The mechanical properties of 
biological tissues vary by length scale due to the heterogeneity and hierarchical nature of 
its building blocks. To understand cellular interactions with its microenvironment, tissue 
mechanics are examined on the microscale (micromechanics) rather than on the 
macroscale (bulk mechanics). This is typically accomplished by indentation via atomic 
force microscopy (AFM) (Kwok et al. 2014, Qu et al. 2015, Sanchez-Adams et al. 2013), 
local strain tracking (Szczesny et al. 2014), or shear rheometry (Chan et al. 2008). As a 
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rule of thumb, tissue collagen content, density, and alignment increase with load-bearing 
capacity, resulting in higher ECM mechanical properties (i.e., Young’s modulus) (Figure 
3-4C), which are often referred to colloquially as the tissue ‘stiffness’ or ‘rigidity’, although 
these last two terms are actually structural properties (depend on sample size/shape) and 
not inherent mechanical properties (independent of a tissue size/shape). 
 
 
Figure 3-4: Collagen content and organization of native tissues. (A) Collagen content (µg/mg 
wet weight) of various mouse and bovine tissues. Data adapted from QuickZyme 
Biosciences (www.quickzyme.com). (B) Matrix density and organization of loose connective 
tissue (lymph gland, Methenamine Silver/Mallory Trichome), dense irregular connective 
tissue (dermis, H&E), and dense regular connective tissue (tendon, H&E). Adapted from 
Histology Guide, University of Leeds (www.histology.leeds.ac.uk). (C) Type I collagen 
content and corresponding stiffness of various mouse tissues. Adapted from (Swift et al. 
2013). (D) Pore size (top) and storage modulus (bottom) of collagen gels commonly used in 
migration studies, as a function of collagen gel concentration. Adapted from (Miron-
Mendoza et al. 2010). 
 
Cells sense matrix stiffness via integrin-mediated adhesions, recruiting focal adhesion 
proteins that activate downstream mechanotransduction pathways (e.g., 
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RhoA/ROCK/myosin II), which ultimate feed back to reinforce the adhesions (Petrie et al. 
2012) (Figure 3-1A). In stiff environments, this signaling feedback loop results in the 
generation of high traction forces by the actomyosin contractile machinery and cell 
spreading. However, when the matrix stiffness is too high, cells in confined spaces cannot 
deform their surroundings to pass through. On the other hand, although focal adhesions 
are not reinforced on compliant substrates, cells may physically enlarge pre-existing gaps. 
Ulrich and colleagues found that increasing the gel stiffness induced a mesenchymal-to-
amoeboid transition in glioma cell motility (Ulrich et al. 2010). Ehrbar et al. found that while 
migration was inhibited with high gel stiffness, introduction of MMP-degradable linkages 
into the gel rescued migration (Ehrbar et al. 2011) (Figure 3-5A). These results indicate 
that cells can partly overcome the steric hindrance of stiff environments via extreme cell 
body deformation and/or matrix degradation. Similar to findings in 2D (Peyton et al. 2005), 
there appears to be a bimodal relationship between matrix stiffness and migration in 3D, 
such that there is an intermediate stiffness that maximizes migration speed (Pathak et al. 
2012, Peyton et al. 2011, Singh et al. 2014, Zaman et al. 2006), although this is 
significantly influenced by the level of cell-ECM adhesion (Singh et al. 2014, Zaman et al. 
2006) and matrix pore size (Pathak et al. 2012, Peyton et al. 2011). In addition, cells sense 
and respond to mechanical gradients in 2D by preferentially migrating towards regions of 
higher rigidity, a phenomenon known as durotaxis (Lo et al. 2000, Raab et al. 2012, 
Vincent et al. 2013). Due to the difficulty of fabricating and encapsulating cells inside 
graded 3D environments, most migration studies have been conducted with collagen-
embedded cells that are laid over graded substrates via a two-stage casting process 
(Hadjipanayi et al. 2009, Raab et al. 2012). While cells do migrate from soft to stiff regions 
in these systems, migration occurs parallel to the stiffness gradient axis of the underlying 
substrate. Thus, the role of durotaxis in 3D remains unclear. In all cases, it is difficult to 
decouple the effect of stiffness from that of pore size and/or adhesivity because hydrogel 
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mechanics are often directly related to matrix density (and in the case of ECM-derived 
materials, adhesive ligand concentration). Moreover, since the collagen concentration, 
stiffness, and fibril organization of most gels used in these 3D assays are extremely low 
(~100X lower concentration than that of connective tissues, Figure 3-4A and Figure 
3-4D), it is unknown to what extent these findings apply to migration in dense connective 
tissues. 
 
3.4.2 Matrix Microstructure 
The microstructure of connective tissues is dependent on collagen content, fiber 
alignment, and inter-fiber porosity and pore size. Cells in a loose ECM with large pores 
are rounded, whereas cells in a dense ECM with small pores are elongated and spindle-
shaped, due to a reduction in cell diameter. Wolf et al. found that migration speed through 
collagen gels decreased with pore size, an effect that was accentuated with MMP 
inhibition (Wolf et al. 2013) (Figure 3-5B). Using a lattice Monte Carlo simulation to 
independently evaluate the effects of matrix deformability, pore size, and MMP 
degradation, Zaman et al. demonstrated that even a high level of cell-mediated matrix 
deformation (50%) cannot compensate for decreased pore size below a certain limit 
(Zaman et al. 2007). The number of cells translocating through microporous membranes 
also decreases with pore size (Wolf et al. 2013) (Figure 3-5C). Together, these results 
suggest that pore size, and not stiffness, is the true limiting physical factor. As with ECM 
stiffness, a bimodal relationship exists between pore size and migration speed (Kim et al. 
2012b, Lautscham et al. 2015, Pathak et al. 2012, Peyton et al. 2011, Singh et al. 2014, 
Zaman et al. 2007), although this also depends on adhesion ligand concentration (Kim et 
al. 2012b, Lautscham et al. 2015, Peyton et al. 2011). Since contact guidance (response 
to topographic cues) is diminished in wide channels, migration is optimal at pore diameters 
that match or are slightly less than the diameter of migrating cells (Friedl et al. 2010). 
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Figure 3-5: Cell migration is impaired in stiff and dense matrices. (A) Cell migration through 
RGD-modified PEG hydrogels decreases with increasing gel stiffness. Addition of MMP-
degradable linkages partially rescues migration. Adapted from (Ehrbar et al. 2011). (B) 
Migration speed through collagen gels decreases as a function of pore size. Cell-produced 
MMPs are inhibited in the GM6001 group. Adapted from (Wolf et al. 2013). (C) Confocal 
cross-sections show cells migrating though polycarbonate pores of increasing size (red = 
cytoplasm, green = nucleus). Cells are immobilized by 1 µm diameter pores. Scale = 10 µm. 
Adapted from (Wolf et al. 2013). 
 
Migrating cells adapt to the spatial confinement of their environment by traveling along a 
path of least resistance (Friedl et al. 2010). For example, T-cells avoid areas of dense 
ECM, preferring to travel along fibrillar strands (Friedl et al. 1998). Due to the fibrous, 
interconnected nature of ECMs, contact guidance can play a central role in interstitial 
migration. Indeed, cells preferentially align and migrate along fibers in collagen gels, and 
migration speed increases with collagen alignment (Fraley et al. 2015, Petrie et al. 2009, 
Provenzano et al. 2008). This directional migration is mediated by Rho/ROCK-mediated 
contractility, which preferentially aligns new cellular protrusions along the fiber axis, 
increasing migration persistence (Petrie et al. 2009). Conversely, migration orthogonal to 
the fiber direction is suppressed (Dickinson et al. 1994, Riching et al. 2014). 
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3.4.3 Biochemical Signals 
The ECM provides a wealth of signaling molecules. Of the insoluble signals, the most 
important are ECM ligands, which enable direct coupling of the cytoskeleton to the 
environment by binding to cellular integrins. In general, higher ECM ligand density 
increases cell adhesion and contractility, but reduces 3D migration speed compared to an 
intermediate density (Lautscham et al. 2015, Singh et al. 2014). On the other hand, a low 
ECM ligand density promotes cell detachment and does not support contractile force 
generation, leading to even slower migration. The most prevalent adhesive peptide motif 
within the ECM is Arginine-Glycine-Aspartic acid (RGD) (Walters et al. 2015). This 
sequence is present in fibronectin, laminin, vitronectin, fibrinogen, and various other ECM 
proteins, and binds with high affinity to 8 types of integrin heterodimers. Another common 
motif, glycine-phenylalanine-hydroxyproline-glycine-glutamate-arginine (GFOGER), is 
found on collagen types I, II, and III. Different integrins bind to fibronectin and collagen, 
resulting in disparate downstream signaling and behavior (Seong et al. 2013, Walters et 
al. 2015). 
Fibronectin also functions to sequester a host of growth factors, including latent 
transforming growth factor-β1 (TGF-β1), platelet-derived growth factor (PDGF), 
hepatocyte growth factor (HGF), and fibroblast growth factor 2 (FGF2) (Hinz 2015). While 
TGF-β1 is kept in a latent form, it can be activated by cellular contraction to stimulate 
migration in some cell types, notably epithelial cells (Giehl et al. 2006). PDGF, HGF, and 
FGF2 are all known chemoattractants, which stimulate directional migration of cells (the 
ability to move in a persistent direction) (Vorotnikov et al. 2014). The rapid release of 
soluble growth factors from the ECM during matrix degradation and/or after injury may 
induce chemotaxis, defined as the directed movement of cells towards the source of a 
soluble gradient. Directional sensing is accomplished via binding of the chemoattractant 
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to cell surface receptors, which activates signaling pathways that promote cell polarization 
and the formation of protrusions, adhesions, and contractile forces. Similarly, cells may 
migrate towards a substrate-bound gradient, such as that of fibronectin (Wu et al. 2012). 
 
3.5 Role of Cell Migration in Dense Connective Tissue Repair 
Dense connective tissues include the knee and temporomandibular menisci, tendons and 
ligaments, and the annulus fibrosus of the intervertebral disc (Figure 3-6). These tissues 
are characterized by densely packed and highly organized collagen fibers, which impart 
tensile strength along the fiber direction. Given that this structure-function relationship is 
essential for resisting forces within the musculoskeletal system, injuries that disrupt the 
fibrous architecture significantly reduce the mechanical functionality of these tissues. 
 
 
Figure 3-6: Collagen organization of fiber-reinforced tissues. (A) Scanning electron 
micrographs of the annulus fibrosus of the intervertebral disc, (B) knee meniscus, and (C) 
ligament. (D) Top down view of the aligned circumferential collagen fibrils in the knee 
meniscus. (E) Fibrochondrocytes within the ECM. (F) Transverse view of the circumferential 
collagen fibrils of the knee meniscus. Scale = (A) 200 µm, (B) 500 µm, (C) 100 µm, and (D and 
F) 2 µm. Adapted from (A) (Iatridis et al. 2004), (B) (Petersen et al. 1998), (C) (Provenzano et 
al. 2002), and (E) (Chevrier et al. 2009). Images (D) and (F) courtesy of Qing Li. 
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3.5.1 Phases of Wound Repair 
In the case of fibrous wound repair, effective migration is critical for the initial inflammatory 
phase (hours to days), during which immune cells clear dead cells, pathogens, and debris, 
and for the later proliferative phase, during which reparative cells actively divide and 
migrate into the wound bed to deposit new tissue and contract the wound (days to weeks) 
(Yang et al. 2013). This is followed by a period of matrix remodeling (weeks to months), 
where the scar tissue is organized into mature, crosslinked type I collagen fibers that 
become aligned along the direction of stress to restore biomechanical function. While 
tissues with a well-established vascular supply may depend in part on circulating 
mesenchymal stem cells to promote repair, most dense connective tissues in the mature 
state are hypovascular (Arnoczky et al. 1983, Hiraki et al. 2005) and thus must rely on 
cells intrinsic to the tissue and/or from extrinsic sources to affect repair. 
For example, in tendon injuries, both tenocytes from the endotenon and epitenon and 
fibroblasts from the tendon sheath and synovium contribute to the proliferative and 
remodeling phases (Manske et al. 1985). While intrinsic repair by native tenocytes results 
in superior functional outcomes (Fujita et al. 1992), exogenous cells often dominate the 
repair process, leading to scar tissue and adhesion formation (Lo et al. 2002, Sharma et 
al. 2006). Cadby et al. recently demonstrated that cells derived from the peritenon migrate 
faster than those derived from the tendon core, suggesting that enhanced ability to reach 
the wound site may increase the propensity for extrinsic repair (Cadby et al. 2014). This 
suggests therapeutic potential for regulating the ability of endogenous and extrinsic cells 
to reach the wound interface. 
In addition to endogenous primary cells, the adult knee meniscus harbors a stem cell-like 
population that is capable of migration and fibrochondrogensis in vitro (Mauck et al. 2007, 
Shen et al. 2014). However, lesions in the inner avascular portion remain hypocellular and 
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fail to self-repair in the long-term (Mesiha et al. 2007). While a fibrovascular scar may 
eventually physically bridge the wound gap, it is mechanically inferior and prone to re-
injury (Newman et al. 1989). Moreover, cells fail to colonize the central core of devitalized 
meniscal autografts after 6 months in a canine model (Arnoczky et al. 1992), and 
repopulation of meniscal allografts remain incomplete after 16 months in human patients 
(Rodeo et al. 2000). Overall, these studies indicate that impeded interstitial migration may 
contribute to poor meniscal wound healing. 
 
3.5.2 Cellular and Extracellular Changes with Age 
Unlike adult dense connective tissues, many fetal tissues, including meniscus (Ionescu et 
al. 2011), tendon (Beredjiklian et al. 2003), ligament (Provenzano et al. 2002), and 
intervertebral disc (Roughley 2004), exhibit a robust healing capacity. This regenerative 
capacity is independent of the fetal environment. For example, when fetal sheep tendons 
are injured, removed, and implanted into the subcutaneous space of adult immune-
deficient mice, healing proceeds in a manner comparable to that in the fetus (Favata et al. 
2006). Furthermore, fetal bovine meniscal explants (in the absence of vasculature) still 
exhibit superior integration in vitro compared to adult specimens, suggesting that there 
are intrinsic age-related differences that influence repair (Ionescu et al. 2011). Since cells 
make up a significantly higher proportion of the fetal tissue mass compared to adult tissues 
(Russo et al. 2015) (Figure 3-7C), it is not surprising that the intrinsic repair potential is 
much greater for fetal tissues. 
Several age-related factors may exacerbate the impaired healing of adult tissues. During 
development, ECM collagen content and alignment increase with load bearing while cell 
density declines (Clark et al. 1983, Marturano et al. 2013, Russo et al. 2015) (Figure 
3-7A–C), resulting in higher mechanical properties on the microscale (Marturano et al. 
2013) and bulk tissue levels (Ionescu et al. 2011) (Figure 3-7E). Compressive forces on 
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the inner meniscus also lead to substantial proteoglycan accumulation (Figure 3-7D), 
most notably aggrecan (Di Giancamillo et al. 2014, Ionescu et al. 2011, Melrose et al. 
2005). It is likely that the dense network of aligned collagen bundles of the mature 
meniscal ECM, coupled with a highly pressurized, proteoglycan-rich inner zone, prevent 
a sufficient population of endogenous progenitor cells from migrating to the defect to 
initiate repair (Morales 2007). 
 
 
Figure 3-7: Dense connective tissues become denser, stiffer, and less cellular with age. 
Tendons from fetal and adult sheep illustrate changes with maturation. (A) H&E staining 
showing ECM and cells, (B) immunostaining for type I collagen (green) with DAPI nuclear 
counterstain (blue), and (C) DAPI staining for cell nuclei. Cells in fetal tendon are numerous 
and ellipsoid, whereas the few cells in adult tendon are elongated along the fiber direction. 
Collagen content and organization increase with tendon age. § = tendon tissue proper, * = 
endotenon. Scale = (A) 50 µm, (B) 25 µm, and (C) 10 µm. Adapted from (Russo et al. 2015). 
(D) Radial sections from fetal, juvenile, and adult bovine menisci stained with Picrosirius 
Red (collagen) and Alcian Blue (proteoglycans). Adult tissue contains more proteoglycans 
in the inner zone than fetal and juvenile tissues. Scale = 10 mm. (E) Micromechanics (elastic 
modulus normalized to fetal tissue, measured via AFM indentation) and bulk mechanics 
(compressive equilibrium modulus) of fetal, juvenile, and adult bovine meniscus. Tissue 
becomes stiffer on both length scales with age. Adapted from (Ionescu et al. 2011). 
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As the ECM becomes stiffer and denser, cells become deformed within the narrow spaces 
between adjacent collagen bundles (Figure 3-7C) and must establish narrow cytoplasmic 
projections for cell-cell communication (Lo et al. 2002). In addition to reducing ECM 
porosity and pore size, the densely packed collagen may also increase adhesion ligand 
concentration, resulting in overly strong adhesive and contractile forces that impede 
forward movement. Furthermore, cells adapt their mechanotransduction machinery to 
reflect the mechanical changes to the microenvironment (Buxboim et al. 2014, Swift et al. 
2013). For example, nuclear stiffness and lamin A content increase when mesenchymal 
stem cells undergo differentiation (Pajerowski et al. 2007), and further escalate with aging 
of the meniscus (Figure 3-8). Since nuclear deformability is essential for interstitial 
migration through small pores, it is likely that adult meniscal cells are intrinsically less 
mobile in situ than fetal cells. Interestingly, the premature aging disorder Hutchinson-
Gilford Progeria Syndrome, caused by a mutation in the lamin A gene, is characterized by 
stiffer nuclei and decreased cell mobility in tight interstitia (Booth-Gauthier et al. 2013). 
 
 
Figure 3-8: Nuclear stiffness and lamin A content increase with cell age. (A) Schematic 
showing relative nuclear stiffness of stem cells as they differentiate over time. Adapted from 
(Swift et al. 2014). (B) Nuclear modulus and (C) lamin A content (normalized to β-actin) of 
fetal (Fet), juvenile (Juv), and adult (Adu) bovine meniscal fibrochondrocytes, and juvenile 
bovine mesenchymal stem cells (MSCs). Data courtesy of Claire McLeod (B) and Tristan 
Driscoll (C). 
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While monolayer migration of fetal and adult cells from various connective tissues has 
been evaluated, including the meniscus (Ionescu et al. 2011), ligament (Stalling et al. 
2008), tendon (Brink et al. 2006), and dermis (Sandulache et al. 2005), there is not a clear 
age-dependent trend, nor are these results indicative of migratory capacity in a more 
physiologic 3D setting. Sandulache et al. found that fetal dermal fibroblasts were more 
invasive of low-density collagen gels than adult fibroblasts at early time points, in part due 
to more frequent cell-matrix detachment (Sandulache et al. 2007). However, these 
collagen matrices were too compliant and porous to sterically hinder migration. Thus, while 
several cellular and ECM factors may contribute to the limited intrinsic repair capacity of 
adult dense connective tissues, the relationship between aging, interstitial cell mobility, 
and fibrous tissue healing remains to be explored.  
 
3.6 Cell Migration in Engineered Materials 
A fundamental understanding of how cells interact with their microenvironment is crucial 
to success in tissue engineering. Ideally, the scaffold material would allow for cell 
attachment, proliferation, and differentiation into a phenotype that culminates in synthesis 
of the desired ECM components. In the presence of proper environmental signals, this 
neo-tissue can be coaxed to mature, such that over time, the biochemical and 
biomechanical properties resemble that of native tissue. However, rapid cell attachment 
and proliferation on the scaffold surface may prevent cell penetration into the scaffold 
depth, resulting in a cell-rich outer edge but a necrotic center. As such, achieving sufficient 
cell density and homogenous distribution within the scaffold volume are vital steps towards 
generating functional tissue replacements. The remainder of this chapter will focus on 
techniques to enhance cell infiltration into 3D scaffolds, either after cell seeding in vitro or 
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implantation in vivo, by modulating scaffold micromechanics, microstructure, and insoluble 
and soluble biochemical cues. 
 
3.6.1 Scaffold Micromechanics 
A major objective of orthopaedic tissue engineering is to recapitulate the macroscopic 
mechanical properties of native tissues. Tensile moduli for dense connective tissues can 
be up to several hundred MPa along the primary fiber direction (Bullough et al. 1970, 
LeRoux et al. 2002, Proctor et al. 1989), although physiological loading usually occurs at 
lower strains within the toe region, which has somewhat lower moduli (Jones et al. 1996, 
Richards et al. 2003). One common way to fabricate biomimetic scaffolds is through 
electrospinning, a technique that utilizes an electrical potential difference to draw polymers 
into nanofibrous networks that can be either randomly deposited on a collector or highly 
aligned by collection on a rotating mandrel, replicating the organization of dense 
connective tissues (Mauck et al. 2009). Typical materials utilized for electrospinning 
include biocompatible and biodegradable synthetics such as poly(ε-caprolactone) (PCL), 
poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), as well as naturally-derived 
polymers like chitosan, silk fibroin, and collagen (Mauck et al. 2009). The mechanical 
properties of acellular constructs are determined by the intrinsic material properties of the 
electrospun polymer, electrospinning parameters and environment, and fiber organization 
within the scaffold. Most notably, uniaxial tensile strength is increased when nanofibers 
are deposited parallel to the loading direction, as it is in native tissue (Baker et al. 2007, 
Li et al. 2007). 
Although bulk mechanics are undeniably important, the resulting micromechanical 
environment is often overlooked and may not be optimized for cell migration. For example, 
few studies provide insight to the forces seen by cells grown on nanofibrous substrates, 
where focal adhesions may exert traction forces on single fibers and cellular processes 
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are influenced by mechanical feedback. A study by Meehan et al. found that cell migration 
speed on single, suspended polystyrene nanofibers decreased with structural stiffness, 
whereas focal adhesion complex length increased (Meehan et al. 2014). Although bulk 
tensile moduli for aligned nanofibrous scaffolds are typically in the MPa range, indentation 
of single nanofibers reveal a Young’s modulus between ~0.1–3 GPa for PCL (Croisier et 
al. 2012, Tan et al. 2005b, Thomas et al. 2006) and ~1 GPa for PLA (Inai et al. 2005, Tan 
et al. 2005a), a difference that reflects the crystalline structure of the polymer. When 
densely packed, these rigid fibers could present a formidable physical barrier to cell 
ingress. Consequently, cell colonization of PCL scaffolds is limited to the scaffold 
periphery after 10 weeks of in vitro culture (Baker et al. 2007, Baker et al. 2008), limiting 
matrix accumulation in the construct interior as well as integration with native tissue. 
To expedite cell infiltration of dense, stiff scaffolds, a common approach is to introduce 
MMP-sensitive moieties to the polymer backbone or crosslinker to enable cell-mediated 
remodeling. While this technique has been widely explored in the context of non-fibrous 
hydrogels (Bott et al. 2010, Ehrbar et al. 2011, Feng et al. 2014, Miller et al. 2010), it can 
also be applied to nanofibers (Law et al. 2007, Wade et al. 2015b). Cell-secreted 
proteolytic enzymes result in localized polymer degradation over time, softening the 
pericellular environment to enable cell mobility (Lee et al. 2005, Schultz et al. 2015). 
Indeed, micrometer-sized tracks generated by migrating cells are observed, which 
disappear with the addition of an MMP inhibitor. Cell migration and 3D network formation 
is faster in MMP-degradable PEG hydrogels compared to MMP-insensitive gels, a 
difference that is further accentuated in high stiffness gels (Ehrbar et al. 2011). As such, 
cell infiltration into stiff hydrogels in vivo is enhanced in the presence of MMP-cleavable 
linkages (Ehrbar et al. 2011) (Figure 3-9A). Adjusting the concentration and/or proteolytic 
sensitivity of the peptide may offer control over the rate of migration (Lutolf et al. 2003).  
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Figure 3-9: MMP-degradable hydrogels enhance cell invasion, matrix remodeling, and 
matrix synthesis. (A) H&E staining of soft and stiff MMP-degradable and MMP-insensitive 
(Non-degradable) poly(ethylene glycol) (PEG) hydrogels implanted within rat calvarial 
defects. After 2 weeks, endogenous cells invade, degrade, and remodel MMP-degradable 
matrices in a stiffness-dependent manner. Cell invasion is homogenous in soft gels and 
becomes less regular in stiff gels, and fewer cells invade Non-degradable gels. Adapted 
from (Ehrbar et al. 2011). (B) Schematic showing encapsulation of human mesenchymal 
stem cells (hMSCs) in hyaluronic acid (HA) hydrogels using either MMP-degradable 
peptides or MMP-insensitive (Non-degradable) crosslinkers. (C) Glycosaminoglycan (GAG) 
and collagen content (normalized to the DNA content) of hMSC-laden HA hydrogels after 4 
weeks of in vitro culture. Adapted from (Feng et al. 2014). 
 
In addition to promoting migration, proteolytic remodeling enhances proliferation in stiff 
environments (Bott et al. 2010) and encourages matrix synthesis (Feng et al. 2014) 
(Figure 3-9C). Therefore, it may be possible to direct cell recruitment by controlling the 
spatial distribution of soft vs. stiff territories within the scaffold (Singh et al. 2014, 
Sundararaghavan et al. 2011). Interestingly, cellular MMP activity increases with substrate 
stiffness (Leight et al. 2013, Nicodemus et al. 2011), illustrating the need for active cell 
remodeling in the presence of biophysical barriers. Taken together, a promising strategy 
to foster cell colonization of without compromising initial bulk mechanics may be to 
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incorporate protease-sensitive domains into one fiber fraction within a composite 
nanofibrous scaffold (Wade et al. 2015b). 
 
3.6.2 Scaffold Microstructure 
Macroscopically, the scaffold shape dictates the boundaries of tissue formation. 
Microscopically, the scaffold’s structural framework controls cell ingrowth, neo-tissue 
organization, and nutrient diffusion. Thus, a common strategy to increase cell infiltration 
is to provide interconnected void spaces through which cells can migrate, such as pores 
or channels. Polymer processing techniques utilized to create highly porous morphologies 
include high-pressure gas foaming (Silva et al. 2006), porogen leaching (De Groot et al. 
1996, van Tienen et al. 2003, van Tienen et al. 2002), freeze-drying (De Groot et al. 1996, 
van Tienen et al. 2003, van Tienen et al. 2002), and phase separation (Liu et al. 2009). 
Porous polyester and polyurethane foams (De Groot et al. 1996, Maher et al. 2010, Silva 
et al. 2006, van Tienen et al. 2003, van Tienen et al. 2002) and type I collagen-based 
sponges (Rodkey et al. 1999, Stone et al. 1992) have long been explored as meniscal 
substitutes, with a pore diameter range of ~150–300 μm and porosity greater than 80% 
being the most efficacious for cell infiltration (Klompmaker et al. 1993, van Tienen et al. 
2002). While these materials facilitate cellular ingrowth, matrix deposition, and integration 
with native meniscal tissue within 6 months (van Tienen et al. 2003, van Tienen et al. 
2002), the internal microstructure does not permit the generation of circumferentially 
oriented collagen fibers, which are essential for load transfer. Indeed, a study investigating 
polyurethane foams for meniscal replacement found scaffold fragmentation and cartilage 
damage after 2 years in a canine total meniscectomy model (Welsing et al. 2008). 
To engineer functional dense connective tissues, it may thus be necessary to provide an 
instructive microstructure that fosters organized collagen deposition and maturation. It is 
well known that cells sense and respond to micro- and nanoscale topography, such as 
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ridges, grooves, and channels (Lim et al. 2007). Anisotropic features, such as those 
provided by aligned electrospun fibers, induce cell polarization and de novo collagen 
alignment along the primary fiber direction (Figure 3-10), leading to greater increases in 
tensile modulus compared to non-aligned scaffolds (Baker et al. 2007). 
 
 
Figure 3-10: Nanofibrous topography organizes cells and matrix. (A) Scanning electron 
micrographs of aligned (top) and non-aligned (bottom) PCL scaffolds. Scale = 50 µm. (B) 
Mesenchymal stem cells cultured on nanofibrous scaffolds for 7 days (green = actin, blue = 
nuclei). Cells are oriented with the primary fiber axis on the aligned scaffold. Scale = 50 µm. 
(C) En face section of scaffold stained after 10 weeks of in vitro culture with Picrosirius Red 
(collagen) and Alcian Blue (proteoglycans). Deposited collagen is aligned with the fiber 
direction. Scale = 100 µm. Adapted from (Baker et al. 2007, Mauck et al. 2009). 
 
Although these organized scaffolds promote ordered matrix deposition, dense aligned 
nanofibers pose a challenge to cell infiltration. While scaffold alignment may increase 
migration speed and persistence along the fiber length (Fraley et al. 2015, Riching et al. 
2014), contact guidance also hinders migration normal to the fiber axis (Dickinson et al. 
1994). Introducing porogens such as salt particles (Nam et al. 2007), ice crystals (Simonet 
et al. 2007), or fibers with faster degradative rates (Baker et al. 2008, Lee et al. 2013a, 
Phipps et al. 2012a), have been shown to increase porosity and cell infiltration.  
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Figure 3-11: Fast-degrading nanofibers in a composite scaffold increase scaffold porosity, 
cell infiltration, and integration with native tissue. (A) Schematic illustrating composite 
PCL/PEO scaffold with fast-degrading PEO fibers (green) and slow-degrading PCL fibers 
(red) before and after removal of PEO. (B) Scanning electron micrographs of scaffold with 
0% or 60% PEO content removed. Scale = 50 µm. (C) DAPI staining showing nuclei of cell-
seeded scaffolds after 12 weeks of in vitro culture indicates enhanced cell colonization of 
60% PEO scaffold. Scale = 0.5 mm. (D) Percent of nuclei in the center of the scaffold after 
12 weeks of in vitro culture. (A–D) Adapted from (Baker et al. 2012). (E) Integration strength 
of PCL/PEO scaffold with native meniscus after 4 and 8 weeks of in vitro culture shows 
enhanced scaffold-tissue integration with 60% PEO scaffold at 8 weeks. Adapted from 
(Ionescu et al. 2013).  
 
For example, a composite scaffold of aligned, slow-degrading PCL fibers can be 
interspersed with a second population of water-soluble poly(ethylene oxide) (PEO) fibers 
(Baker et al. 2008) (Figure 3-11A). Rapid removal of the ‘sacrificial’ PEO fraction via 
aqueous hydration results in a highly porous scaffold while preserving fiber directionality 
and mechanical anisotropy (Figure 3-11B). Although high porosity scaffolds (60% PEO) 
were initially weaker than low porosity scaffolds (0% PEO), collagen content within high 
porosity scaffolds (60% PEO) was significantly higher after 12 weeks of in vitro culture, 
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resulting in superior tensile properties in the long-term (Baker et al. 2012). Furthermore, 
cellular infiltration of high porosity scaffolds (Figure 3-11C and Figure 3-11D) improves 
integration with tissue explants compared to scaffolds without PEO (Ionescu et al. 2013) 
(Figure 3-11E). Alternatively, instead of removing scaffold components, adding an 
interpenetrating fiber population (Cai et al. 2013, Lee et al. 2013b, Moutos et al. 2007) can 
provide vertical avenues for cellular ingress into the scaffold. 
 
3.6.3 Biochemical Signals 
Cellular perception of the biophysical microenvironment depends on the ability to adhere 
and exert forces on the surroundings. Thus, tunable systems that offer combined control 
over scaffold micromechanics, microstructure, and adhesivity have gained considerable 
interest. An attractive strategy is to use crosslinkable hydrogels, where synthetic polymers, 
such as poly(ethylene glycol) (PEG), and natural polysaccharides, such as hyaluronic acid 
(HA), are modified with functional groups (e.g., vinyl or thiol groups) to form hydrophilic 
crosslinked networks (Geckil et al. 2010). Mechanical properties rely on hydrogel 
crosslinking density, which is largely controlled by macromer modification and macromer 
density. Microstructure can be engineered via micromolding (Kim et al. 2012a), 
photolithography (Singh et al. 2014, Wade et al. 2015a), electrospinning (Kim et al. 2013, 
Wade et al. 2015a), and 3D printing (Billiet et al. 2012). Importantly, small oligopeptide 
sequences found within ECM proteins (e.g., RGD) can be conjugated to core molecules 
to provide adhesive ligands within the 3D matrix. For instance, Kim et al. fabricated 
nanofibrous scaffolds using methacrylated hyaluronic acid (MeHA) macromers with either 
35% or 100% modification, resulting in soft and stiff fibers after final crosslinking (Kim et 
al. 2013). Additionally, RGD was coupled to the fibers at low, medium, or high 
concentrations. Although there was almost an order of magnitude difference between the 
bending moduli of soft and stiff fibers, cellular deformation of soft fibers were similar to 
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that of stiff fibers at a low RGD density, and only became significantly different at a high 
RGD density, illustrating that proper adhesive cues are necessary for cell 
mechanosensing.  
Furthermore, a depth-wise haptotactic RGD gradient can be formed within nanofibrous 
scaffolds by altering the flow rate of two polymer solutions with different conjugated-RGD 
concentrations to affect cell infiltration. Sundararaghavan and Burdick found that cell 
migration from aortic arch explants was more efficient in the presence of a low-to-high 
RGD gradient versus a high-to-low gradient (Sundararaghavan et al. 2011). Similarly, 
RGD-gradient channels formed by UV laser micropatterning guided neurite outgrowth 
towards a higher RGD concentration within a 3D hyaluronan gel (Musoke-Zawedde et al. 
2006). Photo-immobilization of a laminin-1 gradient, an ECM glycoprotein found basement 
membranes, also increased neurite outgrowth in an agarose gel (Dodla et al. 2006). These 
results suggest that targeting adhesion via different ligand concentrations (Kim et al. 2013, 
Peyton et al. 2011, Singh et al. 2014, Sundararaghavan et al. 2011), ligand peptide 
sequences (Mhanna et al. 2014), and/or integrin antibodies (Wolf et al. 2013), can 
modulate migration without changing underlying material properties. 
Cells isolated from the meniscus (Bhargava et al. 1999), tendon (Caliari et al. 2011), 
ligament (Hannafin et al. 1999), and shoulder capsule (Suzuki et al. 2001) can migrate 
towards a wide variety of soluble chemical gradients, including platelet-derived growth 
factor (PDGF) AB and BB (Bhargava et al. 1999, Bhargava et al. 2005, Hannafin et al. 
1999, Suzuki et al. 2001), epidermal growth factor (EGF) (Kong et al. 2011), hepatocyte 
growth factor (Bhargava et al. 1999, Bhargava et al. 2005, Hannafin et al. 1999, Suzuki et 
al. 2001), bone morphogenetic protein-2 (BMP-2) (Bhargava et al. 1999, Hannafin et al. 
1999), and interleukin-1 (Bhargava et al. 1999). Additionally, meniscal progenitors (Shen 
et al. 2014) and mesenchymal stem cells (Kucia et al. 2004) home towards stromal-cell 
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derived factor-1α (SDF-1α), although this effect may be reduced in the absence of an 
injury (Abbott et al. 2004). 
Therefore, biomaterials functionalized with chemoattractants also have potential to affect 
3D cell infiltration. For example, Moore et al. immobilized neurotrophic gradients to 
advance neurite penetration into hydrogels (Moore et al. 2006). However, immobilization 
limits gradient sensing to cells that are already in contact with the scaffold, whereas 
delivery of soluble chemoattractants may also induce cell migration towards the wound 
site, thereby enhancing the intrinsic repair response of endogenous cells. In particular, the 
large surface area of nanofibers is well suited for an initial burst delivery, followed by 
sustained release as the fiber eventually degrades. Phipps et al. found that eluant from 
nanofibrous PCL/collagen/hydroxyapatite composites adsorbed with PDGF-BB enhanced 
directional migration of MSCs in vitro (Phipps et al. 2012b). Jin et al. used a PLA 
nanofibrous scaffold, embedded with PLGA microspheres releasing PDGF-BB, to 
enhance scaffold tissue ingrowth and neovascularization in a subcutaneous rodent model 
(Jin et al. 2008). Notably, sustained PDGF release from microspheres was more effective 
than a surface coating of PDGF, demonstrating that temporal control is necessary to 
establish a soluble gradient in vivo. Likewise, localized release of SDF-1α increased 
progenitor cell engraftment and colonization of scaffolds in subcutaneous experiments 
(Thevenot et al. 2010), reducing inflammatory cell infiltration (Sarkar et al. 2011, Thevenot 
et al. 2010) and improving the repair of various mesenchymal tissues, including bone 
(Holloway et al. 2015), myocardium (Purcell et al. 2012), skeletal muscle (Rybalko et al. 
2015), and skin (Sarkar et al. 2011). Collectively, these findings indicate that scaffolds 
delivering soluble chemoattractants may also enhance dense connective tissue repair. 
However, it is important to note that the steric hindrance posed by dense, stiff, and/or non-
degradable scaffolds may limit cellular ingress regardless of haptotactic or chemotactic 
cues. 
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3.7 Summary and Future Directions 
In conclusion, cell migration in confined 3D environments is governed by a complex set of 
cellular and extracellular variables, including cell mechanics and force transduction, matrix 
micromechanics and microstructure, and biochemical signals in the environment. While 
blocking metastatic invasion remains the primary impetus behind basic research in this 
field, enhancing interstitial migration can potentially benefit fibrous tissue repair and 
regenerative medicine. Decreasing matrix density and stiffness at the wound interface 
may facilitate local cell migration and intrinsic repair (Qu et al. 2015). Further modulating 
cell mechanosensing after cell movement into tissue and scaffolds may direct cells toward 
a proper lineage. For instance, while RGD ligands promote MSC adhesion and migration, 
prolonged adhesion may inhibit chondrogenic differentiation in the long-term. By 
combining a MMP-degradable sequence with the RGD peptide, Salinas and co-workers 
demonstrated that cells within a hydrogel could self-regulate the amount of adhesive 
ligands in the environment to support a chondrogenic phenotype (Salinas et al. 2008). 
Recent advances in biosynthetic polymers (Krishna et al. 2010), drug encapsulation and 
delivery (Garg et al. 2012), micro- and nanopatterning (Hahn et al. 2006, Kim et al. 2012a, 
Lim et al. 2007), and rapid prototyping (Billiet et al. 2012) gives us more control over the 
3D microenvironment now than ever before. However, most of the aforementioned studies 
were performed in vitro with little or no mechanical loading. In an in vivo environment, 
tissues and scaffolds experience a variety of tensile, compressive, and/or shear forces. In 
dense connective tissues, strain transfer often depends on the relative sliding of collagen 
fascicles, fibers, and/or fibrils, resulting in spatiotemporal changes in the tissue 
microstructure (Han et al. 2013, Nerurkar et al. 2011, Szczesny et al. 2014). Dynamic 
tensile loading also activates mechanoactive signaling pathways that influence 
downstream cell force sensing and differentiation (Driscoll et al. 2015, Heo et al. 2011). 
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Lastly, cell migration may be influenced by intercellular interactions, such as cell-cell 
adhesions and paracrine signaling (Friedl et al. 2010, Raeber et al. 2007), inflammation 
(Frenkel et al. 1996), and changes with cell age (Pajerowski et al. 2007). Although it is 
unknown how these physiological events collectively affect interstitial migration in vivo, it 
may be possible to study this phenomenon in vitro using bioreactors and live cell tracking 
systems, coupled with real-time second harmonic generation imaging to visualize ECM 
collagen. By designing smart, dynamic scaffolds that reflect the optimal 
microenvironmental niche for tissue growth and maintenance over time, ultimately we may 
recapitulate, and perhaps even augment, the natural biological cues that direct repair and 
regeneration. 
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CHAPTER 4: BIOMATERIAL-MEDIATED DELIVERY OF DEGRADATIVE ENZYMES 
TO IMPROVE MENISCUS INTEGRATION AND REPAIR 
 
4.1 Abstract 
Endogenous repair of fibrous connective tissues is limited, and there exist few successful 
strategies to improve healing after injury. As such, new methods that advance repair by 
promoting cell growth, extracellular matrix (ECM) production, and tissue integration would 
represent a marked clinical advance. Using the meniscus as a test platform, we sought to 
develop an enzyme-releasing scaffold that enhances integrative repair. We hypothesized 
that the high ECM density and low cellularity of native tissue present physical and biologic 
barriers to endogenous healing, and that localized collagenase treatment might expedite 
cell migration to the wound edge and tissue remodeling. To test this hypothesis, we 
fabricated a delivery system in which collagenase was stored inside electrospun 
poly(ethylene oxide) (PEO) nanofibers and released upon hydration. In vitro results 
showed that partial digestion of the wound interface improved repair by creating a 
microenvironment that facilitated cell migration, proliferation, and matrix deposition. 
Specifically, treatment with high-dose collagenase led to a 2-fold increase in cell density 
at the wound margin and a 2-fold increase in integrative tissue compared to untreated 
controls at 4 weeks (p≤0.05). Furthermore, when composite scaffolds containing both 
collagenase-releasing and structural fiber fractions were placed inside meniscal tears in 
vitro, enzyme release acted locally and resulted in a positive cellular response similar to 
that of global treatment with aqueous collagenase. This innovative approach of targeted 
enzyme delivery may aid the many patients that exhibit meniscal tears by promoting 
integration of the defect, thereby circumventing the pathologic consequences of partial 
meniscus removal, and may find widespread application in the treatment of injuries to a 
variety of dense connective tissues. 
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4.2 Introduction 
Fibrous dense connective tissues of the musculoskeletal system, including the knee and 
temporomandibular menisci, the annulus fibrosus of the intervertebral disc, and tendons 
and ligaments, are characterized by an extracellular matrix (ECM) featuring aligned type I 
collagen bundles. This fiber-reinforced microstructure gives rise to anisotropic mechanical 
properties, permitting resistance to tensile stresses applied along the fiber direction. In the 
knee meniscus, a semilunar fibrocartilaginous structure located between the femur and 
tibia, circumferentially arranged collagen fibers resist tensile hoop stresses that arise with 
joint loading (Fithian et al. 1990). Meniscal tears are common, accounting for over 1 million 
surgical procedures each year in the United States (Hasan et al. 2014). These tears 
disrupt the essential collagen architecture of the meniscus, decreasing its load transfer 
functionality. The intrinsic healing capacity of this tissue is very poor, especially in 
avascular regions. Even if some healing occurs, it does so through the formation of a 
disorganized scar tissue, altering load transmission and eventually leading to 
degenerative osteoarthritis of the affected knee compartment (Kawamura et al. 2003, 
Makris et al. 2011, Tu et al. 2003). 
While multiple repair techniques have been developed, their success is limited to simple 
longitudinal tears that occur in the vascularized, peripheral one-third of the meniscus 
(McCarty et al. 2002). Indeed, a postoperative evaluation of arthroscopically repaired 
avascular meniscal tears reported that up to 75% of repairs had failed to heal completely, 
with 20% requiring a secondary surgery (Rubman et al. 1998). The standard surgical 
treatment after repair failure is a partial meniscectomy (Tu et al. 2003), although many 
surgeons will perform this procedure as a first line treatment option given the poor 
outcomes for most repair scenarios. However, resection of the damaged portion provides 
only temporary alleviation of pain, and long-term consequences include increased peak 
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pressures on the tibial plateau during loading, resulting in further degeneration of both the 
meniscal fibrocartilage and articular cartilage and often culminating in the need for total 
knee arthroplasty (Aagaard et al. 1999, Englund 2004).  
An ideal alternative to surgical removal would be to reestablish native tissue function by 
enhancing surgical repair and promoting cell growth, organized ECM production, and, 
most importantly, integration at the wound site via the creation of an instructive 
regenerative microenvironment. Experimental strategies to augment connective tissue 
repair, specifically the avascular zone of the meniscus and other fibrous tissues, include 
enhancing blood supply via vascular access channels or synovial flaps (Ochi et al. 1996, 
Zhang et al. 1995), delivering growth factors to promote neovascularization, cell 
proliferation, and matrix synthesis (Ionescu et al. 2012b, Petersen et al. 2007, Tumia et 
al. 2004a, Tumia et al. 2009), and providing synthetic scaffolds that fill the tissue defect 
(Baker et al. 2012, Maher et al. 2010, Martinek et al. 2006, Pabbruwe et al. 2010). A 
number of factors play a role in successful meniscal repair, including control of the 
inflammatory state (McNulty et al. 2007), provision of local vascularity (Arnoczky et al. 
2010, Tu et al. 2003), and tissue maturity and matrix density (Ionescu et al. 2011). 
Immature fibrous tissues such as meniscus (Ionescu et al. 2011), tendon (Beredjiklian et 
al. 2003), and ligament (Provenzano et al. 2002) show enhanced healing capacity 
compared to mature tissues, owing to their hypervascular and hypercellular state. Notably, 
collagen content and diameter increase with developmental stage and skeletal maturation, 
while cellularity decreases markedly (Clark et al. 1983). Furthermore, while the biologic 
environment may favor regenerative healing of immature tissue, it has recently been 
shown that fetal sheep tendon undergoes a robust healing response even when 
transplanted to an adult in vivo setting (Favata et al. 2006), suggesting innate differences 
mediate the different healing capacity as a function of developmental state. 
 63 
 
In agreement with this body of literature, our previous work on meniscus healing in vitro 
suggests that the high ECM density of the mature meniscus represents a physical barrier 
to endogenous healing (Ionescu et al. 2011), where matrix density acts to limit cell 
proliferation, migration, and matrix remodeling at or near the wound site, leading to an 
inferior repair response. In contrast to a two-dimensional environment, cells in tissues 
must overcome the biophysical resistance imparted by their surroundings, and a dense 
matrix with low porosity and degradability will obstruct cellular movement and activity 
(Ehrbar et al. 2011, Klompmaker et al. 1993). Indeed, a number of studies have 
demonstrated that treatment of the wound edge with matrix-degrading enzymes, including 
trypsin, collagenase, and hyaluronidase, can enhance articular cartilage graft integration 
(Janssen et al. 2006, Obradovic et al. 2001, van de Breevaart Bravenboer et al. 2004).  
To render this technology clinically feasible, enzymatic degradation must be conducted in 
a controlled and targeted manner to localize digestion to the wound site. One potential 
delivery vehicle is nanofibrous scaffolds fabricated via electrospinning. In this well-
established process, fibers that are hundreds of nanometers in diameter can be formed 
and compiled into a non-woven 3D scaffold. Fibers within the scaffold can be collected to 
resemble the organized collagen bundles found in many fibrous connective tissues. 
Previously, we have shown that mesenchymal stem cells cultured on aligned poly(ε-
caprolactone) (PCL) nanofiber scaffolds organize and deposit collagen along the fiber 
direction, producing meniscus-like engineered constructs that increase in mechanical 
properties with time in culture (Baker et al. 2007). Furthermore, composites with multiple 
fiber populations can be formed with differing degradative characteristics in each fiber 
fraction. For instance, inclusion of water-soluble poly(ethylene oxide) (PEO) fibers into 
such composites increased scaffold pore size upon hydration and expedited cellular 
infiltration and tissue maturation (Baker et al. 2008, Baker et al. 2012, Ionescu et al. 2013). 
These ‘sacrificial’ fibers can be modified to entrap drug-delivering microspheres (Ionescu 
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et al. 2010), where release is dependent on microsphere composition, or directly liberate 
biologic factors into an aqueous environment (Ionescu et al. 2012a).  
With such regenerative tools at hand, our goal was to develop a functionalized scaffold to 
enhance meniscal repair. We hypothesized that the high ECM density of the native adult 
meniscus impedes healing and that decreasing the matrix density may improve cell 
migration, division, and matrix deposition for integrative repair. To test this hypothesis, we 
used an in vitro explant model to show that partial degradation of the wound edge can 
alter the structure of adult meniscus, and demonstrated that this treatment improves 
cellularity and production of new contiguous tissue spanning the wound site. More 
importantly, we developed a novel method to deliver a controlled, low dose of matrix-
degrading enzyme via electrospun composite nanofibrous scaffolds, where the sacrificial 
PEO component released a single localized dose of collagenase. 
 
4.3 Methods and Materials 
4.3.1 Preparation and Culture of Meniscal Repair Constructs 
Menisci from fetal (mid-gestation) and adult (skeletally mature) cows were sterilely 
dissected and the synovium removed. Tissue cylinders were excised with an 8 mm biopsy 
punch and concentrically cored with a 4 mm punch. In a first study, samples were 
incubated in basal media (BM; Dulbecco’s Modified Eagle’s Medium with 10% Fetal 
Bovine Serum and 1% Penicillin/Streptomycin/Fungizone) supplemented with 0.05 mg/mL 
collagenase (type IV from Clostridium histolyticum, ≥125 collagenase digestion units/mg 
solid, Sigma-Aldrich, St. Louis, MO) at 37°C for 6 hours, after which the cores were 
replaced within the annuli. Controls were incubated in BM only. Repair constructs were 
cultured in a chemically-defined medium (high glucose DMEM with 1% PSF, 0.1 mM 
dexamethasone, 50 µg/mL ascorbate 2-phosphate, 40 mg/mL L-proline, 100 mg/mL 
sodium pyruvate, 1X ITS (6.25 mg/mL Insulin, 6.25 mg/mL Transferrin, 6.25 ng/mL 
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Selenous Acid, 1.25 mg/mL Bovine Serum Albumin, and 5.35 mg/mL Linoleic Acid) with 
10 ng/mL TGF-β3) for 4 weeks in non-treated 6-well plates. To investigate the long-term 
effect of collagenase pre-treatment, adult meniscus cores and annuli were incubated with 
0 (BM), 0.01 (LC; low-dose collagenase), or 0.05 mg/mL (HC; high-dose collagenase) 
collagenase, reassembled into repair constructs, and cultured for 1, 4, or 8 weeks as 
above. 
 
4.3.2 Histological, Biochemical, and MicroCT Analysis 
At set intervals, repair constructs were fixed in 4% paraformaldehyde, embedded in 
paraffin, and axially sectioned to 8 μm thickness onto glass slides. Sections were stained 
with Hematoxylin and Eosin (H&E), Picrosirius Red (PSR), and 4’,6-diamidino-2-
phenylindole (DAPI, Prolong Gold; Invitrogen, Grand Island, NY) to visualize ECM density, 
collagen, and cell nuclei, respectively. Quantitative parameters of integration were derived 
from histological sections. Percent integration was defined as the cumulative distance of 
annulus-to-core contact normalized by the core perimeter (n=3–4/group). Cell density at 
the interface was determined by counting the number of nuclei present within 100 µm of 
the interface using ImageJ (Wayne Rasband, NIH) (n=4/group). DNA content was 
biochemically assessed in both the core and annulus at each time point in additional 
constructs (n=6–7/group). Tissue segments were weighed separately, lyophilized, and 
reweighed to determine water content. Following digestion in a buffer containing 2% 
papain at 60°C, DNA content per dry weight was determined via the PicoGreen assay 
(Invitrogen). Lastly, separate constructs from each group were saturated in Lugol’s 
contrast solution (Sigma-Aldrich) for 24 hours and scanned via microcomputed 
tomography at an energy level of 70 kV and intensity of 114 μA (µCT; ScanCo, VivaCT 
70, Wayne, PA) to assess matrix changes at the interface (n=4/group). 
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4.3.3 Fabrication and Characterization of Enzyme-Releasing Nanofibers 
To fabricate enzyme-releasing nanofibers, a solution of 8% w/v PEO (200 kD, 
Polysciences, Warrington, PA) was prepared in 1:1 EtOH and distilled H2O with 0.85% 
w/v NaCl or 2.5% w/v trypsin in the same solution (Invitrogen). These solutions were 
electrospun onto glass cover slips for 10–15 minutes using a custom device (Baker et al. 
2008). The spinneret was charged to 15 kV and the polymer flow rate was set at 1.6 
mL/hour to produce a stable electrospinning jet. Formed nanofibers were sputter coated 
with AuPd and imaged via scanning electron microscopy (SEM; Philips XL 20, SEMTech, 
North Billerica, MA) using an accelerating voltage of 10 kV. Fiber diameter was measured 
using ImageJ (n=100/group).  
To determine whether enzyme activity was preserved through the electrospinning 
process, both cell- and tissue-based assays were employed. Using a cell-based approach, 
approximately 0.2 and 0.4 g of each fiber type (PEO only or PEO-trypsin) were hydrated 
in 4 mL of Hank’s Buffered Salt Solution (HBSS; Invitrogen) on an orbital shaker for 20 
minutes. Confluent monolayers of bovine mesenchymal stem cells (bMSCs, isolated as in 
(Baker et al. 2007)) were exposed to these eluted solutions. Four experimental conditions 
were tested: BM, HBSS, HBSS containing hydrated PEO fibers (PEO), and HBSS 
containing hydrated PEO-trypsin fibers (PEO-T). A standard solution of trypsin (Invitrogen) 
at 0.25% w/v in HBSS was used as a positive control. bMSCs were maintained at 37°C in 
a standard tissue culture incubator with images captured every 10–20 minutes with a light 
microscope (n=2/group). Solutions were aspirated after 60 minutes for final imaging. Cells 
were re-plated and cultured for 24 hours to ensure that cells remained viable after 
treatment.  
 To further demonstrate efficacy and dosage of delivered trypsin, cylindrical articular 
cartilage samples were sterilely isolated using 4 mm biopsy punches from the trochlear 
groove of juvenile bovine femurs and trimmed to a height of 3 mm. Solutions containing 
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hydrated PEO or PEO-trypsin nanofibers (0.4 g) were incubated with the cartilage 
cylinders for 3 and 6 hours, along with BM and HBSS controls. HBSS/trypsin at 1.25% w/v 
(20 minutes) was used as a positive control. After digestion, samples were embedded in 
optimal cutting temperature compound (OCT; Sakura Finetek USA, Inc., Torrance, CA), 
cut into 16 μm axial sections using a cryostat microtome (Microm HM500, MICROM 
International GmbH, Waldorf, Germany), and stained with Alcian Blue (AB) to visualize 
proteoglycan (PG) content. Matrix removal was assessed from diametric sections using 
ImageJ and normalized to BM controls, where 100% indicates no loss in staining area and 
0% indicates a complete removal of staining throughout the sample diameter (n=3/group).  
 
4.3.4 Fabrication and Characterization of Collagenase-Releasing Nanofibers 
Having established a mechanism for entrapping active enzymes, we next fabricated fibers 
containing a more clinically relevant enzyme, namely collagenase. In initial studies, 
nanofibers were spun from a solution of 8% w/v PEO in 1:1 EtOH and distilled H2O with 
or without 1.25% w/v collagenase. Solutions were spun onto glass cover slips for 10–15 
minutes as previously described. To demonstrate retention of collagenase activity, juvenile 
bovine cartilage samples were prepared as described previously. PEO and PEO-
collagenase (PEO-C) nanofibers (0.2 g) were hydrated in BM and the solutions were 
incubated with cartilage cylinders for 3 and 6 hours, along with BM and BM containing 
0.1% w/v collagenase (aqC) controls. Samples were cryotomed and stained with AB and 
PSR to visualize PG and collagen, respectively (n=4/group). To assess 
glycosaminoglycan (GAG) loss, % GAG per wet weight was quantified after papain 
digestion via the 1,9 dimethylmethylene blue (DMMB) assay (n=4/group) (Farndale et al. 
1986). 
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4.3.5 Scaffold-Mediated Degradation of the Meniscal Interface 
Composite scaffolds were fabricated containing 40–50% PEO with the remaining fiber 
fraction composed of PCL (80 kDa, Sigma-Aldrich). PEO solutions containing 0%, 0.125% 
(low-dose collagenase, PEO-LC), or 1.25% w/v collagenase (high-dose collagenase, 
PEO-HC) were electrospun simultaneously with 14.3% w/v PCL in 1:1 tetrahydrofuran and 
N,N-dimethylformamide (Fisher Scientific, Pittsburgh, PA) onto a common rotating 
mandrel as previously described (Baker et al. 2008). Electrospinning was carried out over 
4 hours to form aligned mats approximately 0.5 mm thick, where one jet contained PCL 
solution and the second jet contained PEO solution with or without collagenase. PEO 
content was determined by measuring the dry weight of lyophilized scaffolds before and 
after 24 hours of aqueous submersion on a shaking plate. PEO and PEO-HC solutions 
were electrospun separately for SEM imaging and fiber diameter measurements 
(n=100/group) as previously described.  
To evaluate the efficacy of these composite scaffolds in providing controlled digestion of 
the meniscal wound interface, juvenile bovine meniscal bodies were radially sectioned into 
10 mm wedges and split horizontally along the inner edge to form a pocket, with two sides 
remaining intact. Either no scaffold (NS) or a strip of PCL/PEO or PCL/PEO-HC (5 x 10 
mm) was inserted into the pocket such that fibers aligned with the native collagen 
architecture. The wound edges were pinned closed with a needle and the samples 
cultured in BM for either 6 hours or 1, 3, or 7 days (n=3/group). Radial cryotome sections 
were stained with AB to visualize PG removal from the wound margins. Following this 
preliminary study, a long-term study with NS, PCL/PEO, PCL/PEO-LC, and PCL/PEO-HC 
juvenile bovine explant groups was conducted in a chemically-defined medium 
supplemented with TGF-β3, with culture times of 25 and 50 days (n=8/group). Samples 
were cryotomed to 16 μm radial sections and stained with either AB or DAPI to visualize 
PG and nuclei, respectively (n=2/group). The remaining samples were frozen in OCT and 
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the two intact edges removed by a freezing stage sledge microtome. Trimmed samples 
were glued to sandpaper on a custom grip and extended to failure at 2.5 mm/min using 
an Instron 5848 Microtester equipped with a 10 N load cell (Instron, Canton, MA). Samples 
were imaged with a stereoscope after mechanical testing to quantify the area of potential 
integration. Integration strength was calculated by dividing the maximum load before 
failure by the contact surface area between the two tissue segments (n=5–6/group). To 
determine if collagenase-releasing scaffolds could also improve integration in mature 
meniscus, cylindrical adult bovine meniscal explants (8 mm diameter x 10 mm height) with 
a horizontal defect were fitted with a PCL/PEO-LC or PCL/PEO-HC scaffold. In this case, 
scaffolds were constructed in annular form (8 mm diameter with 5 mm core) to permit 
tissue-to-tissue contact within the constructs, which were cultured for 7 days before 
histological processing. Radial paraffin sections were stained with AB or H&E. 
 
4.3.6 Statistical Analyses 
All statistical analyses were done using SYSTAT (Chicago, IL). Experimental group sizes 
were chosen based on power analysis using preliminary data. Significance was assessed 
by one or two-way ANOVA with Tukey’s HSD post hoc test to make comparisons between 
groups (p≤0.05). Data is presented as the mean ± standard deviation.  
 
4.4 Results 
4.4.1 Partial Enzymatic Degradation Enhances Meniscal Integration 
Digestion of the adult meniscus with aqueous collagenase resulted in a marked decrease 
in matrix density, such that ECM staining more closely resembled that of the fetal 
meniscus (Figure 4-1B). As enzyme dosage was increased, a controllable level of 
digestion of the wound edge was achieved, as was reflected by the altered µCT signal at 
the construct edges 1 week after treatment (Figure 4-2A).  
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Figure 4-1: Aqueous collagenase treatment reduces matrix density and increases cellularity 
in the adult meniscus, producing a more fetal-like tissue state. (A) Schematic of annulus 
and core meniscal repair constructs. (B) H&E (left) and DAPI (right) staining of constructs 
after 4 weeks of culture, where the dashed line indicates the wound interface (n=1–2/group). 
Scale = 0.25 mm. 
 
Long-term culture of adult constructs showed improved cellularity and integration with 
increasing levels of collagenase digestion. By 4 weeks, cells and new collagen fibrils 
closed approximately 92% of the wound gap in adult HC samples, which exhibited superior 
integration compared to LC samples (74%) and BM controls (43%) (Figure 4-2A and 
Figure 4-2B, p≤0.05). Cell density at the annulus-core boundary was significantly higher 
for HC samples compared to all other groups, with a 213% and 170% increase over BM 
controls at 4 and 8 weeks, respectively (Figure 4-2C, p≤0.05). Similarly, total DNA content 
per dry weight of HC samples was significantly higher than BM controls at 4 and 8 weeks, 
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increasing by 44% and 55%, respectively (Figure 4-2D, p≤0.05). Although LC samples 
did not show the same level of cellular proliferation relative to HC samples, cell density 
and total DNA content were significantly higher than BM controls at 8 weeks (Figure 4-2C 
and Figure 4-2D, p≤0.05). For both LC and HC groups, total DNA content increased 
between 4 and 8 weeks by 41 and 38%, respectively, whereas BM controls did not show 
a significant change in DNA over this time period (Figure 4-2D, p≤0.05). 
 
 
Figure 4-2: Improved integration and interface cellularity of adult meniscus after low- (LC) 
and high-dose (HC) collagenase treatment, compared to controls (BM). (A) Left: 1 week µCT 
scans showing low (red) and high (yellow) signal intensity correlating to matrix loss at the 
wound interface (n=4/group). Scale = 1 mm. Right: 8 week PSR staining of the interface 
imaged under polarized light showing improved integration with treatment (n=4/group). 
Scale = 0.25 mm. (B) Quantification of % integration normalized to core perimeter (n=3–
4/group), (C) cell density at the interface (n=4/group), and (D) total DNA content per dry 
weight (n=6–7/group). * = p≤0.05 vs. BM. + = p≤0.05 vs. BM and LC. Line = p≤0.05 between 4 
and 8 weeks. 
 
4.4.2 Nanofibers Store and Deliver Bioactive Enzymes 
To facilitate targeted enzyme delivery, PEO nanofibers containing active trypsin or 
collagenase were fabricated. Nanofibers with and without trypsin were of similar fiber 
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diameter and morphology (200 ± 50 vs. 192 ± 44 nm, p≥0.05). When cell monolayers were 
exposed to PEO-trypsin fibers hydrated in HBSS (PEO-T), a dose- and time-dependent 
change in cell morphology was observed. Cells in PEO-T rounded and lifted from the 
substrate over a period of 60 minutes, mimicking standard trypsin treatment, though at a 
much reduced time scale (Figure 4-3A). Conversely, there was no apparent change in 
cell morphology with exposure to hydrated PEO fibers or BM; HBSS alone slightly 
disrupted monolayer integrity. Cell viability was unaffected by the presence of PEO, as 
lifted cells reattached after 24 hours upon addition of BM (data not shown).  
 
 
Figure 4-3: Sacrificial PEO nanofibers deliver functional enzymes upon hydration. (A) 
Morphology of cell monolayers treated with eluant from fibers containing trypsin for 60 
minutes as a function of fiber mass (n=2/group). Scale = 0.2 mm. (B) Proteoglycan removal 
from cartilage cylinders after 6 hours of incubation with BM or HBSS (controls) or eluant 
from PEO or PEO-T nanofibers (n=3/group). Scale = 0.5 mm. (C) % AB staining of 
proteoglycan in cartilage cylinders as a function of treatment group and time, normalized to 
BM controls (n=3/group). Dashed line indicates treatment with 1.25% w/v trypsin for 20 
minutes as a positive control. * = p≤0.05 vs. other groups at 3 hours. ** = p≤0.05 vs. all other 
groups and time points. 
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To further characterize the activity of delivered trypsin, cartilage cylinders were exposed 
to PEO-T solutions. Staining for PG revealed a time-dependent increase in tissue 
digestion, where exposure for 3 and 6 hours resulted in 52% and 73% PG removal, 
respectively (Figure 4-3B and Figure 4-3C, p≤0.05). This pattern and extent of PG 
removal was comparable to treatment with 1.25% w/v trypsin solution, which showed a 
59% removal after 20 minutes of exposure (Figure 4-3C, dashed line). There was no 
change in PG staining for cartilage exposed to BM, HBSS, or PEO fibers. 
 
 
Figure 4-4: Fabrication of enzyme-delivering nanofibrous composites. (A) SEM micrographs 
of PEO (left) and PEO-HC (right) nanofibers. Scale = 5 μm. (B) Schematic of electrospinning 
setup and (C) composite scaffolds produced with PEO fiber fractions that deliver enzyme. 
 
PEO nanofibers containing active collagenase were produced using a similar approach. 
While SEM images of fibers with and without collagenase were again comparable in 
diameter (Figure 4-4A, 329 ± 114 vs. 321 ± 135 nm, p≥0.05), fibers containing enzyme 
were qualitatively rougher in appearance. To characterize enzyme activity, cartilage 
cylinders were exposed to PEO-collagenase nanofibers hydrated in BM (PEO-C). PG 
removal was evident after treatment with either PEO-C or 0.1% w/v aqueous collagenase 
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(aqC) (Figure 4-5A). Quantitative analysis of cartilage cylinders showed that exposure to 
PEO-C for 3 and 6 hours resulted in a 45% and 61% decrease in GAG content compared 
to exposure to BM, respectively (Figure 4-5B, p≤0.05), and comparable to treatment with 
aqC (61% at 3 hours, dashed line). PSR staining of collagen increased after digestion due 
to the better penetration of the stain after GAG removal from the matrix (D'Andrea 2004). 
 
 
Figure 4-5: Release of active collagenase from PEO fibers. (A) Combined AB and PSR 
staining of cartilage cylinders after 6 hours of exposure to BM, PEO, PEO-C, or aqueous 
collagenase (aqC, 0.1% w/v) solution (n=4/group). Scale = 0.5 mm. (B) GAG content of 
cartilage cylinders as a function of treatment and time (n=4/group). Dashed line indicates 
treatment with aqC for 3 hours. * = p≤0.05 compared to other groups at 3 hours. ** = p≤0.05 
compared to all other groups at 6 hours. 
 
4.4.3 Nanofibrous Composites Localize Enzyme Release to the Wound Site 
When collagenase-releasing scaffolds were placed in a juvenile bovine meniscal defect, 
loss of PG was apparent at the wound edge within 6 hours, with decreased staining 
intensity persisting through day 7 (Figure 4-6B). This loss did not extend to the periphery 
of treated samples and was not observed in controls, suggesting local action of the 
enzyme. Long-term culture of these constructs revealed increased tissue porosity and 
cellularity at the wound edge after collagenase delivery (Figure 4-6C).  
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Figure 4-6: Integrative repair of juvenile meniscus treated with collagenase-releasing 
scaffolds. (A) Schematic of repair construct with scaffold placed inside a horizontal 
meniscal tear. (B) AB staining of meniscus on day 7 with insertion of control and of 
collagenase-releasing composite scaffolds (n=3/group). Scale = 5 mm. (C) DAPI staining of 
wound interface after 50 days of culture with PCL/PEO, PCL/PEO-LC, and PCL/PEO-HC 
scaffolds (n=2/group). Scale = 0.25 mm. (D) Integration strength as a function of culture 
duration. Inset shows mechanical testing setup (n=5–6/group). * = p≤0.05 compared to 
PCL/PEO-HC. Line = p≤0.05 between 25 and 50 days. 
 
Although the integration strength of all groups remained relatively low at 25 days, by 50 
days there was significant improvement for the PCL/PEO and low-dose collagenase 
scaffold (PCL/PEO-LC) groups (Figure 4-6D, p≤0.05). Meniscal repairs with PCL/PEO-
LC scaffolds exhibited the highest integration strength at 50 days (13.5 ± 4.1 kPa), 
showing a trend toward improvement compared to controls without scaffolds (7.5 ± 3.6 
kPa, p≤0.1). However, integration strength of the high-dose collagenase scaffold 
(PCL/PEO-HC) group at 50 days (6.9 ± 6.5 kPa, p≤0.05) was significantly lower than the 
PCL/PEO-LC group, most likely due to over-digestion of the wound interface. 
Collagenase-releasing scaffolds placed inside adult meniscal explants also showed 
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evidence of localized digestion and PG loss after 7 days in culture (Figure 4-7B). 
However, the scaffold appeared to inhibit tissue formation at the sample edge in the short-
term, and integration was only observed within the fenestrated portion of the annular 
scaffold (Figure 4-7D). 
 
 
Figure 4-7: Improved repair of adult meniscus with collagenase-releasing composite 
scaffolds. (A) Repair construct schematic with annular scaffold insert. (B) AB and (C) H&E 
staining of constructs containing annular PCL/PEO-LC scaffolds on day 7. Scale = 1 mm. 
(D) Magnified areas from (C). Left: lack of integration at the edge occupied by the scaffold 
(asterisk). Right: bridging tissue in the interior after collagenase delivery. Scale = 0.25 mm. 
 
4.5 Discussion 
Orthopaedic injuries involving dense connective tissues are prevalent and suffer from a 
limited healing capability (Kawamura et al. 2003, Makris et al. 2011, Tu et al. 2003). In the 
case of the meniscus, treatment success rate declines with age and resulting repair 
failures frequently culminate in tissue removal to alleviate inflammation and pain (McCarty 
et al. 2002, Rubman et al. 1998, Tu et al. 2003). However, partial meniscectomy alters 
joint biomechanics and hastens osteoarthritis (Aagaard et al. 1999, Englund 2004), 
prompting the need for novel methods to enhance endogenous repair processes. We 
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hypothesized that decreasing the local ECM density may facilitate meniscal repair and 
found that the in vitro integration of adult meniscus improved after collagenase treatment 
of the wound boundary. This improvement was accompanied by an initial decrease in local 
ECM density and an increase in cellularity and matrix synthesis at the interface, supporting 
our hypothesis. To translate these findings clinically, we developed a delivery system in 
which active enzyme is stored within water-soluble PEO nanofibers and released into the 
environment upon hydration. Collagenase-releasing nanofibers, incorporated into a 
composite scaffold and placed inside a meniscal defect, localized the degradation process 
to the wound margin and improved tissue integration in a dose-dependent fashion. Given 
its simplicity and capacity for rapid translation, this innovative approach could aid the many 
patients who would otherwise undergo meniscus removal.  
Repair potential of dense connective tissues declines significantly with age (Beredjiklian 
et al. 2003, Ionescu et al. 2011, Provenzano et al. 2002). While this is commonly attributed 
to the hypovascular nature of the tissue as it matures and hence the lack of nutrients and 
growth factors available for repair (Arnoczky et al. 1983, Kawamura et al. 2003, Makris et 
al. 2011, Tu et al. 2003), decreased cellularity and increased ECM density may also play 
a role (Clark et al. 1983, Ionescu et al. 2011). Although dense aligned collagen bundles 
are necessary to resist deformation during physiologic loading, this microstructure may 
also inhibit cell mobility and division, thus preventing reparative cells from migrating to the 
wound site in sufficient numbers. Indeed, ECM of fetal constructs exhibited smaller 
collagen fibers and had a visibly higher cell density compared to adult constructs (Figure 
4-1B). Treating the adult constructs with collagenase from Clostridium histolyticum 
cleaved collagen fibrils at the interface and may have increased ECM porosity near the 
wound edge. Although over-digestion may result in a detrimental loss of structural proteins 
and cell death (Syed et al. 2012), restricting digestion to the outermost portion of the 
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wound interface initiated an integrative repair response that was reminiscent of the 
skeletally immature meniscus. 
Global enzymatic treatment has previously been used to stimulate connective tissue 
repair, most frequently in cartilage-to-cartilage integration studies. Short duration 
exposure of cartilage constructs to matrix-degrading enzymes increased proliferative 
cells, ECM synthesis, and integration strength compared to controls (Janssen et al. 2006, 
Obradovic et al. 2001, van de Breevaart Bravenboer et al. 2004). Similarly, our partially-
digested meniscus constructs had a higher cell density at the interface and greater DNA 
content than untreated controls. More notably, bridging tissue closed over 90% of the 
wound gap in HC constructs by 4 weeks, over a two-fold increase compared to BM 
controls. Tissue filling the wound gap of treated constructs consisted of fine fibrils that did 
not exhibit birefringence under polarized light, indicative of newly synthesized collagen. In 
contrast, BM constructs did not produce bridging tissue even when the interface was 
histologically in contact, making it difficult to determine the extent of true integration in 
untreated controls. Thus, while matrix synthesis at the wound edge declines with 
development (DiMicco et al. 2002), this trend can be reversed by decreasing the ECM 
density to a less mature state, although decrease in tissue stiffness (Peyton et al. 2005), 
removal of matrix PGs (Natoli et al. 2009), and/or presence of collagen fragments (Shi et 
al. 2010) may also have contributed to the enhanced repair of digested constructs. 
Importantly, injectable collagenase is already used to treat Dupuytren’s contracture, a 
fibroproliferative disorder that affects digit mobility (Syed et al. 2012). If applied in a 
targeted and controlled manner, this enzyme may prove beneficial to meniscal injuries as 
well. 
Having established the therapeutic potential of partial digestion for meniscus integrative 
repair, we next developed a method by which local enzyme delivery to the wound site 
could be achieved using well-established biomaterials. While the application of 
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electrospun fibers as carriers of biological agents such as antibiotics (Hong et al. 2008) 
and growth factors (Choi et al. 2008, Liao et al. 2006, Sahoo et al. 2010, Ye et al. 2011) 
is abundant in the literature, the inclusion of enzymes is not well documented. A patent by 
Smith et al. refers to preserving biological materials using fiber-forming techniques and 
documents the storage of trypsin inside electrospun poly(ethyl oxazoline) (Smith et al. 
2004). PEO was chosen for our study because of its biocompatibility, solubility in water, 
and previous use in electrospun composites. In our earlier work, PEO nanofibers were 
exploited as sacrificial filler in composite PCL/PEO scaffolds, designed to increase 
porosity and improve cell infiltration (Baker et al. 2008, Baker et al. 2012, Ionescu et al. 
2013). These fibers can be readily functionalized to include bioactive factors or drug-
containing microspheres during the electrospinning process, as PEO solutions can be 
prepared and electrospun from water rather than organic solvents used for other 
biodegradable polymers (Ionescu et al. 2010). Furthermore, PEO is an ideal delivery 
system for factors that require a rapid initial release, including the degradative enzymes 
in our study that are meant to act immediately upon scaffold implantation and denature 
quickly thereafter to prevent over-digestion. Indeed, our studies show that eluant from 
trypsin-containing fibers caused cell detachment from plastic substrates within 60 minutes 
and both trypsin and collagenase released from PEO fibers removed approximately half 
of the PGs within cartilage cylinders after 3 hours. 
To form stable scaffolds with degradative capacity, enzyme-containing PEO nanofibers 
were electrospun concurrently with PCL to create composites with discrete fiber 
populations with differing roles. The aligned PCL fiber fraction acts as a physical template 
to provide mechanical integrity and instruction for organized ECM synthesis (Baker et al. 
2007). This may be particularly appropriate when such scaffolds are used to treat 
horizontal or vertical tears of the meniscus, where the scaffold architecture matches the 
collagen organization of the native tissue. On the other hand, PEO fibers rapidly dissolve 
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upon hydration to release the embedded collagenase in order to partially degrade the 
wound interface. A major consequence of PEO fiber removal is an increase in the scaffold 
pore size, which facilitates cell migration into the regenerate space (Baker et al. 2008, 
Baker et al. 2012, Ionescu et al. 2013). However, the scaffolds placed within meniscal 
defects were not well colonized despite having an initial PEO content of 40–50%, a 
composition that allowed cell infiltration yet maintained tensile properties in previous 
studies (Baker et al. 2008). It is possible that compression imposed by the defect geometry 
may have reduced scaffold porosity and as such, the increase in integration likely resulted 
from the improved matrix synthesis and integration occurring adjacent to the scaffold. In 
a preliminary study with adult meniscus, the insertion of an annular scaffold that permitted 
contact of opposing tissue at the center of the construct resulted in rapid bridging matrix 
formation (Figure 4-7). In future studies, additional fenestrations could be introduced to 
maximize tissue-to-tissue integration.  
By using complex scaffolds with multiple components, the fiber ratios, individual fiber 
properties, and biofactor doses can be tuned to optimize the instructive microenvironment 
and mechanical properties. For example, composite scaffolds were also utilized by Hong 
et al. for abdominal laparotomy management, wherein poly(lactide-co-glycolide) fibers 
released an antibiotic and poly(ester urethane) urea provided elasticity (Hong et al. 2008). 
Moreover, fiber modification techniques allow bioactive molecules to be blended inside 
fibers (Hong et al. 2008, Sahoo et al. 2010, Smith et al. 2004), conjugated to the fiber 
surface (Choi et al. 2008, Ye et al. 2011), sequestered inside a co-axial core (Liao et al. 
2006, Sahoo et al. 2010), or delivered via microspheres (Ionescu et al. 2010). 
Consequently, numerous factors can be incorporated into a single scaffold to allow for a 
multitude of release profiles and therapeutic effects. Building upon this platform, our 
scaffolds may be further functionalized to include growth factors such as platelet-derived 
growth factor (Tumia et al. 2009) and TGF-β3 (Ionescu et al. 2012b) to recruit reparative 
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cells and stimulate ECM synthesis after the initial enzymatic treatment. Currently, we are 
investigating how biomaterial-mediated collagenase delivery impacts in vivo meniscal 
healing in a subcutaneous rat xenotransplant model. For definitive evidence of scaffold 
efficacy, an ovine model will be used to evaluate integration by inserting the scaffold into 
a surgically created bucket-handle meniscal defect. 
 
4.6 Conclusions 
The principles outlined in this paper establish a new approach to enhance repair that 
recapitulates natural healing processes, including local degradation, cell recruitment, and 
matrix synthesis. Once validated in vivo, the nanofibrous networks developed herein, 
tuned to enhance each phase of fibrous tissue repair, may find widespread application for 
treating a variety of musculoskeletal tissues.  
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CHAPTER 5: REPAIR OF DENSE CONNECTIVE TISSUES VIA BIOMATERIAL-
MEDIATED MATRIX REPROGRAMMING OF THE WOUND INTERFACE 
 
5.1 Abstract 
Repair of dense connective tissues in adults is limited by their intrinsic hypocellularity and 
is exacerbated by a dense extracellular matrix (ECM) that impedes cellular migration to 
and local proliferation at the wound site. Conversely, healing in fetal tissues occurs due in 
part to an environment conducive to cell mobility and division. Here, we investigated 
whether the application of a degradative enzyme, collagenase, could reprogram the adult 
wound margin to a more fetal-like state, and thus abrogate the biophysical impediments 
that hinder migration and proliferation. We tested this concept using the knee meniscus, 
a commonly injured structure for which few regenerative approaches exist. To focus 
delivery and degradation to the wound interface, we developed a system in which 
collagenase was stored inside poly(ethylene oxide) (PEO) electrospun nanofibers and 
released upon hydration. Through a series of in vitro and in vivo studies, our findings show 
that partial digestion of the wound interface improves repair by creating a more compliant 
and porous microenvironment that expedites cell migration to and/or proliferation at the 
wound margin. This innovative approach of targeted manipulation of the wound interface, 
focused on removing the naturally occurring barriers to adult tissue repair, may find 
widespread application in the treatment of injuries to a variety of dense connective tissues. 
 
5.2 Introduction 
Dense connective tissues play central load-bearing roles in the musculoskeletal system 
and thus are commonly injured. Damage to the knee and temporomandibular menisci 
(Makris et al. 2011), the annulus fibrosus of the intervertebral disc (Guterl et al. 2013), and 
tendons and ligaments (Yang et al. 2013), alters joint biomechanics and instigates 
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degenerative changes. The poor intrinsic healing capacity of these tissues, especially 
those lacking robust vasculature, reduces the efficacy of surgical repair procedures. 
Indeed, repair is so limited in some of these tissues that excision, rather than repair, is the 
treatment of choice (Makris et al. 2011). Methods that improve endogenous repair would 
represent a significant advance in the treatment of injuries involving these tissues. 
It is well appreciated that adult dense connective tissues have impaired healing compared 
to fetal tissues (Beredjiklian et al. 2003, Ionescu et al. 2011, Provenzano et al. 2002). This 
decrease in healing potential is independent of the fetal biochemical milieu, in that 
differences persist in vitro (Ionescu et al. 2011, Stalling et al. 2008) as well as when fetal 
tissues are transplanted to the adult in vivo environment (Favata et al. 2006). Instead, the 
biophysical properties of these tissues may dictate repair potential. Since repair and 
integration rely on the de novo synthesis of extracellular matrix (ECM) proteins to bridge 
the wound gap, it follows that access to the wound site and colonization by matrix-
producing cells are essential for repair to occur. In fetal tissue, collagen fibers are slender 
and immature and the matrix is hypercellular relative to the adult. As tissues adapt to 
muscular contractions in utero and ambulation after birth, collagen fiber size and density 
increase, boosting mechanical properties, while cellularity markedly decreases (Ansorge 
et al. 2011, Clark et al. 1983, Ionescu et al. 2011, Scott et al. 1994). While enabling 
function in adults, this high ECM density and stiffness, coupled with a lower cellularity, 
may pose barriers to endogenous healing. In contrast to 2D migration, cells in 3D must 
overcome the biophysical resistance of their microenvironment in order to move, including 
the high matrix stiffness (Ehrbar et al. 2011) and limited pore size (Wolf et al. 2013). 
Similarly, tissue density and steric constraints may limit the capacity for a local proliferative 
response. As tissue cellularity decreases, the distance a cell must travel also increases. 
Therefore, improving interstitial cell mobility through the dense ECM of adult tissues as 
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well as the local proliferative potential may be a crucial first step to fostering repair and 
regeneration. 
In this study, we use the knee meniscus as a test bed in which to evaluate a novel 
approach to enhance connective tissue repair. The meniscus is a fibrocartilaginous 
structure in the knee that mediates force transfer from the femur to the tibia. Meniscal 
ECM structure is intrinsic to its function, where circumferential collagen bundles develop 
to resist tensile hoop stresses (Fithian et al. 1990). Tissue maturation is inversely related 
to the healing capacity of the meniscus, such that increasing patient age is correlated with 
worse clinical outcomes, including higher rates of repair failure (Eggli et al. 1995, 
Vanderhave et al. 2011). Importantly, patients over 40 with meniscal tears have fewer 
cells at the wound interface than younger patients (Mesiha et al. 2007). Since 2D migration 
is comparable between fetal and adult meniscal fibrochondrocytes (Ionescu et al. 2011), 
these results suggest that the 3D microenvironment engendered by tissue maturation 
antagonizes cellular migration, predisposing the meniscus to a limited repair capacity. 
To evaluate the role of the ECM in meniscal healing, we reprogrammed the wound margin 
of the adult meniscus towards a fetal-like state that would be more permissive to cell 
migration and division. Specifically, we tested whether treatment with collagenase, a 
matrix-degrading enzyme, could alter the density and stiffness of the wound 
microenvironment to expedite cellular egress from tissue and/or local proliferation so as 
to increase interfacial cellularity. To localize enzyme release, we developed composite 
electrospun nanofibrous networks that could be tuned to release collagenase upon 
implantation. Finally, we demonstrated enhanced repair using these novel materials in 
both a subcutaneous xenotransplant (rat) model and an orthotopic meniscal injury (ovine) 
model. These findings define a new paradigm in the treatment of connective tissue 
injuries, wherein the ECM at the wound interface can be reprogrammed to a state that is 
more amenable to repair. 
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5.3 Methods and Materials 
5.3.1 Cellular Egress from Meniscal Explants with Digestion 
Menisci were isolated from adult cows (skeletally mature, 20–30 months) and tissue 
cylinders excised using an 8 mm biopsy punch. Cylinders were concentrically cored with 
a 4 mm punch to generate annuli and cores. To determine the effect of partial enzymatic 
digestion on cell egress from explants, annular samples were incubated in basal media 
(BM) (Qu et al. 2013) supplemented with collagenase (type IV from Clostridium 
histolyticum, ≥125 collagenase digestion units/mg solid; Sigma-Aldrich, St. Louis, MO) at 
37°C for 3 hours on an orbital shaker, after which they were rinsed in 1X phosphate 
buffered saline (PBS) (Qu et al. 2013). Three conditions were tested: BM only (Control), 
low-dose collagenase (LowC; 0.02 mg/mL), and high-dose collagenase (HighC; 0.06 
mg/mL). Annuli were cultured at 37°C in BM (n=3 samples/group). Cell egress was 
monitored on a daily basis via bright-field microscopy. After 10 days, explants were 
removed, embedded in optimal cutting temperature (OCT) sectioning medium, and 
cryosectioned axially to 16 µm thickness (Qu et al. 2013). Sections were stained with 
Alcian Blue (AB) or Picrosirius Red (PSR) for sulfated proteoglycans (PGs) and collagen, 
respectively, and imaged under bright-field microscopy. The remaining adherent cells 
were incubated for 20 minutes with Hoechst 33342 (5 µg/mL; Invitrogen, Grand Island, 
NY) to label cell nuclei and imaged by fluorescence microscopy. Cell density from four 
distinct regions per sample was determined using ImageJ (Wayne Rasband, NIH). 
 
5.3.2 Integration of Meniscal Repair Constructs with Digestion 
To study the effect of enzymatic pre-treatment on integration, annuli and cores were 
incubated in BM with 0 (Control), 0.01 (LowC), or 0.05 mg/mL (HighC) collagenase at 
37°C for 6 hours on an orbital shaker, rinsed with 1X PBS, and assembled into repair 
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constructs (Qu et al. 2013). Constructs were cultured in chemically-defined medium with 
10 ng/mL TGF-β3 (Qu et al. 2013) for 1, 4, or 8 weeks. At set intervals, repair constructs 
were fixed in 4% paraformaldehyde, embedded in paraffin, and axially sectioned to 8 μm 
thickness for imaging, or embedded in OCT medium and axially sectioned to 20 μm 
thickness for micromechanical measurements. Second harmonic generation (SHG) 
imaging of the wound interface was performed at an excitation wavelength of 840 nm (Carl 
Zeiss Microscopy GmbH, Jena, Germany) using unstained paraffin sections to visualize 
the fibrillar architecture of collagen at the earliest time point (1 week of in vitro culture). To 
identify nuclei, paraffin sections were stained with 4’,6-diamidino-2-phenylindole (DAPI; 
Invitrogen) and imaged by fluorescence microscopy. Cell density at the interface was 
determined by counting the number of nuclei within 100 µm of the interface present in 
either the annulus or core (n=4 samples/group) (Qu et al. 2013).  
 
5.3.3 Tissue Micromechanics in Meniscal Repair Constructs with Digestion 
Force spectroscopy was performed on cryosections in PBS using an atomic force 
microscope (AFM) mounted on top of an inverted optical microscope (Agilent, Santa Clara, 
California). A V-shaped pyramidal-tipped cantilever was positioned either at the tissue 
center or edge (a region within 100 µm of the wound interface). The probe tip was brought 
into contact and force and displacement recorded. Elastic moduli were computed using a 
Hertzian model (Sanchez-Adams et al. 2013) to an indentation depth of 300 nm using a 
custom program. Measurements with a fitted R2≥0.98 were included (n=3 samples/group, 
n=10 measurements/sample). 
 
5.3.4 Fabrication of Nanofibrous Scaffolds to Enable Localized Digestion 
Nanofibrous composites were formed via electrospinning using a custom tri-jet device 
(Baker et al. 2009b). Composites contained a poly(ε-caprolactone) (PCL; 80 kDa, Sigma-
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Aldrich) structural fiber fraction along with two water-soluble poly(ethylene oxide) (PEO; 
200 kDa, Polysciences, Warrington, PA) fiber fractions. PEO fibers contained either no 
collagenase (Scaffold) or 15.6% type IV collagenase by mass (Scaffold+C) (Qu et al. 
2013). Electrospun mats were ~0.5 mm thick and stored at -20°C until use. To 
demonstrate collagenase activity, cylindrical juvenile articular cartilage samples were 
isolated using 4 mm biopsy punches. Cartilage cylinders were incubated in BM that 
contained either no scaffold (Control), a control scaffold (Scaffold, 0.04 mg), or a 
collagenase-releasing scaffold (Scaffold+C, 0.04 mg) at 37°C for 24 or 72 hours on an 
orbital shaker. Samples were cryotomed to 16 μm, stained with AB, and imaged (Qu et al. 
2013).  
 
5.3.5 Subcutaneous Assessment of Collagenase-Releasing Scaffolds  
To test the effect of enzymatic treatment on meniscal repair in vivo, a nude rat 
xenotransplant model was employed. All procedures were approved by the Institutional 
Animal Care and Use Committee (IACUC) of the Philadelphia Veterans Affairs Medical 
Center. Adult bovine meniscal explants (8 mm diameter, 4 mm height) were incised to 
create a horizontal defect. The defect was either incubated in BM (Control) or in BM with 
0.4 mg/mL collagenase at 37°C for 6 hours on an orbital shaker (aqC), or filled with a 
control scaffold (Scaffold) or a collagenase-releasing scaffold (Scaffold+C). Scaffolds 
were cut to 5 x 5 mm with a 2 mm diameter fenestration to permit tissue-to-tissue contact 
and sterilized by UV. Defects were closed with absorbable sutures (3-0 Monocryl) before 
subcutaneous implantation into male athymic nude rats under aseptic conditions (Hsd:RH-
Foxn1rnu, ~300 g). Under general anesthesia, four pockets were created in each rat. One 
randomized construct per group was placed in each pocket and the incision was closed. 
At 1 week (n=1/group) and 4 weeks (n=4/group), rats were euthanized by CO2 
asphyxiation. Retrieved samples were paraffin embedded, sectioned to 8 µm, and stained 
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with Hemotoxylin & Eosin (H&E), PSR, or DAPI. Integration was quantified by dividing the 
cumulative length of integrated segments by the defect length in PSR sections (n=3–4 
samples/group). Given the increased cell density of in vivo samples, cellularity at the 
interface was evaluated using a modified protocol. Specifically, the nuclear signal from 
DAPI-stained micrographs was converted to white (intensity=255) and background to 
black (intensity=0) using ImageJ. Next, pixel intensity relative to the interface was 
averaged across the defect length, starting from the interface up to a distance 700 µm 
perpendicular to the defect. Signal intensity with respect to location was binned into 100 
µm intervals for analysis (n=4 samples/group). Finally, immunohistochemistry was 
performed to identify type I or type II collagen (Farrell et al. 2013). 
 
5.3.6 Assessment of Collagenase-Releasing Scaffolds in an Ovine Model 
All procedures were approved by the IACUC at the University of Pennsylvania, and studies 
were performed in accordance with the NIH guidelines for the care and use of laboratory 
animals. Under general anesthesia, bilateral femorotibial joint surgeries were performed 
on five adult female Dorsett-Finn sheep. Following aseptic preparation, the medial 
collateral ligament (MCL) was isolated and reflected distally using a bone block to 
preserve the bone-ligament interface. A medial arthrotomy was performed followed by 
placement of stay sutures in the body of the medial meniscus to allow traction for 
increased exposure. A 10 mm full thickness longitudinal cut was made in the avascular 
zone of the meniscus using a scalpel blade, followed by repair with vertical mattress 
stitches using a braided polyester suture (2-0 Ethibond). Four groups were compared: 1) 
repair only, 2) treatment with a control PCL/PEO scaffold placed in the defect (trimmed to 
10 mm in length x 3 mm in width, with three 1 mm diameter fenestrations along the length) 
in combination with repair, 3) treatment with a PCL/PEO scaffold releasing collagenase in 
combination with repair, and 4) a partial meniscectomy (removing the meniscus tissue 
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axial to the longitudinal injury). Treatments were randomized (n=3 for control scaffold 
group, n=2 for all other groups). Afterwards, the joint capsule was repaired and the bone 
block was repositioned and secured using a bone screw and washer. Animals received a 
course of perioperative antimicrobials consisting of Potassium Penicillin and Gentamicin. 
Analgesia was provided in the form of transcutaneous fentanyl patches for 3 days, intra-
articular morphine and bupivacaine delivered intra-operatively, and NSAIDs for 7 days. 
Animals were housed in individual 5 x 5 foot pens allowing for visual and olfactory contact. 
All animals had uneventful recoveries with no noticeable gait deficits after 2 weeks. At 4 
weeks, sheep were sedated and euthanized with an injection of commercial euthanasia 
solution. 
Following euthanasia, stifle joints were opened, and photographs taken of the meniscus, 
cartilage, and other soft tissues. Menisci and other soft tissues (e.g. ligaments, fat pad) 
were isolated and fixed in 10% formalin. Gross damage to the cartilage surfaces of the 
tibial plateau and femoral condyles was assessed via India ink staining as previously 
described (Gruchenberg et al. 2014) and quantified using ImageJ, where damage was 
expressed as a percentage of the total area of the cartilage surface. For histology, menisci, 
cartilage, and bone were paraffin embedded and sectioned to 6 μm thickness (Farrell et 
al. 2013). For the menisci, radial cross-sections through the injury site were stained with 
H&E and PSR and imaged. The cartilage and bone sections were stained with Safranin O 
and Fast Green and imaged to visualize PGs and fibrous tissue, respectively.  
 
5.3.7 Statistical Analyses  
Statistical analyses were done using SYSTAT (Systat Software, Inc., San Jose, CA) and 
SPSS Statistics (IBM Corporation, Armonk, NY). Normality was assessed via the 
Kolmogorov-Smirnov test. One or two-way ANOVA with Tukey’s HSD post hoc test was 
 90 
 
utilized to determine significant differences between groups (p≤0.05). Data is presented 
as the mean ± standard deviation, unless specified otherwise. 
 
5.4 Results 
5.4.1 Enzymatic Digestion Enhances Cellular Egress from Explants 
Adult meniscal explants incubated in collagenase showed dose-dependent degradation 
of collagen and removal of sulfated proteoglycans (PGs) at the tissue margin, indicated 
by Picrosirius Red (PSR) and Alcian Blue (AB) staining, respectively. While matrix 
digestion was minimal for the low-dose collagenase group (LowC), high-dose collagenase 
treatment (HighC) resulted in noticeable loss of peripheral matrix (Figure 5-1A), 
consistent with previous findings (Qu et al. 2013).  
 
 
Figure 5-1: Partial enzymatic digestion with collagenase enhances cellular egress from 
meniscal explants in vitro. (A) Alcian Blue (AB) and Picrosirius Red (PSR) staining for 
proteoglycans (PGs) and collagen, respectively. Collagenase digestion removes PGs and 
collagens from the tissue edge. Scale = 100 µm. (B) Top-down schematic illustrating partial 
enzymatic digestion of ring-shaped explants and emergent cells (blue dots). Box indicates 
area imaged for (A). (C) Cell outgrowth onto tissue culture-treated plates 10 days after pre-
treatment with low- (LowC; 0.02 mg/mL) and high-dose (HighC; 0.06 mg/mL) collagenase 
(n=3 samples/group, 4 measurements/sample, mean ± standard deviation). * = p≤0.05 vs. 
Control and LowC. 
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When treated explants were placed on tissue culture substrates (Figure 5-1B), meniscal 
fibrochondrocytes emerged within 6 days. At 10 days, cell outgrowth was higher for HighC 
samples (94 ± 43 cells/mm2) compared to other groups, with a 36% and 395% increase 
over LowC (69 ± 60 cells/mm2) and untreated control (19 ± 13 cells/mm2) groups, 
respectively (Figure 5-1C, p≤0.05). These data illustrate that the removal of physical 
impediments at the wound edge can expedite cellular egress.  
 
5.4.2 Degradation of the Wound Interface Reduces Matrix Density, Increases 
Cellularity, and Alters Micromechanics 
To focus on the wound interface, partial digestion of annuli and cores was performed prior 
to their reassembly into concentric ‘repair’ constructs. Collagenase pre-treatment resulted 
in dose-dependent modulation of the wound interface. After 1 week, second harmonic 
generation (SHG) imaging revealed dense collagen bundles in untreated controls, with no 
tissue formation across the wound gap. Conversely, HighC samples had thin, immature 
fibrils populated by a higher number of cells bridging the wound gap (Figure 5-2A and 
Figure 5-2B). Indeed, cell density at the annulus-core boundary was greater for HighC 
samples (444 ± 139 cells/mm2) compared to all other groups by the 1 week time point, 
with a 96% and 242% increase over LowC (226 ± 62 cells/mm2) and control (130 ± 37 
cells/mm2) groups, respectively (Figure 5-2C, p≤0.05). These differences in matrix 
density, defect integration, and cellularity persisted through 8 weeks for HighC compared 
to all other groups, despite stable tissue-to-tissue apposition in all groups. Once the 
differences in cell density were established, these values did not change with additional 
time in culture, suggesting that partial degradation leads to a rapid and sustainable 
accumulation of cells at the wound margin. 
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Figure 5-2: Degradation of the wound interface reduces matrix density and increases 
cellularity in an in vitro meniscal repair model. (A) Second harmonic generation imaging 
shows collagen fibers (green) at the wound interface of control, low-dose collagenase 
(LowC; 0.01 mg/mL), and high-dose collagenase (HighC; 0.05 mg/mL) repair constructs after 
1 week of in vitro culture. Blue indicates autofluorescent signal. Arrows point to cells within 
the matrix. Scale = 100 µm. (B) DAPI staining of axial sections show cell nuclei at the 
interface (dashed line) after 1 week. Scale = 100 µm. (C) Cell density at the interface with 
respect to treatment group and in vitro culture time (n=4 samples/group, mean ± standard 
deviation). Cores (dark) and annuli (light) were counted as independent data points (no 
statistical difference). Inset shows schematic of repair explant in an axial section, where the 
boxes highlight the cell counting regions. * = p≤0.05 vs. Control. † = p≤0.05 vs. Control and 
LowC. There was no difference between time points within the same treatment group. 
 
Force spectroscopy via atomic force microscopy (AFM) of repair constructs (Figure 5-3A) 
cultured for 8 weeks revealed persistent changes in micromechanics at the interface with 
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treatment (Figure 5-3B). The Young’s modulus (EY) of the defect edge for LowC (345 ± 
138 kPa) and HighC (210 ± 79 kPa) samples was lower than that of controls (488 ± 155 
kPa) (Figure 5-3C, p≤0.05). Digestion with high-dose collagenase also reduced EY of the 
HighC construct center (312 ± 133 kPa) compared to that of LowC (441 ± 151 kPa) and 
control (496 ± 120 kPa) groups. Taken together, our results suggest that collagenase dose 
can be tuned to mediate local matrix digestion and advance repair.  
 
 
Figure 5-3: Location-dependent matrix micromechanics of repair constructs after 8 weeks 
of in vitro culture. (A) Schematic of AFM nanoindentation measurements of matrix stiffness 
across the wound interface of a HighC construct stained with PSR (collagen). Scale = 50 µm. 
(B) Force indentation curves for each condition taken at the wound edge (mean ± standard 
error of the mean for all samples). (C) Elastic modulus of the construct center and wound 
edge of Control, LowC, and HighC constructs (n=3 samples/group, 10 
measurements/sample, mean ± standard deviation). * = p≤0.05 vs. Control. † = p≤0.05 vs. 
Control and LowC. ‡ = p≤0.05 vs. all other groups.  
 
5.4.3 Scaffolds Improve Integration in a Subcutaneous Model 
Given the improvements in repair observed in vitro with collagenase pre-treatment, we 
next translated these findings to the in vivo scenario. Here, we utilized a multi-jet 
electrospinning setup in which poly(ε-caprolactone) (PCL) fibers (stable, structural) were 
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electrospun along with two poly(ethylene oxide) (PEO) fiber fractions (soluble, factor 
delivering), with each fraction collected simultaneously onto a common rotating mandrel 
(Figure 5-4A) (Baker et al. 2009b). This fabrication scheme resulted in an aligned 
composite scaffold containing ~50–60% PEO by mass, where the PEO fraction delivered 
collagenase at varying doses. The morphology and bioactivity of PCL and PEO nanofibers 
with or without collagenase have been previously characterized (Baker et al. 2008, Qu et 
al. 2013). Incubation of cartilage explants with collagenase-releasing scaffolds 
(Scaffold+C) (Figure 5-4B) decreased AB staining intensity at the tissue edge within 24 
hours (data not shown), with further reductions at 72 hours (Figure 5-4C). Untreated 
explants (Control) or those incubated with non-bioactive scaffolds (Scaffold) did not show 
any alterations in staining intensity.  
 
 
Figure 5-4: Fabrication of composite nanofibrous scaffolds with and without collagenase. 
(A) Schematic of tri-jet electrospinning. (B) Schematic of composite scaffold composed of 
poly(ε-caprolactone) (PCL) and poly(ethylene oxide) (PEO) fiber fractions, where enzyme 
activity was localized to soluble PEO fibers. Bioactivity was verified by incubation with 
cartilage cylinders. (C) AB staining of cartilage after 72 hours in Control, Scaffold, and 
Scaffold+C groups. Staining intensity decreased at the tissue edge, indicating bioactivity of 
the released collagenase. Scale = 250 µm. 
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To evaluate scaffold-mediated repair in an in vivo setting, we placed bovine meniscal 
repair constructs, either pre-treated with aqueous collagenase (aqC) or provided with a 
bioactive scaffold (Scaffold+C), subcutaneously in nude rats (Figure 5-5A). Empty defects 
(Control) and non-bioactive scaffolds (Scaffold) were used as negative controls. Control 
and Scaffold groups retained a dense local ECM, had few cells present at the wound 
margin, and showed little matrix deposition at the center of the defect. In contrast, samples 
pre-treated with aqC or with Scaffold+C showed increased cellularity and interface 
bridging by 1 week (data not shown). Quantification showed a trend towards improved 
integration for Scaffold+C samples (87 ± 9%) compared to controls (59 ± 16%) by 4 weeks 
(Figure 5-5B, p=0.07), with regions of the scaffold staining positive for cells (Figure 5-5C) 
and type I and II collagen (Figure 5-5D). 
As seen with aqueous collagenase treatment in vitro, the increase in cellularity at the 
wound edge began as early as 1 week (data not shown). After 4 weeks, cell signal intensity 
local to the interface was higher in Scaffold+C repairs compared to all other groups 
(Figure 5-6A). This increase in cell number was significant for a distance up to 300 µm 
from the wound compared to aqC, and 400 µm compared to Control and Scaffold groups 
(Figure 5-6B, p≤0.05). The highest cell density was within 100 µm of the interface for both 
aqC and Scaffold+C groups. This gradient in cellularity was not observed in Control or 
Scaffold groups, where the matrix remained intact. Collectively, these data suggest that 
collagenase-releasing scaffolds can modulate repair in vivo. 
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Figure 5-5: Collagenase treatment improves meniscal integration after 4 weeks of 
subcutaneous implantation. (A) Schematic of repair construct assembly. Scaffold is 
fenestrated to allow tissue-to-tissue contact. (B) Quantification of histological integration 
normalized to defect length (n=3–4 samples/group, mean ± standard deviation). Line 
indicates trend for difference between groups (p=0.07). (C) H&E (cells and matrix) and PSR 
(collagen) staining at the defect site after 4 weeks. Asterisk indicates scaffold. Scale = 100 
µm. (D) Immunohistochemistry for type I and II collagen. Staining at interface was of higher 
intensity for collagenase-treated groups (aqC and Scaffold+C), and largely absent in Control 
and Scaffold groups. Arrow indicates suture track in aqC sample. Schematic illustrates 
transverse cross-section with or without fenestrated scaffold present. Scale = 2 mm.  
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Figure 5-6: Cellularity proximal to the wound interface increases with collagenase treatment 
after 4 weeks of subcutaneous implantation. (A) Thresholded images of DAPI-stained nuclei 
for each group at 4 weeks. Interface is on the left (red line). Scale = 100 µm. (B) Average 
intensity with respect to distance from the interface (n=4/group, mean ± standard deviation). 
* = p≤0.05 vs. all other groups at the same distance, † = p≤0.05 vs. Control and Scaffold at 
the same distance, ‡ = p≤0.05 vs. aqC distances ≥400 µm, § = p≤0.05 vs. all other Scaffold+C 
distances. 
 
5.4.4 Scaffolds Promote Meniscal Repair in an Ovine Model 
To advance this technology towards clinical translation, we tested scaffolds in a pilot study 
using an orthotopic large animal model representative of the mechanically challenging and 
avascular environment of the adult synovial joint. The ovine model was chosen based on 
its consistency with human meniscal anatomy, function, and limited healing response 
(Arnoczky et al. 2010). Full-thickness vertical incisional defects were created in the 
avascular body of the medial meniscus (Figure 5-7A). Defects were repaired by suture 
following standard surgical protocol (Repair), or repaired with suture in addition to a control 
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scaffold (Scaffold) or a scaffold releasing collagenase (Scaffold+C). One additional group 
consisted of a partial meniscectomy (partial removal).  
 
 
Figure 5-7: Collagenase-releasing scaffolds promote repair at 4 weeks in an ovine meniscal 
defect model. (A) Schematic and photograph of surgical approach, longitudinal meniscal 
injury, and suture repair with scaffold. Asterisk indicates the bone block. (B) Radial sections 
of the repaired meniscus at 4 weeks, stained with PSR (collagen). Arrow indicates suture 
track. Scale = 2 mm. Magnified area shows enhanced integration of Scaffold+C with adjacent 
tissue, where the asterisk indicates the scaffold. Scale = 100 µm. (C) Quantification of 
damage to cartilage using India ink. Collagenase release by Scaffold+C did not adversely 
affect the cartilage. 
 
Four weeks post-operatively, all Scaffold and Scaffold+C groups and one Repair group 
remained intact. One Repair sample failed partially due to suture pulling through the injury 
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site. Histological staining of the meniscus (Figure 5-7B) revealed variations in healing 
based on group. For partial meniscectomy, the original injury site was readily visualized, 
with no new tissue formation. For the Repair group, the injury was clearly identified as a 
gap that persisted across the inner and outer portions of the meniscus, with no new tissue 
formation. Similar findings were obtained for the Scaffold group. Defects treated with 
Scaffold+C groups, however, showed clear apposition of the margins and tissue formation 
both within and around the scaffold across the length and height of the defect, suggestive 
of a robust healing response (Figure 5-7B, inset). 
To determine whether cartilage and other joint structures were perturbed by either injury 
or treatment, India ink staining was performed. This analysis revealed low levels (<5%) for 
all specimens from the non-operative joint compartment (the lateral tibial plateau, Figure 
5-7C). In the operative compartment (the medial tibial plateau), the partial meniscectomy 
group had the highest values. All repair groups had low levels of cartilage damage (3–
11%), though all were higher than that of the non-operative side. Evaluation of other joint 
tissues (anterior cruciate ligament, posterior cruciate ligament, fat pad, synovium) showed 
no changes with Scaffold or Scaffold+C compared to controls (data not shown), indicating 
that enzymatic degradation was indeed confined to the wound margin. 
 
5.5 Discussion 
This study demonstrates that matrix reprogramming of the adult meniscal ECM to a fetal-
like state improves integrative repair. This in vivo analysis, consistent with our previous in 
vitro studies (Qu et al. 2013), illustrates the potential of partial degradation of the meniscal 
wound edge to enhance healing. Here, we establish that delivery of collagenase facilitates 
repair by expediting cell migration to and/or proliferation at the wound site. Furthermore, 
we reduce this concept to practice by demonstrating that localized collagenase delivery 
via composite nanofibrous scaffolds in vivo enhances closure of meniscal defects without 
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perturbing other intra-articular tissues. Collectively, these data define a novel methodology 
for the treatment of dense connective tissues that are recalcitrant to regenerative healing 
due to the intrinsic characteristics of their dense and hypocellular ECM. 
 
 
Figure 5-8: Extracellular matrix reprogramming of the wound interface to a fetal-like state 
augments dense connective tissue repair. (A) Injury to fetal tissue results in a robust repair, 
with cells rapidly colonizing the wound site and depositing new matrix. (B) Conversely, 
healing of adult tissue is limited because few cells arrive at the wound site. (C) Scaffold-
mediated reprogramming via collagenase-releasing nanofibers (green) reduces local matrix 
stiffness and density, thereby releasing cells from these steric constraints. The wound gap 
is bridged as cells colonize the defect and deposit matrix around the remaining scaffold 
(pink). Over time, the scaffold degrades, allowing cells to remodel the interface. 
 
This new endogenous tissue engineering approach may find widespread application in 
injuries to tissues having low cellularity or lacking proper blood supply. When circulating 
stem cells are precluded from the repair response (as is the case with dense connective 
tissues), the pool of reparative cells is limited to those residing within the tissue itself or 
those that migrate from neighboring structures. Unlike the hypercellular repair response 
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seen in injured fetal tissue (Figure 5-8A), cells within adult tissue do not readily undergo 
interstitial migration or local proliferation, resulting in a hypocellular wound margin with 
minimal repair tissue formation (Figure 5-8B). It is likely that the high density and stiffness 
of collagen bundles retard proteolysis-mediated migration and restrict proliferation. To 
enhance cell mobility and provide sufficient space for division, we digested the tissue 
border with collagenase, a proteolytic enzyme that cleaves fibrillar collagens (Figure 
5-8C). Until recently, partial degradation has only been explored in the context of articular 
cartilage repair. Short-term enzymatic treatment can increase interfacial chondrocyte 
density and improve interfacial strength in vitro (van de Breevaart Bravenboer et al. 2004), 
as well as enhance integration of cartilage explants to engineered cartilage (Obradovic et 
al. 2001) and to acellular scaffolds (Ng et al. 2012). In concordance with this literature, we 
show here that collagenase also enhances the integration of the knee meniscus, and can 
be applied in conjunction with a standard suture repair to meniscal injuries in vivo. 
Reducing ECM stiffness and density at the wound margin via enzymatic treatment may 
improve fibrous wound healing by freeing cells from their spatial confinements to improve 
migration and/or local proliferation, although other factors may contribute as well. For 
instance, collagen fragments can act as biochemical signals for cell proliferation 
(Koohestani et al. 2013) and migration (Shi et al. 2010). Likewise, exposing cells to the 
underlying collagen network via depletion of PGs may stimulate matrix deposition 
(MacBarb et al. 2013). Degrading the defect edge may also release matrix-bound latent 
transforming growth factor-beta (TGF-β) (Tatti et al. 2008), which could promote either a 
myofibroblastic phenotype that may be beneficial to fibrous wound healing (Hinz 2007, 
Kambic et al. 2000) and/or recruit endogenous stem cells to the wound environment (Lee 
et al. 2010). Regardless of the precise mechanism of action, increasing the quantity of 
matrix-producing cells at the wound interface benefits the early phase of repair. While 
collagenase improved the interface in our study, additional cues may be required to 
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accelerate ECM maturation to prevent re-injury. For example, delivery of TGF-β could 
enhance matrix synthesis (Ionescu et al. 2012b), while lysyl oxidase could stabilize the 
wound interface by promoting collagen crosslinking (DiMicco et al. 2002, Makris et al. 
2014). On the tissue level, controlled resumption of load-bearing activity, engendering 
both tensile and compressive loading, could promote development of native tissue 
architecture (Baker et al. 2011, Puetzer et al. 2012). Since 3D migration depends on 
deformation and contraction-mediated movement through tight interstitia, cell mechanics 
and contractility pathways might also be manipulated to enhance mobility (Harada et al. 
2014, Wolf et al. 2013) and thereby improve endogenous tissue repair. 
In order to translate our findings towards clinical application, we developed methods by 
which enzyme delivery could be localized to the wound margin. Injectable collagenase is 
currently in clinical use for the treatment of Dupuytren’s contracture, a fibroproliferative 
disorder (Bendon et al. 2012), where the factor is directly injected into the aberrant tissue. 
However, such diffuse, non-targeted injection into a synovial joint would reduce the 
efficacy of the factor and could damage surrounding intra-articular structures. To 
overcome this, we developed collagenase-releasing nanofibrous scaffolds that could be 
inserted into the wound site. We and others have used such bioactive nanofiber-based 
systems to direct new tissue formation for the meniscus and other musculoskeletal tissues 
(Fu et al. 2008, Manning et al. 2013, Qu et al. 2013). Here, we took advantage of the rapid 
dissolution of the PEO fiber fraction to provide an immediate and localized burst delivery 
of enzyme. Incubating these scaffolds with cartilage and meniscus resulted in matrix 
digestion and PG removal at the tissue margins, demonstrating retention of bioactivity 
during scaffold fabrication and sterilization. When inserted into meniscal defects, 
composite scaffolds released collagenase in a targeted manner, creating a gradient of 
matrix loss. After PEO dissolution, the stable, aligned PCL fiber fraction remained as a 
physical template to provide instruction for ECM synthesis (Baker et al. 2012). Both PEO 
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and PCL are FDA-approved materials, making these acellular scaffolds an attractive 
system for translation. 
Having established a biocompatible delivery vehicle, we next evaluated whether 
biomaterial-mediated matrix degradation of the meniscal wound interface could be 
achieved in vivo, and whether this might enhance cellular infiltration, local proliferation, 
and tissue integration. In both a subcutaneous xenotransplant model in the nude rat and 
an orthotopic injury model in adult sheep, meniscal defects treated with collagenase-
releasing scaffolds showed improved cellularity at the wound margin. While it is difficult to 
decouple increased migration at the wound margin from cell division, both may have 
contributed to increase local cellularity within this region; future studies will include BrdU 
labeling during repair to identify the specific contributions of these two complementary 
processes. Regardless, this increased cellularity at the wound margin correlated with 
matrix deposition around and within the scaffolds, resulting in wound closure by 4 weeks. 
Notably, there was neither gross nor histological evidence of adverse changes outside the 
defect. Based on this data, we believe that, when used alongside a standard suture repair, 
this acellular, bioactive scaffold will enable wound healing in an environment that is 
biologically and biomechanically unfavorable for repair. 
While nanofibrous composites have previously been exploited for tissue engineering of 
the meniscus (Baker et al. 2012), this is the first instance where localized delivery of 
therapeutics via nanofibers was used to enhance endogenous meniscal integration. 
Simultaneous electrospinning of multiple, discrete fiber families allows for the fabrication 
of highly tunable scaffolds (Baker et al. 2009b) that are capable of delivering multiple 
biologic factors with varying release profiles. As such, this technology may be modified to 
deliver additional agents to facilitate repair, including chemoattractants to recruit both 
native (Bhargava et al. 1999) and endogenous stem cells (Barreto Henriksson et al. 2013), 
growth factors to promote matrix deposition (Ionescu et al. 2012b), and anti-
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inflammatories to prevent matrix catabolism (McNulty et al. 2009). Likewise, the aligned 
nanofibers themselves can direct matrix deposition (Baker et al. 2007), allowing the 
scaffold topography to foster tissue formation that recapitulates essential structural and 
mechanical anisotropies of the native meniscus and other organized connective tissues, 
such as tendons and ligaments (Zhang et al. 2012). Lastly, biomaterial-mediated matrix 
reprogramming may be utilized to enhance the integration of autologous meniscal 
fragments (Kobayashi et al. 2010) or bioengineered replacements (Cook et al. 2006, 
Gruchenberg et al. 2014, Kon et al. 2014, Maher et al. 2010, Verdonk et al. 2011) to 
surrounding native tissue, currently a major logistical hurdle to translation. 
 
5.6 Conclusions 
In summary, limited cell mobility arising from inherent changes that occur with maturation 
may limit endogenous healing of the adult meniscus and other dense connective tissues. 
An innovative strategy to promote repair may be to first reduce the natural biophysical 
constraints on native cells so as to facilitate their migration to and local proliferation at the 
wound site. Given the long time course and high re-failure rate of fibrous tissue repair, 
translational tools that enhance integration will improve treatment options for a multitude 
of common orthopaedic injuries, changing the paradigm from one of resection to one of 
regeneration. 
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CHAPTER 6: MATRIX REPROGRAMMING ENHANCES INTERSTITIAL CELL 
MIGRATION IN THE ADULT MENISCUS  
 
6.1 Abstract 
Few regenerative approaches exist for the treatment of injuries to adult dense connective 
tissues. Compared to fetal tissues, adult connective tissues are hypocellular and show 
limited endogenous cell-mediated healing after injury. However, it is unknown whether this 
deficiency in repair is due to the limited cell number itself, by steric constraints to cell 
mobility imposed by the extracellular matrix (ECM), or by a combination of the two. We 
hypothesized that robust repair occurs in fetal tissues due to an immature ECM conducive 
to cell migration, and that this process fails in adults as a consequence of the dense and 
stiff ECM that acts as a biophysical impediment. Using the knee meniscus as a test 
platform, this study evaluated the microstructure and micromechanics of fetal and adult 
tissues, with a particular focus on the inter-fibrillar regions through which cells might 
migrate. Further, we monitored the morphology and interstitial migration of adult meniscal 
cells through fetal and adult tissue microenvironments. Finally, building from our recent 
studies showing that local pre-treatment with collagenase improves cellular colonization 
of the wound interface in the adult meniscus, we measured adult cell migration through a 
pre-digested adult ECM. Our results show that the microstructure and micromechanics of 
the adult meniscus ECM act as physical barriers to cell mobility, and that modulating the 
ECM microstructure via an exogenous matrix-degrading enzyme permits cell migration 
through this otherwise impenetrable collagenous network. 
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6.2 Introduction 
Dense connective tissues, such as the knee and temporomandibular menisci, tendons 
and ligaments, and the annulus fibrosus of the intervertebral disc, are essential for the 
mechanical functionality of the musculoskeletal system. However, injuries often result in 
poor self-repair, leading to altered biomechanical function and eventually joint 
degeneration. Unfortunately, what little regenerative capacity exists also declines with 
tissue maturation. For example, fetal connective tissues exhibit a robust healing response 
(Beredjiklian et al. 2003, Ionescu et al. 2011, Provenzano et al. 2002), and meniscal tears 
are rarely seen in young children but are a common orthopaedic injury in adults (Andrish 
1996, Clark et al. 1983). Moreover, increasing patient age is correlated with worse clinical 
outcomes after meniscal repair, including higher rates of repair failure (Barrett et al. 1998, 
Eggli et al. 1995, Tenuta et al. 1994, Vanderhave et al. 2011). Consequently, many clinical 
treatments focus on tissue removal instead of restoration, which reduces pain in the short-
term but ultimately leads to irreversible deterioration of the affected joint (Makris et al. 
2011). As such, strategies that enhance endogenous repair may benefit the aging 
population by delaying or even eliminating the need for end-stage total joint replacement. 
Healing is characterized by cellular invasion into the defect, with subsequent proliferation, 
synthesis of new matrix to bridge the wound gap, and tissue remodeling (Kambic et al. 
2000, Kawamura et al. 2003). Therefore, a sufficient number of reparative cells at the 
wound interface are critical for successful integrative repair. However, cellularity 
decreases progressively with maturation until a low cell density is reached in the adult 
(Clark et al. 1983, Ionescu et al. 2011). Importantly, Mesiha et al. found that patients with 
meniscal tears who were over 40 years old had significantly fewer cells at the wound 
interface than younger patients (Mesiha et al. 2007). This deficiency may be compounded 
by the limited cell mobility through the physically restrictive microenvironment of adult 
tissue. During development, ECM collagen and proteoglycan (PG) content increase with 
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load-bearing use of the tissue, resulting in increased bulk mechanical properties (Ionescu 
et al. 2011). Unlike migration in 2D, adult cells in 3D must overcome the increased 
biophysical resistance of their surrounding environment. As the pores through which cells 
crawl become progressively smaller, migration rates decline and eventually cells are 
rendered immobile (Wolf et al. 2013). Extremely stiff or non-degradable matrices also 
obstruct cell movement because they cannot be effectively remodeled to allow cell 
passage (Ehrbar et al. 2011, Raeber et al. 2007). Thus, spatial confinement within the 
ECM may prevent endogenous cells from reaching the injury site to affect repair in adult 
dense connective tissues. 
Despite the wealth of knowledge gained from recent 3D migration studies, the vast 
majority of in vitro microenvironments, such as Matrigel (Zaman et al. 2006) and collagen 
gels (Miron-Mendoza et al. 2010, Wolf et al. 2013), synthetic hydrogels (Ehrbar et al. 2011, 
Singh et al. 2014), or microfabricated chambers (Lautscham et al. 2015, Pathak et al. 
2012), bear little resemblance to native dense connective tissues. Importantly, the 
collagen content of juvenile bovine dense connective tissues (200–250 mg/mL) 
(Eleswarapu et al. 2011) is up to 100 times the concentration typically used for collagen 
gels in vitro (Even-Ram et al. 2005). Furthermore, the high level of collagen crosslinking 
and alignment in native tissue results in a tightly packed fibrous network with increased 
resistance to proteolysis (Reiser et al. 1992). This matrix density and organization likely 
make such interstitial spaces considerably less permissive to migration than in vitro 
preparations commonly used in this field to evaluate migration. Indeed, it is likely that such 
in vitro observations in isotropic, non-native environments will not fully recapitulate the 
impediments to migration seen in dense connective tissues, and so there is a pressing 
need to develop new systems to study 3D cell migration in a more physiologic context. 
To address this limitation, we investigated interstitial cell migration in a physiologically 
relevant environment by using devitalized tissue substrates as our experimental 3D milieu. 
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We hypothesized that the native ECM is a biophysical impediment to cell mobility during 
repair, and that reduction of this steric hindrance would expedite cell migration to the 
wound site. Using the adult knee meniscus as a test platform, we determined that age-
related micromechanical and microstructural changes in the ECM are inhibitory to cell 
migration. Furthermore, we demonstrated that modulating ECM properties via the 
application of an exogenous matrix-degrading enzyme enhances interstitial mobility, and 
that this acted synergistically with cell-produced endogenous MMPs to promote cell 
migration through the dense ECM. By clarifying the role of local matrix properties in wound 
repair, these studies may establish new clinical strategies to promote endogenous repair 
of the meniscus and other fibrous tissues of the musculoskeletal system. 
 
6.3 Materials and Methods 
6.3.1 Tissue Substrate Fabrication 
Fetal (late 2nd–3rd trimester) and adult (20–30 months) bovine stifle joints were sterilely 
dissected and the knee menisci isolated. Cylindrical tissue explants (8 mm diameter) were 
excised from the middle zone of medial meniscal bodies and embedded in Optimal Cutting 
Temperature sectioning medium (OCT; Sakura Finetek, Torrance, CA). Samples were 
axially cut into ~35 µm thick sections onto positively charged glass slides using a cryostat 
microtome (Microm HM500; MICROM International GmbH, Waldorf, Germany), such that 
the predominant fiber direction was parallel with the slide surface (Longitudinal). Also, 
samples cut in the radial plane, such that the majority of fiber bundles were perpendicular 
to the slide surface, were used to qualitatively image interpenetrating radial fibers (Cross 
Section). Sections were stored at -20ºC until use. 
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6.3.2 Second Harmonic Generation Imaging and Microstructural Analysis 
Second harmonic generation (SHG) imaging was utilized to visualize fibrillar collagen 
bundles in fetal (fECM) and adult (aECM) tissue sections (n=4 samples/group) (Qu et al. 
2015). Prior to imaging, slides were hydrated and coverslipped with Permount. Beam 
scanning was performed using a Zeiss LSM 510 NLO/META with a Zeiss Axiovert 200M 
inverted microscope (Carl Zeiss Microscopy GmbH, Jena, Germany). A 20X, 0.8 NA Plan 
Apochromat air immersion objective was used for image acquisition (1X zoom). A tunable 
1W Coherent Chameleon laser with a 90 MHz repetition rate and pulse width of <200 
femtoseconds was used to generate an excitation wavelength of 840 nm. SHG and 
autofluorescent signals were separated into different channels using bandpass filters of 
390–465 and 500–550 nm, and represent fibrillar collagen parallel with the slide surface 
and tissue ECM, respectively. Z-stacks at 1 µm intervals were acquired through the entire 
tissue thickness, beginning at the apical tissue surface. Image analysis was performed via 
the open-source platform Fiji (Schindelin et al. 2012). Maximum z-stack projections were 
converted into binary images to identify discrete areas of positive and negative SHG 
signal, representing organized fiber bundles parallel to the substrate and inter-fibrillar 
material that constitutes the remaining tissue ECM (including radial fibers that interject 
perpendicularly to the in-plane circumferential fibers). Inter-fibrillar area fraction was 
calculated as a percentage of the total region of interest (450 x 450 µm). The average 
diameter of each inter-fibrillar region was quantified via the Local Thickness plugin 
(Dougherty et al. 2007). Regions smaller than 50 µm2 were excluded as artifacts. 
 
6.3.3 Atomic Force Spectroscopy and Micromechanical Analysis 
To assess tissue micromechanics as a function of age, force spectroscopy was performed 
on hydrated fECM and aECM sections using an atomic force microscope (AFM). 
Cryotomed sections on glass slides were gently rinsed in 1X phosphate buffered saline 
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(PBS) to remove residual OCT compound prior to micromechanical testing. Force 
spectroscopy was conducted in PBS with a Dimension Icon AFM (Bruker, Billerica, MA), 
using a colloidal spherical tip (R ≈ 5 µm, nominal k ≈ 0.6 N/m) as described in (Li et al. 
2015). Indentation force as a function of depth into the tissue was measured as the 
microspherical tip indented the sample at a rate of 10 µm/s (n=50 indentations/group for 
3 samples). Effective indentation modulus, Eind, was calculated using a finite thickness-
corrected Hertz model (Dimitriadis et al. 2002) with a Poisson’s ratio (ʋ) of 0.01 (Sweigart 
et al. 2004) and a 35 µm nominal sample thickness via a custom MATLAB program 
(MathWorks, Inc., Natick, MA). 
 
6.3.4 Scanning Electron Microscopy  
Scanning electron microscopy (SEM) was used to make qualitative assessments of ECM 
organization at the nanoscale. Cryosections were fixed with Karnovsky’s fixative (Electron 
Microscopy Sciences, Hatfield, PA) for 3 hours at room temperature, and stored in PBS 
at 4°C until dehydration (<24 hours). The samples were dehydrated in a series of graded 
ethanol-water mixtures (ethanol volume ratio: 25%, 50%, 75%, 80% and 100%), each for 
two 10 minute immersions. Slides were then immersed in a series of graded mixtures of 
hexamethyldisilazane (HMDS) (Sigma-Aldrich) and ethanol (HMDS volume ratio: 25%, 
50%, 75% and 100%), each for two 10 minute immersions. Samples were air dried 
overnight and stored in a desiccator prior to imaging. Samples were sputter coated with 
platinum and micrographs were taken under high vacuum with a 3 kV electron beam using 
a Supra 50VP SEM (Zeiss, Jena, Germany).  
 
6.3.5 Cell Egress onto Tissue Substrates 
Cell interaction and infiltration of devitalized tissue substrates were investigated using fetal 
(fECM) and adult (aECM) meniscal cryosections, which were UV sterilized for 1 hour and 
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triple rinsed in PBS to remove residual OCT compound. To assess the effect of tissue age 
on interstitial cell mobility and to determine whether the matrix can be ‘reprogrammed’ to 
influence migration, three substrate conditions were tested in a first study (n=4 
samples/group): fetal (fECM), adult (aECM), and aECM pre-treated with basal media (BM; 
Dulbecco’s Modified Eagle’s Medium (DMEM) with 10% Fetal Bovine Serum (FBS) and 
1% Penicillin/Streptomycin/Fungizone (PSF)) supplemented with 0.1 mg/mL of 
collagenase (type IV from Clostridium histolyticum, ≥125 collagenase digestion units/mg 
solid; Sigma-Aldrich, St. Louis, MO) for 1 hour (aECM-C). To obtain freshly isolated cells, 
adult explants (4 mm diameter, 3 mm height) from the middle zone of the medial meniscus 
were incubated in BM. After ~3 weeks of in vitro culture, explants were rinsed in PBS and 
incubated in 5 µg/mL of 5-chloromethylfluorescein diacetate (CellTracker™ Green; 
Thermo Fisher Scientific Inc., Waltham, MA) in serum-free media (DMEM with 1% PSF) 
for 1 hour to fluorescently label cells lining the explant surface. Explants were maintained 
in serum-free media for an additional 30 minutes prior to being placed atop tissue 
substrates to allow for cell egress. Slides with explants were placed in 4-well plates (Nunc, 
Rochester, New York), covered with BM, and cultured at 37 ºC. Tissue explants cultured 
directly on glass slides were used as controls.  
 
6.3.6 Confocal Imaging and Morphometric Analysis 
After 48 hours in BM, explants were removed from the substrate, and slides were rinsed 
in PBS, fixed in 4% paraformaldehyde for 12 minutes, and rinsed twice more in PBS before 
staining with 4’,6-diamidino-2-phenylindole (DAPI, Prolong Gold; Invitrogen, Grand Island, 
NY) to visualize cell nuclei. Confocal z-stacks at 20X magnification and 1 µm intervals 
were obtained in the FITC and DAPI channels to visualize cells, nuclei, and devitalized 
matrix (autofluorescent in the DAPI channel) using a Nikon A1 confocal microscope (Nikon 
Instruments; Melville, NY). Binarized maximum z-stack projections (GFP channel only) 
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were used to quantify 2D cell projected area and morphology, including aspect ratio, 
circularity, and solidity, using the software Fiji (n=71–97 cells/group) (Table 2-1). In 
addition, samples were imaged via SHG to visualize collagen and cells, which were highly 
autofluorescent. 
 
Shape descriptor Description Equation 
Aspect Ratio (AR) 
Measure of elongation; ratio of the largest 
diameter and the smallest diameter 
orthogonal to it  
Circularity 
Measure of the degree to which a particle 
is similar to a circle, taking into 
consideration perimeter smoothness  
Solidity 
Measure of the boundary irregularity (the 
overall concavity of a particle) 
 
Table 6-1: Morphometric descriptors used for 2D projected cells. 
 
6.3.7 Analysis of Interstitial Cell Migration  
Interstitial cell migration was assessed by quantifying infiltration depth, defined as the 
distance between the apical surface of the tissue and basal surface of the cell (n=15 
cells/group). To edge detect cell and tissue boundaries respectively, confocal z-stacks in 
the FITC (cell) and DAPI (tissue) channels were binarized using Fiji. Specifically, cells and 
tissue were converted to white (intensity=255) and the background to black (intensity=0). 
A region of interest (ROI) that circumscribed each cell was derived from the FITC 
maximum projection. Then, a signal intensity profile in the z dimension (z-profile) was 
generated, where 0 and 255 indicated 0% and 100% area with positive signal within the 
ROI. The z location where the ROI first reached 127.5 (50% positive signal) was defined 
as the apical surface of the cell or tissue. Similarly, the basal surface was defined as the 
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last z location before the signal dropped below 127.5. Cells within artificial substrate 
defects were excluded from analysis.  
 
6.3.8 Enzymatic Degradation of Tissue Substrates 
To better understand the effect of matrix degradation on the tissue microenvironment and 
interstitial migration, 3 adult ECM groups of varying degraded states were tested: 
untreated adult ECM (Control), and adult ECM pre-treated with 0.05 or 0.1 mg/mL of 
collagenase in BM for 1 hour (LowC or HighC). Adult meniscal explants were incubated in 
CellTracker™ Green and then placed atop sections to allow for cell egress as previously 
described. To assess the contribution of endogenous, cell-produced matrix degrading 
enzymes to migration, two media conditions were tested for each substrate group (n=4 
samples/group): BM with or without 1 µg/mL of the broad spectrum MMP inhibitor GM6001 
(MMPi; EMD Millipore Corporation, Billerica, MA). After 48 hours of incubation, samples 
were processed as in the previous study, and cell morphology and infiltration depth were 
quantified (n=100 cells/group). 
To assess changes in tissue microstructure after collagenase treatment, SHG imaging 
was used to characterize the inter-fibrillar area fraction and average diameter, as 
previously described (n=10 stacks/group). Analysis focused on z-stacks that contained 
primarily circumferential fibers, and those with large areas of perpendicular radial fibers 
were excluded. Lastly, to assess changes in tissue micromechanics, force spectroscopy 
was performed on a separate set of adult ECM substrates. Cryosections were first 
incubated in BM with varying concentrations of collagenase (n=19–20 indentations/group): 
0 (Control), 0.005, 0.01, 0.025, or 0.05 mg/mL. Samples were rinsed in PBS after 30 
minutes of incubation, and micromechanics evaluated as previously described. 
Afterwards, samples were processed for SEM imaging as previously described. 
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6.3.9 Statistical Analyses 
All experiments were performed for 2–3 meniscal donors per condition. Statistical 
analyses were done using SYSTAT (Systat Software, Inc., San Jose, CA). Significance 
was assessed by one or two-way ANOVA with Tukey’s HSD post hoc for matrix stiffness, 
inter-fibrillar area fraction and average diameter, cell area and shape descriptors, and 
infiltration depth (p≤0.05). A cumulative distribution plot, coupled with the Kolmogorov-
Smirnov test, was used to determine whether the distribution of infiltration was different 
between groups (p≤0.05). Independent variables include tissue age, substrate treatment, 
and media condition. Data are presented as mean ± standard error of the mean unless 
specified otherwise. 
 
6.4 Results 
6.4.1 Microstructural and Micromechanical Changes with Meniscus Age 
Devitalized tissue substrates, approximately 30–35 µm thick, were successfully prepared 
and evaluated on glass slides. SHG imaging and AFM analysis of fetal (fECM) and adult 
(aECM) meniscal sections revealed distinct microenvironments (Figure 6-1A). For 
Longitudinal substrates in both age groups, the majority of tissue was positive for SHG 
signal (green), confirming that the bulk structural component of the meniscal ECM was 
aligned, fibrillar collagen (McDevitt et al. 1992). As with Longitudinal substrates, Cross 
Section substrates showed increasing collagen fiber organization with age. The collagen 
fibers in fetal tissue had poorly defined boundaries and appeared as a disorganized 
network that weaved in and out of the substrate plane (Figure 6-1B). In contrast, the 
radial fibers in aECM were evident as an arborizing pattern that wrapped around distinct 
collagen fiber bundles. Examination of Cross Section substrates revealed significant SHG 
signal attenuation when the prevailing fiber direction was perpendicular to the slide 
surface, whereas the autofluorescent signal (red) intensity remained constant for 
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substrates from both sectioning planes. SHG attenuation was also seen in the fiber 
bundles in adult Longitudinal sections, suggestive of fiber crimping (Williams et al. 2005). 
Despite regions of low SHG signal, the homogeneous and ubiquitous autofluorescent 
signal indicated that the tissue did not contain vacuous pores through which cells might 
migrate, but rather discontinuities in the collagenous microstructure (areas negative for 
autofluorescence appeared to be sectioning artifacts). Thus, the inter-fibrillar regions 
identified in the Longitudinal substrates corresponded either to organized collagen (so 
called radial) fibers in the perpendicular plane, or other non-collagenous material in the 
ECM, such as proteoglycans. 
 
 
Figure 6-1: Collagen fiber organization increases with age. SHG images of fetal and adult 
meniscal ECM in orthogonal planes with composite SHG (green) and autofluorescent signal 
(red). (A) Longitudinal and (B) Cross Section substrates show circumferential and radial 
fibers parallel to the glass slide, respectively. Scale = 100 µm. 
 
Qualitatively, aECM had thicker and more organized collagen bundles than fECM. The 
area fraction of inter-fibrillar ECM, indicated by the absence of SHG signal (black), was 
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lower for aECM compared to fECM (Figure 6-2C, p≤0.05). However, discrete inter-fibrillar 
areas were on average larger for aECM compared to fECM, most likely due to the well-
developed radial fibers in this tissue (Figure 6-2D, p≤0.05). The average local modulus of 
aECM was approximately 2 times greater than that of fECM (Figure 6-2E, p≤0.05). 
 
 
Figure 6-2: Adult meniscal microenvironment is denser and stiffer than that of fetal tissue. 
(A) Experimental schematic. (B) Top: SHG signal (green) of fECM and aECM. Scale = 50 µm. 
Bottom: Binarized images depicting inter-fibrillar areas in black. (C) Area fraction and (D) 
average diameter of inter-fibrillar regions (n=7–9 stacks/group, mean ± standard error of the 
mean). (D) Tissue elastic modulus measured via AFM indentation and normalized to fECM 
(n=50 indentations/group, mean ± standard error of the mean). # = p≤0.05 vs. fECM. 
 
6.4.2 Cell Morphology and Migration Are Dependent on ECM Properties 
We next investigated the impact of matrix age and ECM degradation on interstitial cell 
migration. Adult meniscal cells from explants adhered, spread, and infiltrated into fECM, 
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aECM, and aECM collagenase-treated (aECM-C) substrates within 48 hours (Figure 
6-3B). The absence of tracker dye dilution over this period indicated minimal proliferative 
activity. Cell morphology on native tissue showed an ECM-dependent response. Cells on 
aECM were 3x larger than on fECM (Figure 6-3C, p≤0.05). Cells on both substrates 
aligned in the fiber direction of the underlying tissue, although cells on aECM had a higher 
aspect ratio and exhibited lower circularity and solidity compared to cells on fECM (Figure 
6-3C, p≤0.05). Cells that egressed onto aECM-C were smaller and rounder compared to 
those on aECM, better approximating those on fECM (Figure 6-3C, p≤0.05). 
 
 
Figure 6-3: Cell morphology is dependent on tissue age and treatment. (A) Experimental 
schematic. (B) 2D z-projections of cells on fECM, aECM, and aECM-C. Scale = 50 µm. (C) 
Morphology of adult meniscal cells on aECM and aECM-C, normalized to fECM values 
(dashed red line) (n=71–97 cells/group, mean ± standard error of the mean). # = p≤0.05 vs. 
fECM. * = p≤0.05 vs. all other groups. 
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Cells migrating through aECM were visibly more deformed compared to those migrating 
through fECM and aECM-C. Indeed, within this dense ECM, cells formed narrow 
protrusions into the surrounding matrix (Figure 6-4A and Figure 6-4B). Infiltration depth 
was greater for cells on fECM compared to cells on aECM (Figure 6-4C and Figure 
6-4D, p≤0.05). When the adult ECM was digested, cells migrated to a similar extent as on 
fECM, with 20% of the population reaching depths of ≥25 µm from the surface (Figure 
6-4C and Figure 6-4D, p≤0.05). Collagen degradation was confirmed with SHG and SEM 
imaging (Figure 6-5A and Figure 6-5B), which demonstrated the disruption of organized 
collagen fiber bundles on the microscale and breakdown of collagen fibrils on the 
nanoscale. These microstructural changes were reflected by changes in the local 
modulus, which decreased with increasing collagenase dose (Figure 6-5C, p≤0.05). 
 
 
Figure 6-4: Interstitial cell migration is dependent on tissue age and treatment. (A) 2D 
confocal slices showing cells (green) within the tissue depth (blue). Scale = 50 µm. (B) 3D 
confocal reconstruction of the cells in (A). Arrows indicate protrusions. Scale = 10 µm. (C) 
Cell infiltration depth with schematic inset (n=15 cells/group, mean ± standard error of the 
mean). (D) Cumulative frequency of infiltration depth. * = p≤0.05 vs. all other groups. 
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Figure 6-5: Degrading fibrillar collagen reprograms adult matrix to a fetal-like state. (A) 2D 
SHG images of autofluorescent cells (red) interacting with collagen fibers (green) on the 
tissue surface. Box indicates relative scale of micrographs in (B). Scale = 50 µm. (B) SEM 
micrographs of collagen fibrils. Scale = 1 µm. (C) Local indentation modulus of tissue 
substrates after digestion with varying concentrations of collagenase, normalized to 
untreated adult Control values (dashed red line) (n=19–20 indentations/group, mean ± 
standard error of the mean). Dashed blue line indicates relative modulus of fetal tissue. * = 
p≤0.05 vs. Control. ** = p≤0.05 vs. all other groups except 0.025 mg/mL. 
 
6.4.3 Dose-Dependent ECM Degradation Enhances Interstitial Cell Migration  
SHG imaging of adult meniscal sections pre-treated with various levels of collagenase 
revealed distinct microenvironments (Figure 6-6A). Qualitatively, untreated Control 
substrates had thicker and more organized collagen bundles than the low-dose (LowC) 
and high-dose (HighC) collagenase groups. The area fraction of inter-fibrillar ECM, 
indicated by the absence of SHG signal, increased with collagenase dose (Figure 6-6B, 
p≤0.05). The average diameter of discrete inter-fibrillar regions also increased with 
collagenase dose, suggesting local interruption of the native collagen network (Figure 
6-6C, p≤0.05).  
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Figure 6-6: Matrix degradation decreases ECM density in a dose-dependent manner. (A) 
SHG signal (green) of substrates showing altered fibrillar collagen structure with digestion. 
Arrows indicate inter-fibrillar regions. Scale = 20 µm. (B) Area fraction and (C) average 
diameter of inter-fibrillar regions (n=10 stacks/group, mean ± standard error of the mean). * 
= p≤0.05 vs. all other groups. 
 
Adult meniscal cells from explants adhered and infiltrated into the devitalized tissue 
substrates within 48 hours (Figure 6-7A). Cells in the untreated Control group remained 
predominantly spread on the tissue surface, whereas cells in the collagenase groups were 
found within or below the tissue substrate (Figure 6-7B). Cell infiltration depth was 
significantly greater for the HighC group compared to the LowC and Control groups, with 
approximately half of the cells migrating ≥10 µm from the surface, and over 10% of cells 
reaching depths of ≥20 µm (Figure 6-7C and Figure 6-7D, p≤0.05). When cell-produced 
MMPs were inhibited (MMPi), cellular infiltration depth was decreased for the HighC group 
only. This suggests that endogenous MMPs play a lesser role than exogenous MMPs in 
enhancing interstitial cell mobility, and that a certain degradative threshold must be 
reached before cell-mediated proteolysis can effectively promote migration through adult 
meniscal ECM.  
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Figure 6-7: Exogenous and endogenous matrix degradation work synergistically to enhance 
interstitial cell migration. (A) 3D confocal reconstruction of adult meniscal cells (green) on 
tissue substrates (blue). Scale = 20 µm. (B) Cross-sectional view of (A). Arrows point to 
infiltrating cells. Scale = 10 µm. (C) Average and (D) cumulative frequency distribution of 
cell infiltration depth (n=100 cells/group, mean ± standard error of the mean). * = p≤0.05 vs. 
all other groups. ++ = p≤0.1 vs. Control. 
 
While cells on all substrates aligned in the fiber direction of the underlying tissue, cell 
morphology was dependent on substrate degradation and MMP inhibition. Cell area 
decreased with increasing substrate degradation, but was not affected by MMPi (Figure 
6-8B, p≤0.05). Circularity and solidity also increased with substrate degradation in the 
absence of MMPi (Figure 6-8D and Figure 6-8E, p≤0.05).  
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Figure 6-8: Migratory cell morphology is determined by exogenous and endogenous matrix 
degradation. (A) Binarized confocal maximum projections showing cells (white) on 
substrates of various degradative states with or without MMP inhibition (MMPi). Scale = 50 
µm. (B) Cell area and morphometric values, including (C) aspect ratio, (D) circularity, and 
(E) solidity, were calculated from z-projections (n=100 cells/group, mean ± standard error of 
the mean). * = p≤0.05 vs. Control and LowC. + = p≤0.05 vs. Control. ++ = p≤0.1 vs. Control. # 
= p≤0.05 vs. MMPi. 
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Figure 6-9: Cell morphology as a function of infiltration depth for different substrate 
treatments (Control, LowC, and HighC) and media conditions (with or without MMPi). Scatter 
plot markers represent individual cells and lines represent group averages. (A) Cell area and 
morphometric values, including (B) aspect ratio, (C) circularity, and (D) solidity, were 
calculated from z-projections (n=100 cells/group). Cells with infiltration depth ≥10 µm are 
considered highly infiltrative.  
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Cells became more elongated, less circular, and less solid (more cellular protrusions) in 
the presence of MMPi for both the LowC and HighC samples (Figure 6-8C–E, p≤0.05). 
Morphometric changes due to MMPi were only observed in the collagenase-treated 
groups, and were most striking when comparing highly infiltrative cells on substrates with 
low levels of digestion (Figure 6-9). That is, cells in the LowC MMPi group that reached 
depths of ≥10 µm into the tissue (4% of the cells) were extremely elongated, with an 
average aspect ratio 2 times greater than the population average and an average 
circularity 2 times lower than the population average (Figure 6-9B and Figure 6-9C). 
These differences were present but attenuated in the LowC group and altogether absent 
in the HighC substrate groups. These findings suggest that once sufficient enzymatic 
degradation is achieved, the degree of deformation required for migration is reduced. 
 
6.5 Discussion 
Cell migration plays a pivotal role during tissue repair, where cells must first migrate to the 
defect, and then proliferate and form new matrix. Both high extracellular matrix (ECM) 
stiffness and density have been implicated as barriers to 3D migration (Ehrbar et al. 2011, 
Wolf et al. 2013), especially when cell-mediated proteolysis via matrix metalloproteinases 
(MMPs) is inhibited. Although the highly organized ECM of mature dense connective 
tissues enables mechanical function, these densely packed collagen fibers may inhibit cell 
migration after injury, resulting in poor healing in adults. Our findings suggest that cell 
mobility through dense connective tissues decreases with tissue maturation, which may 
be attributed to biophysical impediments in the adult microenvironment. Compared to the 
fetal ECM, adult ECM is denser and stiffer on the microscale. Circumferentially aligned 
collagen fibers, the bulk constituent of the meniscal ECM, are thicker and more organized 
in adult tissue. This qualitative difference extends to collagen fibrils (the building blocks of 
fibers), indicating there may be also age-dependent supramolecular changes on the 
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nanoscale. Furthermore, the interdigitating radial fibers in adult ECM appear to 
circumscribe the circumferential fibers and group them into distinct bundles, a 
phenomenon that is largely absent in fetal ECM. Consequently, there is less matrix 
discontinuity in adult tissues, although the presence of well-developed radial fibers and/or 
proteoglycan-rich microdomains (Han et al. 2013) gives rise to larger inter-fibrillar regions. 
These observations are consistent with previous histologic findings (Ionescu et al. 2011, 
Melrose et al. 2005), as well as other anatomical descriptions that span a wide range of 
imaging modalities (Andrews et al. 2014, Campo-Ruiz et al. 2005, Rattner et al. 2011).  
To study interstitial cell mobility within a native tissue microenvironment, freshly isolated 
meniscal cells and devitalized tissue cryosections were used. Cells sense and respond to 
the anisotropic topography of meniscal tissue, where they align along the primary fiber 
axis of Longitudinal substrates but do not exhibit a preferred orientation on Cross Section 
substrates (data not shown), similar to behavior on aligned versus non-aligned 
electrospun nanofibrous scaffolds (Baker et al. 2007). Furthermore, cell morphology and 
behavior is dependent on both ECM and cell age. In addition to biophysical changes to 
the microenvironment, differences in the amount and distribution of adhesion ligands such 
as fibronectin (Singh et al. 2014) may affect cell mechanotransduction and migration. Cell-
intrinsic factors, such as cell mechanics (Harada et al. 2014), receptor-mediated adhesion 
(Wolf et al. 2013), and cytoskeletal contractility (Wolf et al. 2013), may also contribute to 
these discrepancies. Interestingly, the morphological disparities seen between fetal and 
adult substrates are lost with cell expansion on tissue culture plastic (data not shown). 
This phenotypic convergence is likely due to increased contractility and α-smooth muscle 
actin expression that occurs with in vitro culture on rigid substrates (LeBlon et al. 2015, 
Majd et al. 2009, Talele et al. 2015, Yang et al. 2014). As such, we chose to use Passage 
0 cells for our migration studies to preserve the native cell phenotype. 
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While enhanced microstructural organization, combined with higher collagen and 
glycosaminoglycan content, improves the mechanical properties of adult tissues, it does 
so at the expense of interstitial cell mobility. Adult meniscal cells on fetal tissue are smaller 
and more invasive than the same cells on adult tissue, which exhibit enhanced cell 
spreading on the substrate surface and elongation along the collagen fiber direction. 
Importantly, infiltration occurred primarily at inter-fibrillar regions, which are more 
numerous and compliant in immature fetal tissue. Migrating cells appear rounded within 
fetal tissue, whereas cells migrating through adult tissue must deform through narrow 
crevices between rigid, aligned collagen bundles, similar to the steric constraints imposed 
by decreasing pore size in Transwell assays (Rowat et al. 2013, Wolf et al. 2013) and 
microchannels (Lautscham et al. 2015). It is known that large pores and a soft matrix favor 
cell rounding and rapid migration, whereas small pores and a stiff matrix force cells to 
shrink their diameter and lengthen, reducing migration speed (Friedl et al. 2010). 
Interestingly, cells do not prefer direct routes through the depth of adult tissues, which 
would force them to advance perpendicular to the circumferential bundles. Instead, highly 
infiltrative cells navigate downward with a gradual, sloped trajectory, such that the cell and 
nucleus remain highly elongated and aligned with the surrounding collagen. This behavior 
is not apparent in isotropic environments and highlights how ECM density and architecture 
of the mature meniscus influence the mode and efficiency of cell migration. In addition, 
deformation through small pores (≤3 µm diameter) is limited by the nucleus (Lautscham 
et al. 2015, Rowat et al. 2013, Wolf et al. 2013), which is the largest organelle and 2–4 
times stiffer than the surrounding cytoplasm (Guilak et al. 2000). Stem cell differentiation 
and increased tissue micromechanics have been implicated in higher nuclear stiffness 
(Pajerowski et al. 2007, Swift et al. 2013), and our preliminary data indicate that adult 
meniscal cell nuclei are less deformable than their fetal counterparts (data not shown). 
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Thus, the biophysical properties of both the cells and their surrounding matrix may 
contribute to the dearth of reparative cells at the wound site and subsequent poor repair 
in the adult meniscus, and could be simultaneously targeted in future therapies to optimize 
cell migration. 
Since obstructed interstitial cell migration may prevent proper healing of the adult 
meniscus and other dense connective tissues, an innovative strategy to promote repair 
may be to first free native cells from the matrix so as to facilitate migration to the wound 
site. Indeed, we found that interstitial cell mobility increases with matrix degradation. Adult 
meniscal cells on devitalized adult tissue sections pre-treated with collagenase were 
smaller, rounder, and more invasive than the same cells on untreated tissue, similar to 
cells on fetal tissue. Partial enzymatic digestion improved cell mobility by increasing the 
area fraction and size of inter-fibrillar regions (via cleavage of collagen fibrils and/or 
removal of PGs (Qu et al. 2013)) and also by decreasing the local ECM stiffness. The 
softer, fetal-like matrix may also promote cell invasion by up-regulating endogenous MMP 
secretion and inducing the formation of protrusive structures called invadosomes (Gu et 
al. 2014). In addition, denatured collagen fragments may influence cell migration by acting 
as chemoattractants (Shi et al. 2010) and/or by altering cell-substrate binding (Tuckwell 
et al. 1994). On a smaller scale, proteolytic remodeling of the pericellular matrix by cell-
secreted enzymes may generate gaps to allow for cell passage (Friedl et al. 2009). 
Blocking cellular MMPs in our system increased cell elongation and decreased infiltration 
depth, suggesting that exogenous and endogenous MMPs act synergistically to remodel 
the ECM during migration. However, this effect was only observed in the high-dose 
collagenase group, indicating that when the steric barrier is too great, endogenous MMPs 
are insufficient to enable migration, and cells instead rely more on cell deformation through 
the inter-fibrillar clefts. Since only one time point was evaluated, it is unclear whether 
endogenous MMP activity will increase with time and eventually become sufficient to 
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counteract physical hindrance. To address these unknowns, we are currently developing 
a computational model that predicts the likelihood of migration based on cellular and 
extracellular parameters. 
Our results suggest that a critical dose of exogenous matrix-degrading enzyme may be 
required to initiate interstitial cell migration after injury. This may be especially relevant in 
the context of aged and/or degenerate menisci in osteoarthritic tissues, which exhibit 
increased micromechanical heterogeneity and overall higher moduli than healthy human 
menisci (Kwok et al. 2014). However, treatment must be targeted to the defect to prevent 
further structural and mechanical damage to the meniscus and adjacent articular tissues. 
To that end, we developed a nanofibrous system that delivers a controlled release of 
collagenase directly to the wound site (Qu et al. 2013). Previously, we showed that 
reprogramming the meniscal wound interface with collagenase reduces local ECM density 
and stiffness, increases interfacial cellularity, and facilitates repair in vitro as well as in vivo 
in an orthotopic model of meniscal repair (Qu et al. 2015). This technique has been widely 
explored in the context of articular cartilage repair, where short-term treatment with 
enzymes such as trypsin, collagenase, and hyaluronidase increased chondrocyte density 
at the interface and improved interfacial strength of native and engineered cartilage in vitro 
(Bos et al. 2002, Janssen et al. 2006, Obradovic et al. 2001, van de Breevaart Bravenboer 
et al. 2004). Partial enzymatic degradation with collagenase has also successfully 
enhanced interfacial cellularity and integration of cartilage to a synthetic scaffold (Ng et al. 
2012). Here, we provide further evidence that expedited migration to the injury site is a 
major mechanism underlying these superior healing responses. Once cells have reached 
their destination, additional cues may be introduced to stimulate matrix deposition 
(Ionescu et al. 2012b), prevent matrix catabolism (McNulty et al. 2007), and promote 
collagen crosslinking (Makris et al. 2014) and alignment (Baker et al. 2011). By combining 
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these diverse but complementary processes, the standard treatment paradigm for fibrous 
tissue injuries will soon shift from resection and replacement to preservation and repair. 
 
6.6 Conclusions 
Partial enzymatic digestion of the adult ECM expedites interstitial cell migration, a first step 
in endogenous tissue repair. Collectively, our data indicate that providing the proper 
microenvironment for interstitial migration may ultimately result in enhanced cellularity and 
integration at the wound interface. By addressing the inherent limitations to repair imposed 
by the mature ECM, these studies may define a new clinical methodology for repairing 
damaged dense connective tissues. 
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CHAPTER 7: DIRECTING CELL MIGRATION VIA A CHEMOATTRACTIVE 
GRADIENT TO ENHANCE MENISCAL REPAIR 
 
7.1 Abstract 
Few regenerative approaches exist for the treatment of injuries to adult dense connective 
tissues. Compared to fetal tissues, adult tissues are hypocellular and lack a sufficient 
population of endogenous cells at the wound site to affect repair. We hypothesized that 
this deficiency in cell number at the wound edge is exacerbated by the dense and stiff 
adult extracellular matrix (ECM), a biophysical barrier that restricts cell mobility. We also 
hypothesized that chemotactic cues might help overcome this barrier and promote cell 
migration through small pores. Using the knee meniscus as a test platform, we 
investigated the age-dependent response of cells to physical migratory barriers and 
developed a novel ‘tissue Boyden chamber’ system to determine whether interstitial cell 
migration through native tissue is enhanced by a chemoattractant. Our findings show that 
while adult cells were less mobile than fetal cells, provision of a local platelet-derived 
growth factor-AB (PDGF-AB) gradient enhanced migration of this adult cell population. To 
translate this new knowledge towards potential improvements in meniscal repair, we 
developed nanofibrous composites that release a matrix-degrading enzyme and PDGF-
AB in a localized and coordinated manner at the site of injury. By first decreasing matrix 
density at the wound interface and then recruiting endogenous cells, the staged delivery 
of biologics from these scaffolds promoted healing of this dense connective tissue. 
 
7.2 Introduction 
Dense connective tissues of the musculoskeletal system function in demanding 
biomechanical environments. To withstand cyclic mechanical loads, tissues such as the 
knee meniscus (McDevitt et al. 1992), tendons and ligaments (Russo et al. 2015), and the 
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annulus fibrosus of the intervertebral disc (Adams et al. 1977), develop densely aligned 
extracellular matrices (ECM) composed primarily of type I collagen. Although this 
structure-function relationship is optimal for load transfer in the healthy state, injuries 
compromise this fiber-reinforced architecture and severely reduce load-bearing capacity 
(Makris et al. 2011, Yang et al. 2013). Moreover, mature dense connective tissues exhibit 
impaired healing capacity (Beredjiklian et al. 2003, Ionescu et al. 2011, Provenzano et al. 
2002), thus predisposing the joint to further degenerative changes. This deficit is 
commonly attributed to the poor vascular supply and low cell density of adult tissues, which 
limit the local supply of regenerative cells that can affect repair. Additionally, there is 
evidence that interstitial migration of cells to the injury site is restricted by the adult 
microenvironment (Qu et al. 2015). We thus hypothesized that improving the number of 
endogenous cells at the wound margin may be the critical first step towards enhancing 
dense connective tissue repair. 
Age-related changes in native tissue cells and ECM during development may be 
implicated in the reduced cell-mediated healing response of adult tissues compared to 
fetal tissues, which exhibit robust integrative repair even without a blood supply in vitro 
(Ionescu et al. 2011). At the ECM level, collagen density and organization, as well as bulk 
tissue stiffness, increase during development (Clark et al. 1983, Ionescu et al. 2011), 
resulting in an environment that may physically impair cell mobility, proliferation, and 
matrix remodeling. At the cellular level, differences in cell adhesion, contractility, and 
nuclear mechanics may likewise influence migration through the dense connective tissue 
(Friedl et al. 2010). Since adult cells reside in a stiffer microenvironment (Marturano et al. 
2013, Swift et al. 2014), it is likely that they sense and exert higher forces than fetal cells. 
While adhesive and contractile forces are prerequisites for cell locomotion, forces that are 
too high may resist forward translocation (Peyton et al. 2005) and cause cell stiffening 
(Solon et al. 2007). Furthermore, cells with stiff nuclei display limited migratory capacity 
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within physically restrictive environments (Booth-Gauthier et al. 2013, Lautscham et al. 
2015), whereas cells with compliant nuclei that lack lamin A/C, such as leukocytes and 
certain cancer cells, remain highly mobile (Friedl et al. 2011, Rowat et al. 2013, Wolf et al. 
2013). Since both stem cell differentiation and increased tissue micromechanics have 
been implicated in higher nuclear stiffness (Pajerowski et al. 2007, Swift et al. 2013), we 
hypothesized that adult cells are stiffer than their fetal counterparts, and consequently less 
mobile in the presence of steric constraints, and that this may contribute to the poor repair 
of adult tissues.  
Previously, we showed that partial degradation of the wound site enhances cellular 
infiltration and tissue integration of the knee meniscus by reducing local ECM stiffness 
and density (Qu et al. 2015), suggesting that adult cells are capable of repair once they 
have reached the wound margin. While manipulating the ECM is one approach to 
enhancing cellularity, the mechanical function of the tissue may be compromised in the 
process, leading to unwanted secondary tears. Therefore, it is necessary to maximize cell 
migration while minimizing the amount of matrix degradation required. Since directional 
movement of reparative cells into damaged tissue is integral to neotissue formation during 
the normal healing response (Yang et al. 2013), we hypothesized that the provision of an 
exogenous chemoattractive gradient might similarly recruit cells to the wound site to 
accelerate repair, and that this effect would be enhanced with partial matrix degradation. 
In addition, this chemoattractive gradient may expedite cell colonization of acellular 
scaffolds (Bhargava et al. 2005, Robu et al. 2013) and encourage rapid tissue-to-scaffold 
integration.  
In this work, we used the knee meniscus to test whether a chemoattractant can augment 
cell mobility and dense connective tissue repair. To localize effects in vivo, we used 
electrospun nanofibrous scaffolds as a drug delivery vehicle. This technique utilizes an 
electrical potential difference to draw polymers into highly aligned nanofibrous networks 
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that replicate the organization of dense connective tissues (Mauck et al. 2009). Scaffolds 
can be fabricated with multiple discrete fiber components (Baker et al. 2009b), which can 
be functionalized with bioactive factors, either adsorbed or annealed to the fiber surface 
(Choi et al. 2008, Fu et al. 2008, Phipps et al. 2012b), blended directly into the fiber (Fu 
et al. 2008, Qu et al. 2013, Sahoo et al. 2010, Thakur et al. 2008), contained within the 
core of a hollow ‘co-axial’ fiber (Kuihua et al. 2013, Liao et al. 2009, Sahoo et al. 2010), or 
by including drug-loaded microspheres (Ionescu et al. 2010). Depending on the fiber 
fabrication method and degradative rate, release profiles can range from an immediate 
burst release to a sustained delivery over the course of several weeks.  
In this study, we sought to enhance endogenous meniscal repair via the application of 
tailored tri-component nanofibrous scaffolds releasing multiple factors to enhance healing 
in a targeted manner. To enable cell migration, a ‘sacrificial’ water-soluble poly(ethylene 
oxide) (PEO) fiber fraction first delivered a burst dose of a matrix-degrading enzyme to the 
wound interface (Qu et al. 2015), after which slower-degrading fibers composed of 
hyaluronic acid (HA) (Purcell et al. 2012), a natural polysaccharide, released a 
chemoattractant to guide cells to the defect. A remaining population of stable poly(ε-
caprolactone) (PCL) fibers acted as a physical template that provided mechanical integrity 
and instruction for organized ECM synthesis upon cell arrival at the wound site (Baker et 
al. 2012). By combining these diverse but complementary approaches to remove the 
natural impediments to endogenous meniscal repair, we recapitulated the hypercellular 
healing response exhibited by fetal menisci, an initial step towards repair and regeneration 
of dense connective tissues. 
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7.3 Materials and Methods 
7.3.1 Cell Isolation and Culture 
Fetal (late 2nd–3rd trimester) and adult (20–30 months) bovine stifle joints were sterilely 
dissected and the knee menisci were removed. To isolate cells, medial menisci (middle 
zone) were minced, placed onto tissue culture plastic (TCP), and incubated in basal media 
(BM), which consisted of Dulbecco’s Modified Eagle’s Medium (DMEM) with 10% Fetal 
Bovine Serum (FBS) and 1% Penicillin/Streptomycin/Fungizone (PSF). Cells that 
egressed from the minced tissue onto TCP were grown to 80% confluency before being 
detached with trypsin-EDTA (0.25%; Invitrogen). These cells (Passage 1; P1) were re-
plated, expanded, and passaged again (Passage 2; P2) for initial Transwell assays of cell 
mobility through pores. Subsequent studies either used P1 or Passage 0 (P0) cells, which 
have not been exposed to TCP. This was done to minimize cell de-differentiation and 
alteration of their mechanobiologic state as a consequence of culture on stiff substrates 
(Talele et al. 2015). Prior to chemotaxis studies, cells were starved overnight in low-serum 
media (LM; DMEM with 1% FBS and 1% PSF) to minimize exposure to serum, which can 
mask the effect of the chemoattractant being tested. 
 
7.3.2 Transwell Migration Assay 
A first study to screen for potential chemoattractants and their optimal doses was 
conducted using a 96-well Transwell migration assay (Chemicon QCM™ 96-well Migration 
Assay; Millipore). This assay system consists of a top well insert with a microporous 
membrane (8 µm diameter pores) for cell seeding and a bottom feeder chamber for the 
chemoattractant. Four agents were investigated: human recombinant platelet-derived 
growth factor-AB (PDGF-AB; Prospec Bio), human fibroblast growth factor 2 (FGF2; 
Prospec Bio), recombinant human stromal cell-derived factor-1α (SDF-1α; R&D Systems), 
and transforming growth factor-β3 (TGF-β3). Each factor was reconstituted to 10 µg/mL 
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in either H2O or 1X phosphate buffered saline (PBS) with 0.1% bovine serum albumin and 
stored at -20ºC until use. For the assay, factors were further diluted in LM to 
concentrations of 10, 50, 100, and 250 ng/mL, and 150 µL of each solution was added per 
bottom feeder chamber (n=4 wells/group). Low serum (LM) and high serum (BM) were 
used as negative and positive controls, respectively (n=4 wells/group). Afterwards, the top 
well insert was placed atop the bottom feed chamber, with the microporous membranes 
in contact with the chemoattractant solutions. Adult meniscal cells (P2) in LM were seeded 
at 50,000 cells per top well and incubated for 16 hours before being detached from the 
bottom surface (i.e., isolating cells that had migrated through the pores). These cells were 
lysed, and the DNA content was fluorimetrically quantified according to the manufacturer’s 
instructions. The average background signal from the dye/lysis buffer solution (n=4/group) 
was subtracted from the each well. Fluorescence signal intensity was normalized to the 
LM group for each condition. 
 
7.3.3 Cell Age and Pore Size-Dependent Migration 
To assess migration in the presence of physical barriers, 96-well Transwell migration 
assays with pore diameters of 3, 5, or 8 µm were used (Millipore). Cells (P1) in LM were 
seeded at 50,000 cells per top chamber and incubated for 16 hours before being 
fluorimetrically quantified as previously described. Three media conditions in the bottom 
chamber were tested (n=3 wells/group): LM (Control) and LM with either 50 or 100 ng/mL 
PDGF-AB (Low or High PDGF). Fluorescence signal intensity was normalized to the 3 µm 
pore group for each condition. To visualize cell migration, fetal and adult tissue explants 
(8 mm diameter) were incubated in 5 µg/mL of 5-chloromethylfluorescein diacetate 
(CellTracker™ Green; Thermo Fisher Scientific Inc., Waltham, MA) in serum-free media 
(DMEM with 1% PSF) for 1 hour to fluorescently label cells on the surface of explants. 
Explants were maintained in serum-free media for an additional 30 minutes prior to being 
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placed on the microporous membranes to allow for cell egress. After 48 hours in LM, 
explants were removed from the substrate, and microporous membranes were rinsed in 
PBS, fixed in 4% paraformaldehyde for 12 minutes, and rinsed twice more in PBS before 
staining with 4’,6-diamidino-2-phenylindole (DAPI, Prolong Gold; Invitrogen, Grand Island, 
NY) to visualize cell nuclei. Membranes were mounted onto glass slides, and confocal z-
stacks at 20X magnification and 1 µm intervals were obtained 20X in the FITC, DAPI, and 
TRITC channels to visualize cells, corresponding nuclei, and membranes (autofluorescent 
in the TRITC channel) using a Nikon A1 confocal microscope (Nikon Instruments; Melville, 
NY). To evaluate the nuclear dimensions of cells engaged with the membranes, binarized 
z-stacks from the DAPI channel were used to quantify nuclear volume (n=150 cells/group) 
using the open source platform Fiji (Schindelin et al. 2012). 
 
7.3.4 Tissue Boyden Migration Assay 
To generate a tissue-like microenvironment as a barrier to migration, cylindrical tissue 
explants (8 mm diameter) were excised from the middle zone of fetal medial meniscal 
bodies and embedded in Optimal Cutting Temperature sectioning medium (OCT; Sakura 
Finetek, Torrance, CA). Samples were axially cut into ~35 µm thick sections onto positively 
charged glass slides to cover four laser-cut holes (1 mm diameter) using a cryostat 
microtome (Microm HM500; MICROM International GmbH, Waldorf, Germany), such that 
the predominant fiber direction was parallel with the slide surface. Prior to tissue mounting, 
a thin mesh of randomly aligned methacrylated hyaluronic acid (MeHA) nanofibers (Kim 
et al. 2013) was electrospun onto the slides to provide support over the holes. To fabricate 
a ‘tissue Boyden chamber’ that allows interstitial migration of cells towards a chemotactic 
gradient, the tissue-mounted slide was set atop a concave glass slide containing 140 µL 
of either LM (Control) or LM with 200 ng/mL PDGF-AB (PDGF). The top and bottom slides 
were sealed with stainless steel clips, and fetal or adult tissue explants incubated in 
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CellTracker™ Green were placed atop the tissue sections (n=3/group). After 48 hours in 
LM, slides were stained as above. Confocal z-stacks were obtained at 10X and 2 µm 
intervals in the FITC and DAPI channels to visualize cells and nuclei engaging with and 
migrating through the devitalized tissue spanning the slide holes (autofluorescent in the 
DAPI channel). To assess interstitial migration within the slide holes, cells from five tissue 
cross-sections were counted for each hole (n=3 holes/group). Cells that were entirely 
embedded within the tissue or had emerged onto the opposite side were considered to 
have migrated through the tissue. 
 
7.3.5 Traction Force Microscopy  
Traction force microscopy (TFM) was conducted using fetal and adult meniscal cells (P0 
and P1) to assess whether differences in cell contractility contributed to age-dependent 
migration. For the P0 group, cylindrical tissue explants (8 mm diameter) excised from the 
middle zone of fetal and adult medial meniscal bodies were placed atop fibronectin-coated 
polyacrylamide hydrogels (5 kPa elastic modulus, verified by atomic force microscopy) 
that contained 2 µm diameter fluorescent microspheres (Invitrogen). Explants were 
incubated in BM for 2–3 days to allow for cell egress onto the hydrogel. For the P1 group, 
cells that had first egressed onto TCP from minced meniscal tissue were seeded onto the 
hydrogels at 3,000 cells/cm2 and allowed 24 hours for attachment. Phase contrast and 
fluorescence images of individual cells and associated beads within the substrate were 
captured at 40X magnification before and after cell lysis with SDS buffer in an 
environmental chamber (37°C, 5% CO2) using a Deltavision Deconvolution Microscope. 
Images were used to determine cell area and surrounding bead displacement after lysis 
using a freely available plugin suite for ImageJ created by Tseng et al. (Tseng et al. 2012), 
which was adapted from (Dembo et al. 1999). Using a custom MATLAB script, traction 
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force vectors maps were analyzed to determine cellular area, average traction stress 
generated by each cell, and total force exerted per cell (n=12 cells/group). 
 
7.3.6 Nanofibrous Scaffold Fabrication 
To fabricate nanofibers that deliver a chemoattractant (PDGF-AB), sodium hyaluronate 
(HA) (74 kDa; Lifecore Biomedical) was functionalized with hydroxyethyl methacrylate 
(HeMA) to allow for hydrolysis (via ester groups) and photo-initiated crosslinking (via 
methacrylate groups). Hydroxyethyl methacrylate-modified hyaluronic acid (HeMA-HA) 
was synthesized in a three-step process, as described previously (Purcell et al. 2012, 
Sahoo et al. 2008). HeMA-HA was purified via extensive dialysis against deionized water 
at 4°C, lyophilized, and analyzed by 1H NMR (360 MHz Bruker DMX 360) to determine 
HeMA functionalization percent. To facilitate cell adhesion, the RGD peptide 
(GCGYGRGDSPG, Genscript) was coupled to the HA backbone via a Michael addition 
reaction (1 mM concentration) prior to electrospinning (Kim et al. 2013). 
Fibrous scaffolds were fabricated through tri-jet electrospinning (Baker et al. 2009b) with 
the following components: (1) 14.3 wt% poly(ε-caprolactone) (PCL; 80 kDa; Sigma-
Aldrich) in a 1:1 mixture of dimethylformamide (DMF; Fisher) and tetrahydrofuran (THF; 
Fisher); (2) 8 wt% poly(ethylene oxide) (200 kDa PEO; Polysciences) in 50% ethanol in 
deionized water; and (3) 4 wt% HeMA-HA with 2 wt% PEO (900 kDa) and 0.05 wt% 
Irgacure 2959 (Ciba) in deionized water. For scaffolds containing collagenase, 2 wt% 
collagenase (Type IV from Clostridium histolyticum, ≥125 collagenase digestion units/mg 
solid; Sigma-Aldrich) was added to the PEO solution immediately before electrospinning 
(Qu et al. 2013). For scaffolds with PDGF-AB, 50 μg/mL PDGF-AB (Shenandoah 
Biotechnology Inc.) was added to the HeMA-HA solution immediately before 
electrospinning. Each solution was loaded into individual syringes with 18 gauge needles 
and placed at an equal radial distance focused on a common, vertical collection mandrel 
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that rotated at ~10 m/s to align collected fibers, as in (Baker et al. 2009b). Electrospinning 
was performed using the following parameters: +12–15 kV, 2.0 mL/hr, 15 cm (PCL), +12–
15 kV, 2.5 mL/hr, 15 cm (PEO), and +24–28 kV, 1.4 mL/hr, 16 cm (HA), corresponding to 
the applied voltage, polymer flow rate, and spinneret to mandrel distance. Additionally, 
voltages were applied to the mandrel (-3 kV) and deflectors (+4 kV) to further direct fibers 
to collect on the mandrel. Electrospinning was performed for 3.5 hours in a humidity-
controlled room (20–40% relative humidity) to maintain stable fiber formation and solvent 
evaporation. To enable crosslinking post-fabrication, electrospun fiber scaffolds were 
exposed to 10 mW/cm2 of ultraviolet light under nitrogen for 15 minutes on each side of 
the scaffold.  
 
Polymer 
Flow rate 
(mL/hr) 
Concentration 
(g/mL) 
Flow rate 
(g/hr) 
Theoretical Spin 
Weight (g) 
Fiber Fraction 
(% mass) 
PCL 2 0.143 0.286 1.001 50.2 
PEO 2.5 0.08 0.2 0.7 35.1 
HA 1.4 0.06 0.084 0.294 14.7 
Table 7-1: Polymer fiber fraction calculations (% mass) based on solution flow rate and 
concentration for a 3.5 hour electrospinning period.  
 
Biofactor 
Flow rate 
(mL/hr) 
Concentration 
(g/mL) 
Flow rate 
(g/hr) 
Theoretical Spin 
Weight (g) 
Amount 
(µg/mg 
scaffold) 
Collagenase 2.5 0.02 0.05 0.175 80.65 
PDGF-AB 1.4 0.00005 0.00007 0.000245 0.113 
Table 7-2: Biofactor loading calculations (µg/mg scaffold) based on solution flow rate and 
concentration for a 3.5 hour electrospinning period. 
 
For fiber imaging, thin films of fibers were collected and crosslinked onto either aluminum 
foil or glass slides for scanning electron and fluorescence microscopy measurements, 
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respectively. To determine dry fiber diameter, fibers were imaged using an environmental 
scanning electron microscope (ESEM; FEI Quanta 600), where fiber diameter was 
measured using ImageJ (NIH) (n=4 samples/group, 50 fibers/sample). To visualize distinct 
fiber fractions, the PCL, PEO, and HA solutions were doped with methacryloxyethyl 
thiocarbamoyl rhodamine B (PolyFluor® 570; Polysciences), 5(6)-carboxyfluorescein 
(Sigma), and 4',6-diamidino-2-phenylindole (DAPI; Invitrogen), respectively. Using a 
slowly rotating mandrel, randomly aligned fibers were electrospun onto glass slides and 
imaged using fluorescence microscopy. 
 
7.3.7 In Vitro Biofactor Release and Activity Assays 
Fibrous scaffold biomolecule release was evaluated as a function of time at 37°C for 
scaffolds of ~0.5 mm in thickness. After electrospinning and crosslinking, tri-component 
fibrous scaffolds were immersed in PBS. The eluant was collected and replaced with fresh 
PBS at set time intervals and stored at -20°C until analysis. Bulk scaffold mass loss (%) 
was determined through measurement of the dry fiber weight before and after immersion 
in PBS (and subsequent lyophilization) at various time points (n=3–4 samples/scaffold for 
3 different scaffolds). The amount of uronic acid, a component of HA, in the supernatant 
was quantified over 45 days using a modified uronic acid assay that has been described 
in detail elsewhere (Bitter et al. 1962, Khetan et al. 2009) and compared to known 
concentrations of HA (ranging from 2.0 to 0.1 μg/mL) in order to determine HA loss from 
the HeMA-HA fiber component as a function of time. 
Collagenase release over 96 hours was quantified by measuring the protein absorbance 
in the solution at 280 nm compared to a standard curve (n=5 samples/scaffold). PDGF-
AB release over 16 days was measured using a PDGF-AB enzyme-linked immunosorbent 
assay (ELISA) kit (DY222, R&D Systems) (n=6 samples/scaffold). Additionally, the effect 
of electrospinning on collagenase activity was evaluated using a fluorogenic peptide 
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substrate assay (R&D Systems). After electrospinning and crosslinking, fibrous scaffolds 
were immersed in Triton-Tris-Calcium buffer (TTC; 0.05 (v/v)% Triton X-100 (Sigma-
Aldrich), 50 mM tris hydrochloride (EMD Biosciences), 1 mM calcium chloride (Sigma-
Aldrich), pH 7.4) and shaken to rapidly release the collagenase. After two hours, the eluant 
was collected and immediately analyzed for activity. Using a 96-well plate, 50 µL of the 
sample and 50 µL of a matrix metalloprotease-sensitive fluorogenic peptide substrate 
(Mca-PLGL-Dpa-AR-NH2; R&D Systems), for a final peptide concentration of 10 μM, was 
added to each well before immediately performing a fluorescence kinetic study at 320/405 
nm excitation/emission with continual measurements over five minutes. The initial rate for 
each sample was calculated from the initial linear slope of fluorescence as a function of 
time. These data were compared to a collagenase standard curve to determine the 
amount of active collagenase in the sample. Percent activity was calculated by 
comparison with the total amount of collagenase released from each sample measured 
using absorbance, where the absorbance reading is not adversely affected by activity 
(n=3–4 samples/scaffold for 3 different scaffolds). A tri-component scaffold without 
collagenase was used as a control. 
 
7.3.8 In Vitro Cell Behavior on Nanofibrous Scaffolds 
Cell behavior and viability on nanofibers were evaluated using randomly aligned 
nanofibrous substrates that were electrospun directly onto glass slides (~20 µm 
thickness). Solutions were fluorescently doped with rhodamine prior to electrospinning to 
allow for fiber visualization. To assess the effect of RGD on cell adhesion, adult meniscal 
explants labeled with CellTracker™ Green were placed atop HeMA-HA fibers with or 
without RGD coupling (HA±RGD). After 48 hours in BM, slides were fixed and cell nuclei 
stained with DAPI as previously described. Confocal z-stacks at 20X magnification and 1 
µm intervals were obtained in the FITC, DAPI, and TRITC channels to visualize cells, 
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corresponding nuclei, and nanofibers. To assess the effect of scaffold porosity on cell 
infiltration, labeled explants were placed atop either a nanofibrous composite of 
PCL/PEO/PEO (high porosity) or PCL/PEO/HA with RGD (low porosity). Prior to tissue 
culture, substrates were washed in PBS to remove the sacrificial PEO fiber fraction. After 
48 hours in BM, slides were processed and imaged as previously described. 
Cell infiltration into the nanofibrous substrate was assessed by quantifying infiltration 
depth, defined as the distance between the apical surface of the scaffold and z-centroid 
location of the cell (n=16 cells/group). Z-stacks in the FITC (cell) and TRITC (nanofiber) 
channels were binarized using Fiji, respectively. The first z location where fiber signal was 
detected beneath the cell was defined as the apical surface of substrate. The cell z-
centroid was determined using the BoneJ Particle Analyzer plugin (Doube et al. 2010). 
Cells located within scaffold perforations or defects were excluded from analysis. To 
assess scaffold porosity, the pore size and area fraction were quantified using a central z-
slice from the TRITC channel (n=3 stacks/group), where areas absent of fibers were 
considered pores (areas <20 µm2 were considered artifacts and excluded from analysis). 
The average diameter of discrete pores was determined using the Local Thickness plugin 
in Fiji (Dougherty et al. 2007). 
 
7.3.9 Subcutaneous Xenotransplant Model 
To test the effect of chemoattractant-directed migration on meniscal repair in an in vivo 
setting, a nude rat xenotransplant model was employed (Qu et al. 2015). All procedures 
were approved by the Animal Care and Use Committee of the Philadelphia VA Medical 
Center. Adult bovine meniscal explants (8 mm diameter, 4 mm height) were incised to 
create a horizontal defect. To evaluate the combined effect of collagenase and PDGF, the 
defect was either left empty (Control) or filled with one of 4 scaffolds: a tri-component 
scaffold with RGD-coupled HA fibers (PCL/PEO/HA), a tri-component scaffold releasing 
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collagenase from PEO fibers (PCL/PEO-C/HA), a tri-component scaffold releasing PDGF-
AB from HA fibers (PCL/PEO/HA-P), or a scaffold releasing both factors (PCL/PEO-C/HA-
P). Aligned scaffolds (~0.5 mm thick) were cut to 6 mm diameter with a 2 mm diameter 
central fenestration to permit tissue-to-tissue contact inside the repair construct. Biofactor 
loading was estimated to be ~173 µg of collagenase and/or ~242 ng of PDGF per scaffold 
(~2.14 mg), based on biofactor flow rate and scaffold mass calculations (Table 7-2). 
Scaffolds were sterilized under ultraviolet light for 30 minutes on each side prior to use. 
Defects were closed with absorbable sutures (3-0 Monocryl) before subcutaneous 
implantation into male athymic nude rats (Hsd:RH-Foxn1rnu, 8–10 weeks old, ~300 g, 
Harlan). Rats were anesthetized with isoflurane and the dorsal area shaved and swabbed 
with ethanol and betadine. Four incisions (1 on the cranial and caudal aspects, on each 
side of the midline of the rat) were made on each rat and a subcutaneous pocket formed 
using blunt dissection. One randomized repair construct per group was placed in each 
pocket and the incision was closed with wound clips. 
At 2 and 4 weeks, rats (n=6/time point) were euthanized by CO2 asphyxiation and the 
constructs were removed from the subcutaneous tissue. Retrieved samples were paraffin 
embedded, sectioned to 8 µm, and stained with hematoxylin & eosin (H&E), Picrosirius 
Red (PSR) for collagen, or DAPI for cell nuclei. To assess cellularity at the 2 week time 
point, cell signal intensity relative the interface was quantified by converting the DAPI 
nuclear signal to white (intensity=255) and the background to black (intensity=0) using 
ImageJ, as described in (Qu et al. 2015). Next, the pixel intensity relative to the interface 
was averaged starting from the interface up to a distance 700 µm perpendicular to the 
defect. Intensity of DAPI signal with respect to location was binned into 100 µm intervals 
and normalized to the empty defect (Control) value at the interface (n=4–5 
samples/group). 
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7.3.10 Statistical Analyses 
All experiments were performed for 1–2 meniscal donors per condition. Statistical 
analyses were done using SYSTAT (Systat Software, Inc., San Jose, CA). Significance 
was assessed by one or two-way ANOVA with Tukey’s HSD post hoc for migrated cell 
signal intensity and cell number, nuclear volume, cell spread area, average traction stress 
and total force, scaffold pore size and area fraction, cell infiltration depth, and interfacial 
cellularity (p≤0.05). Independent variables include chemoattractant agent and dose, 
Transwell membrane pore diameter, cell age and passage number, nanofibrous scaffold 
composition, repair construct treatment, and distance from the wound interface. Data are 
presented as mean ± standard deviation unless specified otherwise. 
 
7.4 Results 
7.4.1 Platelet-Derived Growth Factor-AB Stimulates Cell Migration 
Initial screening of potential chemoattractants, including platelet-derived growth factor-AB 
(PDGF-AB), fibroblast growth factor 2 (FGF2), stromal cell-derived growth factor-1α (SDF-
1α), and transforming growth factor-β3 (TGF-β3) revealed that PDGF-AB was most 
effective at increasing adult meniscal cell (P2) migration in a Transwell chemotaxis assay. 
Cell migration was ~1.4 times higher for the 100 ng/mL PDGF-AB group than for the low-
serum (1% FBS) control after 16 hours (Figure 7-1, p≤0.05). However, PDGF-AB at other 
concentrations did not significantly influence cell migration, suggesting a dose-dependent 
response to PDGF-AB. As expected, the presence of 10% FBS also increased cell 
migration compared to controls. 
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Figure 7-1: Adult cell (P2) migration through 8 µm diameter pores is enhanced by PDGF-AB 
but not by FGF2, SDF-1α, or TGF-β3 at similar concentrations (n=4 wells/group, mean ± 
standard deviation). Migrated cell signal intensity is normalized to the low-serum control 
(1% FBS; red dashed line). Blue dashed line indicates 10% FBS. * = p≤0.05 vs. all other 
groups. 
 
7.4.2 Cell Mobility is Dependent on Pore Size and Cell Age 
Having established that PDGF was an effective chemoattractant for meniscal cells, we 
next assessed migration of fetal and adult meniscal cells (P1) as a function of pore size 
and PDGF dose. Confocal images revealed that, for both age groups, nuclei were able to 
deform and pass through 5 and 8 µm pores, but could not pass through 3 µm pores 
(Figure 7-2A and Figure 7-2B). In the absence of a PDGF gradient (Control), there was 
no difference between pore size groups for either age group (Figure 7-2C and Figure 
7-2D, p>0.05). With the addition of PDGF to the bottom chamber, pore size had a 
significant effect, with cell migration increasing as a function of pore size for both ages 
(p≤0.05). Addition of 100 ng/mL PDGF-AB (High PDGF) to the bottom chamber 
significantly increased migration through both the 5 and 8 µm pores compared to the 3 µm 
pores (p≤0.05). A similar trend was seen for the 50 ng/mL PDGF-AB (Low PDGF) group, 
though in this case, migration was increased for only the 8 µm pores (p≤0.05). While 
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migration increased with PDGF dose for both age groups, fetal cells were more mobile 
than adult cells. However, no matter what the concentration of PDGF, migration through 
3 µm pores was limited. 
 
 
Figure 7-2: PDGF-AB enhances fetal and adult (P1) cell migration through intermediate size 
pores. (A) 3D confocal reconstruction of adult cells (green) passing through microporous 
membranes (red) of 3, 5, and 8 µm diameter. Arrow points to constricted nucleus (blue). 
Scale = 10 µm. (B) Cross-section of the cells in (A). Scale = 10 µm. (C) Migrated fetal and (D) 
adult cell signal intensity normalized to the 3 µm pore group for each media condition (n=3 
wells/group, mean ± standard deviation). * = p≤0.05 vs. High PDGF. ** = p≤0.05 vs. all other 
media conditions. # = p≤0.05 vs. 3 µm pore. 
 
To determine whether meniscal cells undergo enhanced interstitial migration towards a 
PDGF gradient in a more physiologic tissue-like environment, a ‘tissue Boyden chamber’ 
was fabricated (Figure 7-3). When fetal and adult tissue explants were placed atop the 
 148 
 
devitalized meniscal tissue, egressing cells adhered, spread, and began migrating into the 
substrate within 48 hours. In the absence of PDGF in the bottom chamber (Control), more 
fetal cells migrated onto the tissue substrate than adult cells, though few cells from either 
age migrated through the tissue depth (Figure 7-4C and Figure 7-4D, p≤0.05). Addition 
of 200 ng/mL PDGF-AB to the bottom chamber significantly increased the total adult cell 
number as well as the number of cells that had migrated through the tissue for both age 
groups, compared to Controls (p≤0.05), such that there was no longer a significant 
difference between fetal and adult cells. 
 
 
Figure 7-3: Construction of a ‘tissue Boyden chamber.’ (A) Experimental schematic. (B) 
Tissue slide atop concave slide containing media. Inset shows tissue cryosection with a 
black box around a slide hole. Scale = 5 mm. (C) 3D confocal reconstruction showing cells 
(green) on the tissue (blue) over a slide hole. Arrow indicates migrated cell. 
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Figure 7-4: PDGF-AB enhances fetal and adult cell (P0) migration through native tissue. (A) 
Confocal z-projection of cells within the slide hole (dotted circle). Scale = 100 µm. (B) Cross-
section showing cells migrating through the tissue section in the region spanning the slide 
hole. Arrows point to migrated cells. Scale = 20 µm. (C) Total number and (D) subset of 
migrated fetal and adult cells within slide hole for each media condition (n=3 holes/group, 
mean ± standard deviation). * = p≤0.05 between groups. 
 
To investigate whether biophysical differences between fetal and adult cells contribute to 
differential 3D migration, nuclear volume and cell contractility were assessed in these cell 
populations. Adult cells (P0) on microporous membranes had larger nuclei than fetal cells 
(Figure 7-5D, p≤0.05), but the average traction stress and the total contractile force 
generated was not significantly different between fetal and adult cells (P0) on 
polyacrylamide gels (Figure 7-5E, p>0.05). Interestingly, when adult cells (P1) were first 
expanded on TCP, their average traction stress and total force increased substantially 
compared to all other groups (p≤0.05), whereas fetal cells (P1) did not exhibit changes in 
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contractility. Cell spread area, which scaled linearly with total force for all groups, 
increased for both fetal and adult cells after passage, although this was significant for adult 
cells only (Figure 7-5F, p≤0.05). This suggests that adult cells are particularly sensitive 
to exposure to stiff tissue culture plastic, and upregulate their mechanosensing machinery 
in response to this mechanical input.  
 
 
Figure 7-5: Biophysical differences between fetal and adult cells. (A) 3D confocal 
reconstruction of fetal and adult cells (P0) and (B) corresponding nuclei atop microporous 
membranes with 3 µm diameter holes. Scale = 20 µm (top) and 10 µm (bottom). (C) Traction 
stress generation by fetal and adult cells (P0 and P1) on 5 kPa polyacrylamide hydrogels. 
Outline indicates cell shape and position. (D) Nuclear volume of fetal and adult cells (P0) on 
microporous membranes (n=150 cells/group, mean ± standard error of the mean). * = p≤0.05 
vs. fetal. (E) Average traction stress of fetal and adult cells (P0 and P1) measured via TFM 
(n=12 cells/group, mean ± standard error of the mean). * = p≤0.05 vs. all other groups. (F) 
Total contractile force generated by individual fetal and adult cells (P0 and P1) as a function 
of cell spread area. Total contractile force and cell spread area were significantly larger for 
adult P1 cells compared to all other groups (p≤0.05). 
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7.4.3 Controlled Biofactor Release from Tri-Component Scaffolds 
Composite nanofibrous scaffolds containing three components were fabricated via 
electrospinning onto a common rotating mandrel: poly(ε-caprolactone) (PCL), 
poly(ethylene oxide) (PEO), and hyaluronic acid (HA) with 25% HeMA functionalization. 
Scaffolds were approximately 50% PCL, 35% PEO, and 15% HA by mass based on 
theoretical loading (Table 7-1), although PEO and HA yields were lower than predicted 
(fibers are lost to neighboring surfaces). Images of fluorescently labeled fibers validated 
the presence of three discrete populations within the scaffold (Figure 7-6B). When these 
fibers were collected on a rotating mandrel, SEM micrographs revealed a uniaxial fiber 
alignment oriented in the direction of rotation (Figure 7-6C). Fibers appeared smooth and 
uniform, with an average fiber diameter of 308 ± 143 nm. 
Collagenase and PDGF-AB were successfully incorporated and released from the PEO 
and HA fiber fractions, respectively. Biofactor release occurred independent of one 
another and corresponded with the degradative rate of the respective fiber fraction 
(Figure 7-6D–G). As expected, there was an instantaneous burst release of collagenase 
from the water-soluble PEO fiber fraction, where 80% was released within 5 hours of 
incubation in PBS (Figure 7-6D). Based on activity assays, ~58% of the total released 
collagenase was bioactive, with 26±4 µg of active enzyme delivered per mg scaffold 
(enzyme activity was not detected in control scaffolds). Bulk scaffold mass loss occurred 
in a similar fashion. After 2 hours, 18% of the total mass was lost, with this mass likely 
representing the loss of the PEO via dissolution and diffusion of uncrosslinked HA from 
the network (Figure 7-6E). After 24 hours, mass loss reached 22%, and remained 
constant thereafter, indicating that the majority of PEO had been removed from the 
scaffold, with ~80% removed in the first 2 hours. In contrast to collagenase release from 
PEO fibers, PDGF release from HA fibers showed a more linear profile over the course of 
2 weeks (Figure 7-6F). Approximately 66% and 85% of PDGF was released after 4 and 
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7 days, respectively, corresponding to 35% and 46% loss in scaffold mass due to HA fiber 
degradation. After 16 days, ~60% of the HA had degraded and PDGF was no longer 
detectable in the eluant (Figure 7-6F and Figure 7-6G). After 45 days, only 14% of the 
HA remained, resulting in a scaffold that was comprised primarily of PCL. 
 
 
Figure 7-6: Controlled biofactor release from tri-component scaffolds. (A) Electrospinning 
schematic with three independent fiber jets collecting simultaneously on a common rotating 
mandrel. (B) Fluorescent image of randomly aligned PCL (red), PEO (green), and HA (blue) 
fibers collected on a slow rotating mandrel. Scale = 20 µm. (C) SEM micrograph of uniaxially 
aligned PCL/PEO/HA scaffold collected onto a fast rotating mandrel. Scale = 5 µm. (D) 
Cumulative collagenase release from PEO fibers and (E) bulk scaffold mass loss (% of total) 
over 96 hours (n=3–4 samples/scaffold for 3 different scaffolds, mean ± standard deviation). 
(F) Cumulative PDGF release from HA fibers (via ELISA, n=6 samples/scaffold, mean ± 
standard deviation) and (G) HA mass loss (% of total) over several weeks (via the uronic 
acid assay, n=5 samples/scaffold, mean ± standard deviation). 
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7.4.4 Cell Adhesion and Infiltration into Tri-Component Scaffolds 
Adult meniscal explants were placed atop nanofibrous substrates to assess cell behavior 
and viability on scaffolds. After 48 hours, cells had egressed onto the substrates and 
appeared viable. Cells adhered and spread on HA fibers with RGD, but failed to spread 
on those without RGD, instead clustering into multi-cellular aggregates (Figure 7-7A). In 
addition, relatively few cells were found on the HA fibers without RGD. To ensure cell 
adhesion and migration into scaffolds, all subsequent experiments included RGD. 
Analysis of cell infiltration into high (PCL/PEO/PEO) and low (PCL/PEO/HA) porosity 
scaffolds revealed that infiltration depth was affected by fiber density. PCL/PEO/HA 
scaffolds had significantly fewer and smaller pores than PCL/PEO/PEO scaffolds, which 
contained an additional sacrificial PEO fraction (Figure 7-7C–F, p≤0.05). Pores consisted 
of 8% of the total area of PCL/PEO/HA composites, with an average diameter of ~4 µm, 
whereas in PCL/PEO/PEO scaffolds, 32% of the area was occupied by pores of ~5 µm 
average diameter (Figure 7-7E and Figure 7-7F). However, a substantial number of 
pores were smaller than the population average for both groups, with the most frequent 
pore diameter being 3 and 4 µm for PCL/PEO/HA and PCL/PEO/PEO scaffolds, 
respectively (Figure 7-7C). Furthermore, the total percentage of small pores (≤3 µm 
diameter) was 2x higher in PCL/PEO/HA scaffolds (43%) compared to PCL/PEO/PEO 
scaffolds (21%) (Figure 7-7D). Consequently, cell infiltration depth through PCL/PEO/HA 
scaffolds was 50% less than through PCL/PEO/PEO scaffolds (Figure 7-7G, p≤0.05). 
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Figure 7-7: RGD and high porosity scaffolds facilitate cell adhesion and infiltration. (A) 3D 
confocal reconstruction of adult cells (P0) on randomly aligned HA fibers ± RGD and (B) on 
high (PCL/PEO/PEO) and low (PCL/PEO/HA) porosity scaffolds. Scale = 20 µm. (C) 
Distribution of pore diameter for randomly aligned PCL/PEO/PEO and PCL/PEO/HA 
scaffolds, shown as % frequency and (D) % cumulative frequency (n=3 stacks/group). Red 
dashed line indicates average pore diameter for PCL/PEO/HA scaffolds. (E) Average pore 
diameter and (F) area fraction of PCL/PEO/PEO and PCL/PEO/HA scaffolds (n=3 
stacks/group, mean ± standard deviation). (G) Cell infiltration depth after 48 hours of in vitro 
culture (n=16 cells/group, mean ± standard error of the mean). * = p≤0.05 vs. PCL/PEO/PEO. 
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7.4.4 Bioactive Scaffolds Enhance Meniscal Cellularity and Integration 
To evaluate the effect of scaffolds on meniscal repair in vivo, adult meniscal repair 
constructs were placed subcutaneously in athymic rats and evaluated histologically at 2 
and 4 weeks. All repair constructs remained intact after 2 weeks, encapsulated by a layer 
of hypercellular, fibrous tissue. At 2 weeks, interfacial cellularity at the center of the repair 
construct was significantly higher for samples that contained bioactive scaffolds compared 
to the empty defect (Control) and PCL/PEO/HA scaffold groups (Figure 7-8B, p≤0.05).  
 
 
Figure 7-8: Collagenase-releasing scaffolds increase interfacial cellularity after 2 weeks of 
subcutaneous implantation. (A) Thresholded images of DAPI-stained nuclei (white) at the 
center of repair constructs. Interface is on the left (red line). Scale = 100 µm. (B) Average 
intensity with respect to distance from the interface, normalized to the empty defect Control 
value at the interface (n=4–5 samples/group, mean ± standard deviation). * = p≤0.05 vs. 
Control and PCL/PEO/HA. ** = p≤0.05 vs. PCL/PEO/HA-P. # = p≤0.05 vs. all other distances 
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Constructs with scaffolds containing collagenase (PCL/PEO-C/HA) and both collagenase 
and PDGF (PCL/PEO-C/HA-P) showed the highest cell signal intensity within 100 µm of 
interface, with increases of 683% and 745% over the Control group, respectively. While 
interfacial cellularity was lower for the PDGF-only scaffold (PCL/PEO/HA-P) compared to 
the collagenase-releasing scaffolds, PDGF delivery on its own did result in a 440% 
increase over Control implants. For all scaffold groups, the cell signal intensity was 
significantly higher within 100 µm of interface than at distances >100 µm from the 
interface, indicating that presence of the material itself may increase interfacial cellularity 
(Figure 7-8B, p≤0.05). There were no significant differences in cellularity between 
treatment groups at distances >100 µm, indicating that biofactor release and activity was 
localized to the defect. 
The high cell density at the tissue-scaffold interface, coupled with collagen degradation, 
appeared to enhance integration of the scaffold with the native meniscal ECM at 2 weeks 
(Figure 7-9A). Despite the complete loss of PEO and partial loss of HA at 2 weeks, few 
cells were observed within the scaffold center for all groups (data not shown), suggesting 
that scaffold porosity was too low at this early time point to allow effective cell infiltration. 
By 4 weeks, however, cells were present within scaffolds from all groups, likely facilitated 
by the additional HA loss over this time period. While cells were evenly distributed 
throughout the entire thickness of collagenase-releasing scaffolds (PCL/PEO-C/HA and 
PCL/PEO-C/HA-P), cell ingress was limited to the periphery of scaffolds lacking 
collagenase (PCL/PEO/HA and PCL/PEO/HA-P) (Figure 7-10). Matrix degradation and 
remodeling at the tissue-scaffold interface were most evident in the collagenase-releasing 
scaffold groups, where a loose network of thin, interconnected collagen fibers bridged the 
scaffold and tissue edges by 4 weeks (Figure 7-9B). Additionally, de novo collagen 
synthesis within the scaffolds themselves was most frequently observed in the groups 
delivering collagenase. While some collagen deposition did occur at the interface of empty 
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defect Control samples at 4 weeks, the amount was minimal, and did not appear well 
integrated with the surrounding tissue. Taken together, these findings suggest that 
localized delivery of a matrix-degrading enzyme appears to be the primary catalyst 
towards advancing cell-mediated wound repair. 
 
 
Figure 7-9: Bioactive scaffolds enhance tissue-scaffold integration. (A) PSR staining of 
repair constructs showing collagen and nanofibrous scaffolds at the wound site after 2 
weeks and (B) 4 weeks of subcutaneous implantation. Matrix degradation and remodeling 
at the tissue-scaffold interface are evident in collagenase-releasing scaffold groups. 
Collagen deposition is observed within collagenase-releasing scaffold groups after 4 
weeks. Scale = 100 µm.  
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Figure 7-10: Collagenase delivery increases cellular infiltration into scaffolds at 4 weeks. (A) 
H&E and (B) DAPI staining of repair constructs showing cells and nuclei within nanofibrous 
scaffolds after 4 weeks of subcutaneous implantation. Cells were distributed throughout the 
full thickness of collagenase-releasing scaffolds, but were limited to the scaffold periphery 
for non-collagenase-releasing groups. Scale = 100 µm.  
 
7.5 Discussion 
The ECM of the knee meniscus and other dense connective tissues is a physically 
restrictive 3D microenvironment. The densely packed, anisotropic arrangement of 
collagen fibers acts as a steric constraint to cell migration, forcing cells into extremely 
deformed states as they squeeze through narrow gaps between fiber bundles. While low 
interstitial cell mobility may contribute to the lack of cell-mediated repair in the adult 
meniscus, this limitation may be partly overcome via the provision of a soluble chemotactic 
gradient that promotes migration to the injury site. Here, we show that a PDGF-AB gradient 
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enhances cell infiltration through membranes of intermediate pore sizes, as well as 
through a physiologic microenvironment using a novel ‘tissue Boyden chamber.’ 
Furthermore, localized delivery of PDGF-AB in vivo increased cellularity at the meniscal 
wound interface, suggesting that combining cell recruitment with a low level of matrix 
degradation may be optimal for promoting meniscal repair. 
As with other cell types (Lautscham et al. 2015, Wolf et al. 2013), meniscal cell migration 
declines with decreasing pore size and eventually the cells are rendered immobile, a trend 
that is made apparent with the addition of a chemoattractive gradient. Consistent with 
other reports in the literature (Bhargava et al. 1999, Bhargava et al. 2005), we found that 
PDGF-AB was the most effective chemoattractant for meniscal cells, although this may 
vary with species, age, meniscus zone, and PDGF-AB concentration. Importantly, PDGF-
AB can also recruit a host of other cell types, including articular chondrocytes, fibroblasts, 
tenocytes, and mesenchymal stem cells (MSCs) (Haugh 2006, Caliari et al. 2011, Mishima 
et al. 2008), rendering it applicable to a wide range of musculoskeletal tissues. Other 
factors that have been noted as potential chemoattractants for meniscal cells include SDF-
1 (Shen et al. 2014), interleukin-1 (IL-1) (Bhargava et al. 1999), bone morphogenic protein-
2 (BMP-2) (Bhargava et al. 1999), and hepatocyte growth factor (Bhargava et al. 1999, 
Bhargava et al. 2005). Although SDF-1 did not affect cell migration in this study, possibly 
due to a lack of the receptor CXCR4 (Kucia et al. 2004), delivery of SDF-1 in vivo has 
been found to enhance mesenchymal stem cell and/or progenitor cell homing to the 
meniscus (Shen et al. 2014), articular cartilage (Chen et al. 2015), and tendon (Shen et 
al. 2010) after injury. 
Our findings also indicate that fetal cells may be more mobile in 3D environments than 
adult cells. Similarly, Sandulache et al. found that fetal fibroblasts attach to and infiltrate 
3D collagen gels faster than adult fibroblasts (Sandulache et al. 2007). Since 3D migration 
depends on deformability through interstitial space, age-related changes in cell and/or 
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nuclear mechanics may play a role in the differential mobility seen between fetal and adult 
cells. Surprisingly, our data indicate that contractility is not different between fetal and 
adult cells (P0), although passaged adult cells are significantly larger and more contractile. 
It is possible that differential expression of adhesion ligands influenced the contractility 
results. Moulin et al. found that freshly isolated adult dermal fibroblasts (P0) were more 
contractile on collagen gels than fetal fibroblasts, and that when grown in monolayer, adult 
cells, but not fetal cells, showed rapid changes in contractile capacity and integrin 
expression at early passages (Moulin et al. 2002). In particular, adult cells express more 
α-smooth muscle actin than fetal cells in the presence of TGF-β (Moulin et al. 2001), 
assuming a myofibroblastic phenotype that is often associated with fibrosis and scarring 
(Tomasek et al. 2002). Taken together, these findings suggest that expansion of adult 
cells on TCP, a common practice in autologous cell therapy, alters the adult cell 
mechanotransduction machinery and may make them less suitable for regenerative 
medicine applications than fetal cells (Talele et al. 2015). 
In order to pass through small pores in stiff or non-degradable matrices, cells must 
overcome the steric constraints that are imposed by its own nucleus, which is 2–4 times 
stiffer than the surrounding cytoplasm and considered the rate-limiting organelle in 
migration (Friedl et al. 2011, Guilak et al. 2000). Notably, nuclear volume scales inversely 
with the ability to navigate narrow channels, and cell velocity significantly decreases when 
the nuclear cross sectional area is 4 times larger than the constriction (Lautscham et al. 
2015). In this study, we found that nuclear volume was significantly larger for adult cells 
compared to fetal cells, which may contribute to their differential mobility. Furthermore, 
recent work from our lab indicate that adult nuclei are 2 times stiffer than fetal nuclei and 
contain twice the amount of lamins A and C (lamin A/C) (data not shown), proteins that 
provide structure and stability to the nuclear envelope (Lammerding et al. 2006). This is 
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consistent with studies suggesting that stem cell differentiation and/or increased tissue 
micromechanics result in increased lamin A/C expression, nuclear stiffness, and volume 
(Pajerowski et al. 2007, Swift et al. 2013, Vishavkarma et al. 2014). Interestingly, restoring 
nuclear plasticity by lamin A/C knockdown enhances migration through small pores 
(Greiner et al. 2014, Harada et al. 2014), and over-expressing lamin A reduces 3D cell 
mobility (Lautscham et al. 2015, Rowat et al. 2013). These data suggest that barriers 
posed by the dense ECM may also be overcome if endogenous cells can adopt a ‘softer’ 
nuclear phenotype, although depletion of lamins beyond a certain threshold may lead to 
apoptosis from migration-induced stress imposed on the nucleus (Harada et al. 2014). 
Given the inherently low cell density and interstitial cell mobility of adult dense connective 
tissues, we sought to increase cellularity at the wound interface by removing ECM 
impediments to migration and by introducing a chemoattractant to recruit endogenous 
cells to the defect. To target these inputs to the injury site, electrospun nanofibrous 
composites were engineered to deliver a burst of the matrix-degrading enzyme 
collagenase from water-soluble PEO fibers over the course of 24 hours, followed by a 
sustained release of PDGF-AB from slower-degrading HA fibers over the course of 2 
weeks. Importantly, since this fabrication is aqueous-based, biologic activity of 
encapsulated factors is easily preserved relative to harsher organic solvents used for 
synthetic fibers. While delivery of a chemoattractant (PDGF-BB) from nanofibrous 
scaffolds has been previously reported (Jin et al. 2008, Phipps et al. 2012b), this is the 
first instance, to the best of our knowledge, that two factors were delivered in a sequential 
fashion to enhance cell migration. Although we investigated only one concentration and 
release rate for each biofactor, our data indicate that these complementary approaches 
can independently enhance interfacial cellularity. The highest cell densities were achieved 
by scaffolds releasing collagenase, most likely due to their impact on enhancing cell 
migration and proliferation after removal of collagen and other matrix constituents at the 
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interface. Delivery of PDGF-AB alone resulted in a significantly higher cellularity than 
control scaffolds at the interface, but its impact was less than either collagenase-releasing 
scaffold, confirming that the ECM presents a formidable barrier to cell-mediated repair. 
Therefore, an ideal formulation may be to combine PDGF-AB delivery with a lower dose 
of collagenase to optimize cellularity while minimizing ECM damage.  
Cellular colonization is essential for acellular scaffolds that rely on endogenous matrix 
deposition to bolster mechanical properties and ensure survival in a dynamically loaded 
environment. While biofactor delivery increased cellularity at the interface, few cells had 
infiltrated into the scaffolds at 2 weeks. Consequently, both the tissue-scaffold interface 
and the scaffold itself were prone to mechanical failure during sectioning, despite the 
abundance of cells at the interface. It is possible that scaffold density was too high to allow 
cell invasion even though a ‘sacrificial’ PEO component was included (Baker et al. 2008). 
Indeed, our in vitro studies showed that replacement of a PEO fiber fraction with HA 
reduced scaffold pore size and number, and impeded cell migration through the scaffold. 
Although the RGD adhesion motif was coupled to HA fibers to encourage cell adhesion 
and migration (Kim et al. 2013), cell infiltration depth was still impaired compared to higher 
porosity substrates. To facilitate interstitial mobility, HA fiber degradation could be 
accelerated by reducing the macromer molecular weight or crosslinking density (Burdick 
et al. 2005), altering the modification of the HA backbone to allow increased rate of 
hydrolysis (Sahoo et al. 2008), or by introducing protease-cleavable peptides (Wade et al. 
2015b). In our study, modification of HA with hydroxyethyl methacrylate (HeMA) groups 
promoted fiber degradation in aqueous environments via the hydrolyzable ester group, 
resulting in a HA mass loss of approximately 80% after 4 weeks. Indeed, cellular ingress 
into scaffolds was apparent by 4 weeks in all groups, although infiltration appeared most 
advanced in the collagenase-releasing scaffolds. It is possible that the fragmented 
collagen at the wound interface weakens cell anchorage to the ECM, allowing temporal 
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detachment to facilitate migration (Carragher et al. 1999). Alternatively, Clostridium 
collagenase and its soluble collagen degradation products may act as chemoattractants 
(Shi et al. 2010). Interestingly, while a PDGF-AB gradient expedited short-term migration 
in vitro and increased cellularity at the wound interface of repair constructs in vivo at 2 
weeks, it did not visibly improve cell infiltration of scaffolds at 4 weeks when combined 
with collagenase. In contrast, Stringa et al. found that PDGF-BB stimulation enhanced 
vascular smooth muscle cell migration on degraded ECM (Stringa et al. 2000). It is 
possible that sustained delivery of a high dose of PDGF-AB, a mitogen (Bhargava et al. 
1999, Tumia et al. 2009) and stimulator of matrix synthesis (Spindler et al. 1995, Tumia et 
al. 2009), resulted in cell proliferation instead of migration (De Donatis et al. 2008). Future 
work will focus on evaluating the long-term anabolic effects of PDGF-AB and tailoring its 
in vivo delivery profile to optimize cell homing after matrix degradation. We will likewise 
explore other chemoattractants whose activity is directed solely towards migration, with 
little mitotic secondary effects (e.g., SDF-1α). 
While this study showed improved migration to the wound site and colonization of the 
scaffold with a two-phase release profile of collagenase and PDGF-AB, additional 
functionality may be added to the system. For instance, to enhance the quantity and 
quality of matrix produced by the recruited cells, the remaining fiber fraction may be further 
modified to incorporate microspheres (Ionescu et al. 2010) that slowly release TGF-β3, a 
potent fibrochondrogenic growth factor (Ionescu et al. 2012b), and/or lysl oxidase, which 
could act to crosslink and stabilize nascent collagen fibrils (Makris et al. 2014). Lastly, 
while the subcutaneous implantation model allows short-term assessment of biofactor 
delivery in an in vivo setting, the subcutaneous environment is vastly different from the 
synovial joint in terms of biochemical milieu, cellular constituents, immune response, and 
dynamic mechanical loading, all of which could affect wound repair. Ultimately, these 
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novel biomaterials must be evaluated in an orthotopic large animal model of meniscal 
injury to prove long-term therapeutic efficacy. 
 
7.6 Conclusions 
In summary, the healing of dense connective tissues is limited in part by the inability of 
endogenous cells to migrate to the wound site. To enhance cell infiltration and tissue 
integration, we developed novel multi-component nanofibrous scaffolds that are both 
biomimetic and bioactive. When tuned appropriately, the release of collagenase and 
PDGF increased cell mobility to the wound margin in the short term and resulted in 
superior scaffold colonization and tissue repair in the long term. Through coordinated 
reprogramming of both cells and matrix, this technology will remove the natural 
impediments to endogenous repair of the meniscus and other dense connective tissues, 
providing a translational framework with which to treat many common musculoskeletal 
injuries. 
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CHAPTER 8: SUMMARY AND FUTURE DIRECTIONS 
 
8.1 Summary 
Repair of dense connective tissues throughout the musculoskeletal system is limited, 
given the density of the matrix and the low cellularity of adult tissues. Like other fiber-
reinforced tissues, the knee meniscus is characterized by highly organized collagen 
bundles that resist tensile stresses. Injuries disrupt this collagen architecture and 
predispose the joint to cartilage erosion. While peripheral tears may be successfully 
repaired, tears in the inner two-thirds of the meniscus have a poorer prognosis due to a 
lack of vasculature and reparative cells. Efforts to biologically augment meniscal repair 
have traditionally focused on increasing vascular supply and growth factors (Chapter 2), 
overlooking the critical impact of extracellular matrix (ECM) properties in wound healing. 
It is well recognized that matrix micromechanics and microstructure play a significant role 
in regulating interstitial cell migration, an essential component of the intrinsic repair 
process of dense connective tissues (Chapter 3). Using imaging and mechanical testing 
modalities at the microscale, this work investigated how the biophysical properties of the 
meniscal microenvironment regulate cell migration and tissue repair. Moreover, a novel 
biomaterial was developed to reprogram the ECM of the meniscal wound interface to 
generate a pro-healing microenvironment. 
 
When limited connective tissue repair does occur, it does so through an orchestrated 
series of events involving matrix breakdown, cellular division and migration, and eventually 
new tissue formation to bridge the wound site. In Chapter 6, we found that cells were 
unable to migrate through adult tissue, suggesting that the inability of the mature meniscus 
to self-repair may be due in part to its dense, stiff, and highly structured ECM, which acts 
as a steric barrier to interstitial cell migration. In contrast, cells were mobile within the more 
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compliant and disorganized fetal ECM. Partially digesting the adult ECM with collagenase, 
a matrix-degrading enzyme, produced a fetal-like environment that was permissible to cell 
infiltration. Thus, the microenvironment of fibrous connective tissues may play a role in the 
differential healing capacity of fetal and adult tissues, and may be modulated via 
exogenous enzymatic degradation to promote cell migration and repair. 
 
To generate a local microenvironment that facilitates the adult healing response, we pre-
treated the meniscal wound interface with collagenase so that the ECM resembled 
immature tissue (Chapters 4 and 5). Through a series of in vitro and in vivo studies, we 
demonstrated that reducing the local matrix stiffness and density at the injury site 
increased cellular ingrowth, matrix remodeling, and tissue integration. Thus, a novel 
strategy to promote meniscal repair may be to deliver a controlled, low dose of matrix-
degrading enzyme to free the living native cells from the matrix and expedite migration 
while allowing the production of new contiguous tissue spanning the defect. 
 
Chapters 4 and 5 also document the development of a synthetic electrospun nanofibrous 
scaffold that rapidly releases collagenase upon implantation into the defect site. 
Electrospun nanofibrous scaffolds are a promising tool for soft tissue repair and tissue 
engineering, given their ability to provide structural integrity and instruction for new tissue 
formation. While they have been previously utilized for meniscal tissue engineering, this 
is the first time, to the best of our knowledge, that nanofibers were used to localize delivery 
of therapeutics to promote endogenous meniscal repair. In Chapter 4, we established the 
retention of enzymatic bioactivity and tunable delivery from water-soluble poly(ethylene 
oxide) (PEO) nanofibers. The technology was further functionalized by creating 
collagenase-delivering fibrous composites containing both enzyme-releasing PEO fibers 
and structural poly(ε-caprolactone) (PCL) fibers. This dual polymer scaffold provided a 
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burst delivery of collagenase where the local enzyme activity enabled cell migration 
through the partially digested wound interface, while the second, aligned fiber component 
provided topographical instruction for ingressing cells. We found that these scaffolds 
enhanced the integration strength of meniscal defects in vitro. In Chapter 5, we showed 
that these scaffolds also increased cellularity and repair in vivo using a subcutaneous 
xenotransplant model (rat) and an orthotopic meniscal injury model (sheep). Importantly, 
matrix digestion was restricted to the wound interface and did not adversely affect 
surrounding tissues.  
 
In Chapter 7, we took the innovative approach of specifically directing the coordinated 
phases of tissue repair. We designed a scaffold that would first enable repair by 
modulating the matrix to permit migration, followed by recruitment of endogenous cells to 
the wound site by providing a chemoattractant. We found that a soluble gradient of 
platelet-derived growth factor-AB (PDGF-AB) stimulated cell migration through 
biophysical barriers (porous membranes and meniscal tissue) in vitro. Next, we fabricated 
a highly tunable scaffold, capable of delivering collagenase and/or PDGF-AB with varying 
release profiles to the injury site to mediate wound repair. When the scaffold was inserted 
into a meniscal defect and placed subcutaneously in vivo, the sequential delivery of 
collagenase and PDGF-AB led to the highest interfacial cellularity compared to delivery of 
either biofactor alone. This versatile platform will allow us to maximize cell recruitment 
while minimizing damage to the tissue microenvironment, as well as deliver additional 
therapeutics, such as anabolic growth factors and anti-inflammatories, to promote matrix 
synthesis and inhibit matrix catabolism in the long-term. By combining multiple bioactive 
components that expedite cell colonization and wound integration in a spatiotemporal 
manner, these novel scaffolds will bring us closer to repairing the meniscus and other 
dense connective tissues. 
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8.2 Limitations and Future Directions 
While much was accomplished in this dissertation, there are of course limitations and 
additional considerations and new experiments to be performed based on these findings. 
 
8.2.1 Cellular and Extracellular Matrix Changes with Age 
To determine whether aging affects interstitial migration in the meniscus, we compared 
fetal and adult meniscal cellular and ECM properties in Chapters 7 and 6, respectively. 
However, using primary cells and tissues limits the degree of control over our studies. 
Since the exact age of donors were unknown (fetal tissues range from late 2nd–3rd trimester 
and adult tissues from 20–30 months), changes during fetal development were not 
considered in the scope of this work. Although experiments were restricted to cells and 
tissues from the middle zone of the medial meniscus, isolated cells and tissue substrates 
were likely heterogeneous. Also, it is unclear whether a specific cell type (e.g., progenitor 
cells) was disproportionately represented due to an intrinsic propensity to migrate out of 
explants, attach to substrates, and/or proliferate.  
The effect of cell passage also warrants further investigation. We found that adult P1 cells 
were more contractile than P0 cells on fibronectin-coated gels, but that fetal cells were 
largely unaffected (Chapter 7). Interestingly, attempts to seed P1 cells onto tissue 
substrates were consistently unsuccessful, most likely due to trypsin-mediated cleavage 
of cell surface receptors. P0 and P2 cells were able to attach and spread, indicating that 
cell adhesion may also depend on passage number. However, fetal and adult P0 cells 
were smaller and more spindle-shaped than P2 cells, whose well-spread morphologies, 
independent of ECM age, suggest mechanical memory (Talele et al. 2015, Yang et al. 
2014) (Figure 8-1). Furthermore, while P0 cells showed signs of matrix invasion, P2 cells 
remained predominantly on the tissue surface. Recent studies indicate cell culture on stiff, 
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planar surfaces (e.g., tissue culture plastic) increases cell stiffness and leads to a 
contractile, myofibroblastic phenotype (LeBlon et al. 2015, Talele et al. 2015). As such, 
future experiments should use minimally passaged cells whenever possible, although 
expanding cells on softer substrates may delay dedifferentiation (Majd et al. 2009, Wu et 
al. 2015). Furthermore, integrin-blocking antibodies and contractility inhibitors (e.g., 
blebbistatin and Y27632 to block nonmuscle myosin II and ROCK) may provide insight to 
how cell and ECM age, as well as cell expansion, affect the mechanosensing machinery. 
 
 
Figure 8-1: Cell morphology is dependent on ECM age, cell age, and cell passage. (A) 
Representative binarized images of fetal and adult meniscal cells spread on fetal and (B) 
adult meniscal tissue substrates. Cells on adult tissues are more elongated than cells on 
fetal tissues. Fetal cells are smaller and more spindle-shaped than adult cells at Passage 0. 
However, there is no difference between fetal and adult cells at Passage 2, indicating that 
cell-intrinsic differences are attenuated with expansion on tissue culture plastic. 
 
An important cellular determinant of 3D mobility is nuclear size and stiffness. In Chapter 
7, we showed that the nuclear volume of meniscal cells (P0) scaled with age. While a large 
nucleus is associated with reduced migration speed (Lautscham et al. 2015), this 
relationship was not directly confirmed in our study. In addition, we did not quantify nuclear 
stiffness or lamin A/C content, although unpublished work suggests that they both 
increase with age in meniscal cells. Future studies will investigate whether interstitial 
migration could be improved by reducing nuclear stiffness, either by virus-mediated lamin 
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knockdown, interrupting lamin processing (farnesyltransferase inhibitors) (Glynn et al. 
2005), or by relaxing heterochromatin condensation (histone deacetylase inhibitors) 
(Gerlitz et al. 2011). 
 
 
Figure 8-2: Fetal and adult meniscal ECM imaged with different SHG systems. SHG signal 
of interpenetrating fibers in the perpendicular plane are attenuated on the Zeiss microscope 
(top). The Leica microscope (bottom) produces superior images in which individual collagen 
fibrils are visible in all planes. Asterisks indicate orthogonal fibers (‘inter-fibrillar’ regions). 
Scale = 50 µm. 
 
To quantify age-related changes in the meniscal microenvironment, Chapter 6 
characterized the microstructure of fetal and adult meniscus using second harmonic 
generation (SHG) imaging. Although the microscope used in the study (Zeiss LSM 510) 
can detect collagen fibers, the signal is highly attenuated when the fibers are oriented in 
the Z plane (Figure 8-2). When imaged on a newer microscope with both forward and 
backward detectors (Leica TCS SP8), the signal and resolution is greatly improved, 
allowing detailed visualization of not only fiber bundles, but individual collagen fibrils in all 
planes. Preliminary images support the idea that inter-fibrillar regions are not void spaces, 
but rather discontinuities in the matrix (Figure 8-2, asterisk), and that fetal ECM is more 
disorganized than adult ECM. Efforts to visualize the meniscal microstructure as a function 
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of anatomical location and age are ongoing under the direction of Dr. Miltiadis Zgonis, and 
will be aided by a recently acquired multiphoton microscope capable of this higher 
resolution SHG imaging. 
 
 
Figure 8-3: Micromechanical heterogeneity and anisotropy of fetal and adult meniscal 
tissues. (A) Schematic of horizontal and (B) vertical sectioning planes and collagen fiber 
units within each plane. (C) Indentation modulus (Eind) of different fiber units in the 
horizontal and (D) vertical planes, as measured by AFM (tip radius ≈ 5 µm). Outer and inner 
zones of fetal and adult tissues are tested for each sectioning plane (n=≥20 positions/group 
for 2 donors per age, mean ± standard error of the mean). * = p≤0.05 vs. all other groups. 
Images and data courtesy of Qing Li and Dr. Lin Han. 
 
To measure matrix micromechanics as a function of age, we utilized atomic force 
microscopy (AFM) indentation. While the elastic moduli reported in this thesis (Chapters 
5 and 6) represent average values, they do not reflect the heterogeneity and anisotropy 
of meniscal tissue. In a collaboration with Qing Li and Dr. Lin Han from Drexel University, 
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we systemically mapped the micromechanical properties of fetal, juvenile, and adult 
bovine menisci. While the overall matrix stiffness increased with age, the sectioning plane 
(horizontal vs. vertical), anatomical location (inner vs. outer zone), and structural fiber unit 
(superficial, circumferential, or radial fibers) influenced the measured modulus (Figure 
8-3). For example, circumferential collagen fibers in the outer zone are more densely 
packed and interdigitated with radial ‘tie’ fibers than in the inner zone, resulting in higher 
matrix stiffness (Figure 8-4).  
 
 
Figure 8-4: Collagen ultrastructure of the adult bovine meniscus is anisotropic and zone-
dependent. (A) SEM and AFM height images of vertical sections showing circumferential 
fiber cross-section and radial ‘tie’ fibers. (B) SEM and AFM height images of horizontal 
sections showing circumferential fiber alignment in the outer and inner regions. 
Arrowheads indicate individual fibrils crossing to adjacent fibers. Images courtesy of Qing 
Li and Dr. Lin Han. 
 
These early results illustrate the inextricable link between ECM structure and mechanics 
on the microscale, which may generate new fundamental knowledge about the 
microenvironment of dense connective tissues. In addition to biophysical properties of the 
ECM, cell mobility depends on the type and distribution of integrin-binding proteins and 
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growth factors. Therefore, to fully comprehend how the ECM changes with age and 
disease to affect migration, future studies should also characterize ECM composition via 
nuclear magnetic resonance imaging or mass spectroscopy (Schiller et al. 2012). 
To integrate our findings, we are building a computational model of 3D migration in a 
collaboration with Drs. Xiao Wang and Vivek Shenoy. This model determines the force 
required for the nucleus of a cell to navigate through a gap in the matrix, taking into 
account the nuclear stiffness and radius, as well as the matrix stiffness and gap width 
(Figure 8-5). Two distinct matrix regions were included in this preliminary model to mimic 
tissue degradation: a soft region at the gap (degraded matrix) and a stiff surrounding 
region (original matrix).  
 
 
Figure 8-5: Computational model for cell migration through dense connective tissues. (A) 
Schematic showing a nucleus above a narrow slot with an infinitely long distance (similar 
to the organized collagen fibers in the meniscus). The slot width is much smaller than the 
nuclear radius. The wall of the slot consists of a layer of digested ECM (red) that is softer 
than the undigested ECM outside. (B) Simulation of cell nucleus moving through a narrow 
and long slot in the ECM. Contour plots show the von-Mises stress at the initial, critical, and 
migrated phases. (C) The resistance force on the nucleus is plotted as a function of the 
vertical displacement of the nucleus. Model parameters are: shear modulus of the 
undigested ECM (Em=20 kPa), the digested ECM (Em=10 kPa), and the nucleus (En=20 kPa); 
nuclear radius (Rn = 10 µm); and width of the slot wall (L = 20 µm). Images and data courtesy 
of Drs. Xiao Wang and Vivek Shenoy. 
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Importantly, we simulated topographic anisotropy by constraining cell migration to a long 
and narrow ‘inter-fibrillar’ slot, thus obliging the cell to deform and elongate as it enters the 
matrix. In agreement with our observations, the model predicts that the force required for 
a cell to penetrate a long slot is significantly lower than for a round hole with the minimum 
diameter, and that the force is further reduced with matrix degradation. By modeling the 
various biophysical parameters that influence cell migration, we may be able to identify an 
optimal wound microenvironment for fibrous tissue repair. 
 
8.2.2 Multiple Biofactor Delivery In Vivo 
Electrospinning is a versatile platform that offers tunable control over the combinatorial 
delivery of therapeutics, including their dose, bioactivity (via emulsion and sonification 
techniques (Briggs et al. 2013)), temporal release profile (via material degradation and 
fiber modification (Ionescu et al. 2010, Liao et al. 2009, Purcell et al. 2014)), and spatial 
localization (via patterns or gradients within the scaffold (Hahn et al. 2006, 
Sundararaghavan et al. 2011, Wade et al. 2015a)). While scaffold-mediated collagenase 
delivery expedited meniscal repair in our proof-of-concept studies (Chapters 4, 5, and 7), 
there are limitations regarding its translation to the clinic. First, a burst release of a matrix-
degrading enzyme might damage surrounding tissues and cells during surgical 
implantation. To address this problem, release could be delayed by controlling the rate of 
scaffold hydration, such as increasing hydrophobicity via an external layer of PCL fibers 
(data not shown). Another option is to slow the rate of PEO fiber degradation by increasing 
the polymer chain entanglement with a higher molecular weight polymer, although this is 
less effective than the previous method (data not shown). 
Second, over-digestion of the tissue may occur, which could result in extensive weakening 
of the tissue’s bulk mechanical properties or might initiate a catabolic, inflammatory 
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response. Despite enhanced interfacial cellularity, enzyme-treated tissues are more likely 
to lose shape and structure over time due to internal cell-mediated contraction. While 
reducing the enzyme dose may prevent this, our data suggest that a certain level of 
digestion may be necessary to initiate cell mobility and matrix remodeling (Chapters 6 and 
7). To maximize cell migration while minimizing the amount of matrix degradation, a 
chemotactic factor (PDGF-AB) could be released into the wound site after collagenase. 
While PDGF-AB enhanced 3D cell migration in vitro, it did not significantly affect migration 
in vivo when delivered alone (compared to control scaffolds) or following collagenase 
(compared to collagenase-only scaffolds). However, only a single biofactor dose and 
delivery profile was investigated in this preliminary study. While these parameters were 
chosen based on scaling results from in vitro experiments, the bioactivity, release kinetics, 
and diffusivity in vivo may be significantly different, due to protein adsorption, pH, 
mechanical forces, tissue permeability, and biofactor inactivation/degradation. 
Furthermore, cell response to PDGF depends on a myriad of factors that were not 
considered in vitro, including cellular expression of ligand receptors, competing 
chemoattractants and/or cell signaling pathways, and growth factor-matrix binding 
(Vanden Berg-Foels 2013). Since PDGF-AB also has mitogenic and pro-matrix effects 
(Bhargava et al. 1999, Tumia et al. 2009), ancillary anabolic stimulation may have 
occurred from sustained delivery in vivo (unlike the transient exposure of in vitro migration 
studies). Indeed, PDGF-AB delivery alone increased cellularity immediate to the wound 
margin compared to control scaffolds, most likely by promoting cell proliferation. 
Interestingly, this did not translate to increased cell invasion of the scaffold, as most cells 
remained at the scaffold periphery. An effective chemotactic signal is difficult to establish 
because it is unclear on what time and length scale to institute the gradient. For example, 
delivering a high dose of PDGF-AB may stimulate migration at far distances, but 
oversaturate cell receptors close to the wound margin (Vorotnikov et al. 2014). Despite 
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these limitations, we demonstrated the capability to sequentially deliver bioactive factors 
from a composite scaffold, which can be easily modified to optimize PDGF-AB loading 
and release rate. Several in vitro studies may elucidate the bioactivity of PDGF-AB 
released over time, including 1) Transwell or ‘tissue Boyden’ migration assays, with the 
scaffold eluant in the bottom chamber, 2) BrdU proliferation assays to assess mitotic 
activity, and 3) long-term culture of cell pellets or cells on scaffolds to evaluate matrix 
deposition. To investigate the release profile in vivo, we may remove implanted scaffolds 
at set time intervals to determine the amount of remaining drug. If PDGF-AB proves 
ineffective in vivo, an alternative candidate is stromal-cell derived factor-1α (SDF-1α), a 
chemokine that recruits mesenchymal stem cells to sites of injury (Lau et al. 2011). 
In addition to the rapid and sustained release above, the third scaffold fiber fraction can 
likewise be functionalized to deliver other molecules, such as a pro-chondrogenic growth 
factor (TGF-β3 (Ionescu et al. 2012b)) to promote cell differentiation and matrix production 
in the weeks to months after the initial phase of proliferative repair (Kim et al. 2015, Park 
et al. 2010) (Figure 8-6). Additionally, to boost the maturation of de novo matrix, lysyl 
oxidase, an enzyme that catalyzes collagen crosslinking, could be introduced alongside 
TGF-β3 (Makris et al. 2014). Complementary delivery of anti-inflammatory agents (e.g., 
interleukin-1 receptor antagonist (McNulty et al. 2007)) and/or tissue inhibitors of 
metalloproteinases (TIMPs) (Eckhouse et al. 2014)) could reduce undesired catabolic 
degradation after the initial migratory process is completed. Strategies to achieve a 
delayed, sustained release include drug encapsulation within hollow fibers or 
microparticles (Ionescu et al. 2010, Liao et al. 2009), addition of surface affinity-binding 
motifs (Purcell et al. 2014), or covalent immobilization to the scaffold (Choi et al. 2008). It 
is paramount that the dosage, spatial distribution, and temporal sequence of multifactor 
delivery systems be confirmed in an appropriate in vivo setting. For example, interfacial 
matrix accumulation early in the proliferative phase may contribute to fibrous capsule 
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formation and restrict scaffold colonization. Inhibiting macrophage function during the 
inflammatory phase may also hinder tissue regeneration (Godwin et al. 2013).  
 
 
Figure 8-6: Biomaterial design strategy for a third-generation electrospun scaffold to 
enhance meniscal repair. (A) Schematic of tri-component electrospinning with three 
discrete bioactive fiber populations. (B) Schematic illustrating fiber cross-sections with or 
without drug loading for PEO, HA, and PCL fibers delivering collagenase, PDGF, and TGF-
β3, respectively. While short- to medium-term release may be accomplished by 
homogeneous blending within the material, long-term delivery may require entrapment 
within a slow-degrading polymer shell. (C) Schematic showing the proposed biological role 
of each biofactor and their time course of delivery. 
 
Besides delivering soluble factors, the scaffold may provide instruction via mechanical 
cues (fiber stiffness, density, and organization) and insoluble signals (e.g., adhesion 
ligands). While these parameters were not extensively probed in this work, our in vitro 
findings reflect the general consensus in the literature that 1) a dense scaffold with small 
pores inhibits cellular ingress and 2) incorporation of RGD facilitates adhesion. While the 
tri-component scaffolds that were compared, PCL/PEO/PEO and PCL/PEO/HA, contain 
different polymer constituents and were randomly aligned (resulting in lower fiber packing 
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than the aligned scaffolds used in vivo), it was clear that cellular ingress was inhibited by 
the physical addition of a HA component in vitro. Cell infiltration into scaffolds after variable 
periods of hydration may shed light on how scaffold density changes with HA mass loss 
to affect migration. Enzymatic removal of HA via hyaluronidase digestion would also 
provide a means to control scaffold density. Incorporating protease-sensitive crosslinkers 
to HA macromers (Wade et al. 2015b) may increase the rate of cell infiltration by permitting 
cell-mediated widening of small pores and formation of migratory tracks through which 
other cells can follow, although this formulation will need to account for the initial burst of 
collagenase. Lastly, while it is difficult to increase the ‘sacrificial’ PEO content via our 
current tri-component electrospinning system, it is certainly feasible to introduce another 
fast-degrading component by increasing number of discrete electrospinning jets. 
The contribution of RGD to fibrous scaffold invasion is more difficult to interpret in vivo 
(Bellis 2011). Although RGD proved necessary for cell adhesion to HA-only scaffolds in 
vitro, the addition of a PCL fiber fraction rescued cell attachment and spreading (data not 
shown), likely due to adsorption of integrin-binding proteins from serum-containing media, 
such as fibronectin and vitronectin, onto this fiber fraction. As such, adsorption of serum 
or blood proteins in vivo will alter the effects of synthetic RGD. Indeed, a pilot 
subcutaneous study found that native cells were able to invade PCL/PEO/HA scaffolds 
without RGD (data not shown). In fact, the competition between synthetic RGD and native 
proteins for binding to integrin receptors may even attenuate the level of integrin signaling, 
especially at high RGD concentrations (Sawyer et al. 2005). Taken together, future work 
should look to optimize biomaterial-mediated delivery of instructive soluble signals while 
simultaneously providing a microenvironment that facilitates cell infiltration and matrix 
organization, all in the context of an in vivo setting. These experiments will be performed 
in collaboration with Dr. Jason Burdick and the members of his laboratory (the PDGF-
delivering fibers described in Chapter 7 were developed by Dr. Julianne Holloway). 
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8.2.3 Translational Animal Models 
While in vitro studies are suitable for probing basic mechanisms, they lack the biological 
complexity of in vivo environments, in which the biochemical milieu, mechanical forces, 
and cell-cell and cell-matrix interactions act in concert to affect outcomes. To move our 
work towards in vivo translation, we first utilized a small animal subcutaneous model 
(Chapters 5 and 7), where adult bovine meniscal repair constructs are implanted in the 
dorsum of athymic rats. This allowed us to evaluate the biocompatibility and bioactivity of 
our scaffold formulations in a physiologic setting that included vasculature, exogenous 
cells (fibroblasts), and an innate immune response (athymic rats lack a humoral immune 
response). While using this system allowed us to discern differences in cellularity and 
tissue integration between experimental groups, there are drawbacks to this approach. 
First, we could not mechanically evaluate the wound interface, as it was too weak to test 
after removing the surrounding fibrous capsule. This could be accomplished in future 
studies by AFM nanoindentation of tissue cryosections, which may detect 
micromechanical changes at the wound interface. Second, rat fibroblasts from the host 
appeared to infiltrate the explants at longer time points. However, increased 
immunohistochemical staining for type II collagen at the interface suggests that native 
meniscal cells synthesized the matrix. To definitively differentiate between rat and bovine 
cells, we may need to utilize fluorescence in situ hybridization (FISH) to identify species-
specific DNA. Third, it has been reported that a delayed xenograft rejection may occur, 
even in nude rats (Candinas et al. 1996). It may therefore be useful to assess immune cell 
infiltration by immunohistochemical staining for CD45, a pan leukocyte marker, as well as 
specific markers for neutrophils and macrophages (Hoemann et al. 2010). Early results 
indicate that the majority of cells within the tissue were not CD45+ at the 4 week time 
point. Lastly, the subcutaneous space is not reflective of the synovial knee joint, which is 
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characterized by viscous synovial fluid, a lack of vasculature and lymphatics, and dynamic 
loading of the connective tissues within. Nonetheless, these subcutaneous experiments 
provided essential data on the feasibility and efficacy of this technology before 
implementation in an orthotopic large animal model. 
After the scaffold was optimized in the small animal model, we assessed its potential to 
heal a bucket handle tear in an ovine injury model (Chapter 5). The 4 week pilot study 
revealed that collagenase-releasing scaffolds may enhance tissue integration without 
adversely affecting the surrounding cartilage, although the sample sizes were too small to 
make statistical comparisons (n=2–3/group). The large animal study had its own set of 
limitations. First, the sterilization method required for in vivo implantation may compromise 
scaffold bioactivity, and should be considered early in device development. Using the 
cartilage-based incubation assay documented in Chapter 4, we confirmed that gamma 
irradiation preserved collagenase activity, whereas ethylene oxide did not. Second, 
visualizing the medial meniscus, creating a standard-sized defect, and inserting the 
scaffold proved to be extremely challenging from a surgical perspective. For the purposes 
of clinical translation, a customized arthroscopic tool should be developed to facilitate 
implantation, similar to those that insert ultra-thin cells sheets under the retina (Nazari et 
al. 2015). Third, the initial bucket handle defect that we created had a tendency to 
propagate over time, resulting in secondary radial tears by 12 weeks in specimens across 
all experimental groups (data not shown). It is possible that long-term unrestricted pasture 
exercise contributed to this deterioration. Unfortunately, as a consequence, it was difficult 
to locate the scaffolds at this later time point, as many had extruded from the defect and 
became embedded in the synovium. In future studies, a controlled rehabilitation regimen 
should be employed, with radiopaque scaffolds to longitudinally track scaffold position 
(Martin et al. 2015). Finally, functional outcomes at either the tissue-level (mechanical 
properties of the meniscal wound interface and underlying cartilage) or organism-level 
 181 
 
(joint range of motion, gait, and activity level) were not assessed due to the pilot nature of 
this work. For example, microindentation testing of both cartilage and repaired meniscus 
may be a viable method to evaluate the mechanical integrity of tissues prior to processing 
for histology (Kim et al. 2015). Ongoing efforts to quantify animal activity and joint function 
are described in the following section. 
  
8.2.4 Method to Assess Joint Kinematics in Humans and Large Animals 
8.2.4.1 Introduction 
Functional outcomes such as joint kinematics and gait are important indicators of efficacy 
in musculoskeletal research (Keegan 2007). Traditional technologies that objectively 
assess these parameters, such as visual tracking systems and/or force plates (Barrey 
1999, Clayton et al. 2001, Zumwalt et al. 2006), are challenging to deploy in long-term 
translational and clinical studies. To address this limitation in our large animal work, we 
developed a low-cost, multi-sensor device that detects animal activity and joint angle, and 
hypothesized that it could quantify post-operative functional recovery. To date, we have 
used the device to establish longitudinal changes in animal activity after a bilateral 
arthrotomy, and have demonstrated the feasibility of measuring joint kinematics in both 
large animals and humans using a magnet-based detection system. 
 
8.2.4.2 Methods 
The device consists of a plastic enclosure containing a 3.7 V polymer lithium ion battery, 
microcontroller board (Arduino Fio), radio board (XBee), sensor board (9 Degrees of 
Freedom Sensor Stick), and data logger (OpenLog). The sensor board integrates a triple-
axis accelerometer, triple-axis gyroscope, and triple-axis magnetometer (Godwin et al. 
2009) and was calibrated prior to use via a custom software tool. A computer with a radio 
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peripheral receives transmitted data to plot it in real time. To measure changes in joint 
angle, the device and a neodymium magnet (1" diameter, 1/4" thick) were affixed 4" distal 
and 4" proximal to a human knee joint on the posterior surface, respectively. The knee 
was moved to flexion angles of 0º, 30º, 60º, and 70º. Position was held for 5 s at each 
angle (n=3-4/group) and the magnetic field strength was recorded at 40 Hz. An equation 
relating sensor-magnet angle as a function of magnetic field magnitude was derived to 
predict flexion angle. To validate that the device could capture dynamic range of motion 
of the knee during normal gait, a human subject (n=1) walked at a step frequency of ~1 
Hz, and the magnetic field strength and angular velocity were recorded. Individual steps 
(n=10) were used to obtain the range of motion (ROM) during the gait cycle.  
To evaluate general activity in a large animal, the device was attached to a harness worn 
by a castrated male Yucatan minipig pre- and post-surgery (n=1, 26 kg pre-op) in an 
unrelated study involving bilateral arthrotomy of the stifle (Fisher et al. 2014), with 
analgesics given for the first 5 days after surgery. Data was collected at 8 Hz for 30 min 
of unsupervised activity in a 4' x 6' pen pre-operatively on Day -1 (Baseline) and post-
operatively on Day 1 and weekly thereafter until euthanasia at Week 12. Angular velocity 
(º/s) parallel to the dorsal plane (animal turning left or right) was recorded and the absolute 
values binned into four activity intensity levels: 0–5 (Rest), 5–50 (Low), 50–100 
(Moderate), and >100 (High). On Week 11, the sensor and magnet were laterally attached 
to the left hindlimb 4" proximal and 5" distal to the stifle joint, respectively. The stifle was 
manually flexed to angles of 20º (maximum extension), 30º, 60º, and 90º. Position was 
held for 5 s at each angle (n=3–4/group) and the magnetic field strength was recorded at 
8 Hz. The animal was allowed to freely ambulate within the pen and the magnetic field 
strength was recorded. Individual steps (n=10) were used to obtain the ROM and were 
visually confirmed with synchronized high-speed video. Significance was assessed by 
one-way ANOVA with Tukey’s post-hoc tests to compare magnetic field strength between 
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groups (p≤0.05). Data are presented as the mean ± standard deviation unless specified 
otherwise. 
 
8.2.4.3 Results 
A wearable device capable of sensing motion and quantifying joint kinematics was 
fabricated with off-the-shelf electronics for <$200. Knee flexion angle was predicted via 
changes in the magnetic field strength, which increased exponentially with flexion (Figure 
8-7B, p≤0.05). Using this method, we measured the range of motion (ROM) of a human 
knee during a normal gait cycle. Flexion angle and angular velocity of the tibia appeared 
as repetitive and predictable patterns during ambulation (Figure 8-7C and Figure 8-7D). 
The average ROM of the human knee during the gait cycle was 54±4º, with a peak flexion 
angle of 55±3º. 
 
 
Figure 8-7. Magnet-based system for quantifying joint kinematics. (A) Experimental 
schematic. (B) Magnetic field strength as a function of flexion angle (n=3–4/group, mean ± 
standard deviation). * = p≤0.05 vs. all other angles. (C) Average flexion angle and (D) angular 
velocity for a human knee during a gait cycle (n=10 steps, mean ± standard error of the 
mean). 
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Next, the device was used to monitor unsupervised large animal activity pre- and post-
surgery, and to quantify stifle joint kinematics. The device was worn by a Yucatan minipig 
and angular velocity in the dorsal plane was recorded over 12 weeks (Figure 8-8). On 
Day -1 (Baseline), the animal had full ROM and activity was characterized by Rest and 
Low intensity activity, with short periods of Moderate and High intensity activity (Figure 
8-8A). Immediately post-operative on Day 1, the animal was predominately sedentary and 
ambulated with a stiff, limping gait. The animal regained 50% of its pre-operative Non-
Rest activity level by Week 1, and was fully recovered by Week 3. Non-Rest activity levels 
were maintained until Week 10, when it slightly declined (Figure 8-8B). The average 
ROM of the porcine stifle during the gait cycle was 55±13º at Week 11, with a peak flexion 
angle of 101±4º (Figure 8-9). 
 
 
Figure 8-8: Unsupervised activity monitoring demonstrates time course of recovery in a 
porcine model. (A) Distribution of activity intensity pre- and post-surgery. (B) Non-Rest 
Activity normalized to the pre-operative Baseline value (red dashed line) and animal weight 
over 12 weeks.  
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Figure 8-9: Dynamic range of motion during unprovoked ambulation. (A) Image of animal 
wearing the device. (B) Sensor and magnet positions during gait cycle. (C) Magnetic field as 
a function of flexion angle (n=3–4/group, mean ± standard deviation). * = p≤0.05 vs. all other 
angles. (D) Average flexion angle during a gait cycle at Week 11 (n=10 steps, mean ± 
standard error of the mean). Red line indicates neutral stance. 
 
8.2.4.4 Discussion 
Objective quantification of joint function is crucial for evaluating experimental treatments 
in translational models. Wearable motion sensors have the potential to provide objective, 
individualized data on physical activity and locomotion for animal models. However, basic 
accelerometer-based monitors cannot assess the type or quality of movement (Brown et 
al. 2010), whereas more complicated analytical systems are costly and often require the 
use of multiple sensor components in a supervised environment (Keegan et al. 2012, 
Roepstorff et al. 2013). To that end, we developed a low-cost device using a single 
integrated sensor that quantifies both joint kinematics and activity. When worn by the 
research subject, the device wirelessly transmits data on acceleration, angular velocity, 
and magnetic field in 3D space, allowing for remote, real time visualization and analysis 
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of unprovoked and unsupervised movement. Using this system, we tracked the time 
course of recovery of a pig after arthrotomy and found that return to baseline activity 
occurred 3 weeks after surgery. Monitoring also revealed a slight decline in activity in the 
long term, which may indicate behavioral changes due to increasing weight or age. By 
placing a magnet opposite the articulating joint, we identified discrete steps and calculated 
the dynamic ROM during unprovoked ambulation in both the human knee and the porcine 
stifle. Importantly, the measured ROM for the porcine stifle was consistent with previously 
reported values for healthy swine (Stavrakakis et al. 2014), indicating functional joint 
recovery by 3 months. This method allows for species-independent, individualized 
assessment of joint kinematics using a single sensor. While magnetometers have 
previously been used for this purpose, the Earth’s magnetic field was utilized as a 
reference, limiting the system to quasi-static measurements (Bonnet et al. 2007, 
O’Donovan et al. 2007). Experiments to validate our method as well as algorithms to 
distinguish standard gait parameters, such as cadence and swing/stance phase ratio, are 
ongoing. Simple and inexpensive, this magnet-based system will facilitate the longitudinal 
assessment of joint abnormalities and functional recovery for animal and human subjects 
in orthopaedic research. 
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8.3 Conclusion 
Orthopaedic injuries are prevalent and poor intrinsic healing of fibrous connective tissues, 
especially in avascular regions, can lead to altered joint biomechanics, inflammation, and 
early degenerative osteoarthritis. The ability of tissues to self-repair depends on the 
availability of reparative cells at the injury site, but steric impediments posed by the dense 
and stiff extracellular matrix of adult dense connective tissues hinder interstitial migration 
of native cells to the wound margin. Targeted reprogramming of the wound interface 
through biomaterial-mediated delivery of a matrix-degrading enzyme can remove the 
natural biophysical barriers to cell migration, generating a microenvironment that favors 
endogenous cell-mediated healing. Likewise, additional functionalization of the delivery 
system to promote and enhance cell migration speed, or to reduce intrinsic barriers to 
migration (such as nuclear stiffness) may likewise improve repair outcomes. Taken 
together, these findings will define a new paradigm for fibrous tissue repair and 
regeneration. 
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